Product Name | CAS | MF | MW | Synonyms |
---|---|---|---|---|
Hancokinol | 132294-77-0 | C30H50O | 426.729 | |
Hancinone C | 111843-10-8 | C23H28O6 | 400.5 | 4,5-dimethoxy-2-prop-2-enyl-4-[(E)-1-(3,4,5-trimethoxyphenyl)prop-1-en-2-yl]cyclohexa-2,5-dien-1-one |
Hamycin | 1403-71-0 | 0 | Hamycin | |
HAMNO | 138736-73-9 | C17H13NO2 | 263.29 | NSC-111847; 1-(2-Hydroxyphenyliminomethyl)-2-naphthol; 2(1H)-Naphthalenone, 1-[[(2-hydroxyphenyl)amino]methylene]- |
HAMI3379 | 712313-35-4 | C34H45NO8 | 595.73 | CHEMBL3342944;GTPL6197; SCHEMBL4518791; DTXSID80439859;3-[(3-carboxycyclohexyl)carbamoyl]-4-[3-[4-(4-cyclohexyloxybutoxy)phenyl]propoxy]benzoic acid |
Hamburger Pentapeptide | 62087-72-3 | C22H36N8O11 | 588.57 | Hamburger Pentapeptide; Asp-ser-asp-pro-arg |
Hamaudol | 735-46-6 | C15H16O5 | 276.3 | (3S)-3,5-dihydroxy-2,2,8-trimethyl-3,4-dihydropyrano[3,2-g]chromen-6-one |
Hamamelitannin | 469-32-9 | C20H20O14 | 484.37 | hamamelitanin; Hamamelofuranose 2,5-digallate |
Halquinol | 8067-69-4 | C18H11Cl3N2O2 | 393.66 | 5,7-Dichloro-8-quinolinol mixed with 5-Chloro-8-quinolinol; Quinolor; Tarquinor; Chlorquinol |
Haloxyfop-P | 95977-29-0 | C15H11ClF3NO4 | 361.70 | (R)-2-[4-[[3-Chloro-5-(trifluoromethyl)-2-pyridinyl]oxy]phenoxy]propanoic acid; Haloxyfop-P; Haloxyfop-p [iso] |
Haloxon | 321-55-1 | C14H14Cl3O6P | 415.59 | Haloxon |
HALOWAX 1000 | 58718-66-4 | 0 | HALOWAX 1000 (100UG/ML IN METHANOL) | |
Glutinone | 508-09-8 | C30H48O | 424.7 | 5-Glutinen-3-one |
Glutinol acetate | 6426-44-4 | C32H52O2 | 468.75 | Glutin-5-en-3beta-O-acetate |
Glucosamine Sulfate Sodium Chloride | 38899-05-7 | C6H12NNaO8S | 281.22 | D-Glucosamine 2-sulfate sodium salt; 2-Deoxy-2-sulfamino-D-glucopyranose; GlcN-2S |
Gliclazide-D4 | 1185039-30-8 | C15H17D4N3O3S | 327.44 | N-[[(Hexahydrocylopenta[c]pyrrol-2(1H)-yl]amino]carbonyl]-4-methyl-(benzene-d4)sulfonamide; Diamicron-d4; Glimicron-d4; Nordialex-d4; S-1702-d4; |
Gliclazide Impurity D | 1136426-19-1 | C15H20N2O3S | 308.40 | |
Gliclazide Impurity C | 5577-13-9 | C10H13NO4S | 243.28 | |
Gliclazide Impurity B | 54786-86-6 | C7H12N2O | 140.19 | 2-Nitroso-octahydrocyclopenta[c]pyrrole; Octahydro-2-nitrosocyclopenta[c]pyrrole; N-Nitroso-3-azabicyclo[3.3.0]octane; 3-Nitroso-3-azabicyclo[3.3.0]octane |
Germanium dioxide | 1310-53-8 | GeO2 | 104.64 | GeO2; Germania; Germanic acid; Germanic oxide (crystalline); germanicacid; germanicoxide(crystalline) |
GERMANIUM DIBROMIDE | 24415-00-7 | GeBr2 | 232.4 | Germanium(II)bromide; GeBr2; dibromogermanium; GERMANIUMDIBROMIDE; AC1O3FC4; 572659_ALDRICH |
Germanium (IV) selenide | 12065-11-1 | GeSe2 | 230.51 | Germanium (IV) selenide; Germanium selenide |
Germanicol acetate | 10483-91-7 | C32H52O2 | 470.782 | Olean-18-en-3-ol, acetate, (3beta)- |
Germanicol | 465-02-1 | C30H50O | 426.729 | (3beta)-olean-18-en-3-ol; Olean-18-en-3beta-ol |
Germane,(4-chlorophenyl)trimethyl- | 56866-67-2 | C9H13 Cl Ge | 229.2925 | Germane,(4-chlorophenyl)trimethyl-; 56866-67-2; AC1L3N5I; (4-chlorophenyl)-trimethylgermane; Germane,(4-chlorophenyl)trimethyl-; OR055865 |
Germacrone 4,5-epoxide | 92691-35-5 | C15H22O2 | 234.334 | (1S,6E,10S)-6,10-Dimethyl-3-(1-methylethylidene)-11-oxabicyclo[8.1.0]undec-6-en-4-one;(4S,5S)-(+)-Germacrone 4,5-epoxide |
Germacrone | 6902-91-6 | C15H22O | 218.33 | |
Germacr-1(10)-ene-5,8-dione | 13657-68-6 | C15H24O2 | 236.34 | Curdione;(3S,6E,10S)-6,10-Dimethyl-3-propan-2-ylcyclodec-6-ene-1,4-dione;Germacr-1(10)-ene-5,8-dione;6,10-Dimethyl-3-isopropyl-6-cyclodecene-1,4-dione;AaruginousTurmericRhizome;Curcuma Tuber Extract;Zedoary turmeric extract |
Germaben II | 84517-95-3 | C29H42O15N4 | 686.68 | |
Ethyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-thioglucopyranoside | 4239-72-9 | C16H25NO8S | 391.44 | |
Ethyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranoside | 76155-50-5 | C16H25NO9 | 375.37 | |
ethyl 2-(ethylamino)benzoate | 38446-21-8 | C11H15NO2 | 193.242 g/mol | ethyl2-(ethylamino)benzoate; Ethyl2-(ethylamino)benzoate; EthylN-ethylanthranilate; 38446-21-8; Diethylanthranilate; UNII-DY1X596TSE |
Gap 19 | 1507930-57-5 | C55H96N14O13 | 1161.45 | |
GANT-61 | 500579-04-4 | C27H35N5 | 429.612 | GANT 61; 2-[[3-[[2-(dimethylamino)phenyl]methyl]-2-pyridin-4-yl-1,3-diazinan-1-yl]methyl]-N,N-dimethylaniline |
GANT58 | 64048-12-0 | C24H16N4S | 392.48 | GANT58; 2,3,4,5-tetra(4-pyridyl)thiophene; 4-(2,4,5-tripyridin-4-ylthiophen-3-yl)pyridine |
Ganstigmine hydrochloride | 412044-92-9 | C21H26ClN3O3 | 403.9 | Carbamic acid, (2-ethylphenyl)-, (1R,3aS,8aS)-1,2,3,3a,8,8a-hexahydro-1,3a-dimethyl-1-oxidopyrrolo(2,3-b)indol-5-yl ester, monohydrochloride; [(3R,3aS,8bS)-3,8b-dimethyl-3-oxido-1,2,3a,4-tetrahydropyrrolo[2,3-b]indol-3-ium-7-yl] N-(2-ethylphenyl)carbamat |
Ganomycin I | 1191255-15-8 | C21H26O4 | 342.4 | 2-(2,5-dihydroxyphenyl)-4-[(3E)-4,8-dimethylnona-3,7-dienyl]-2H-furan-5-one |
Ganolactone B | 1028449-53-7 | C27H38O6 | 458.59 | 3beta,7beta-Dihydroxy-11,15-dioxolanost-8-en-24->20 lactone |
Halothane | 151-67-7 | C2HBrClF3 | 197.38 | 2-bromo-2-chloro-1,1,1-trifluoroethane 1,1,1-Trifluoro-2-Chloro-2-Bromoethane Fluothane Ftorotan Halothane Narcotan |
Halopyramine | 59-32-5 | C16H20ClN3 | 289.81 | Chloropyramine;1,2-Ethanediamine, N-[(4-chlorophenyl)methyl]-N',N'-dimethyl-N-2-pyridinyl-;2-((p-Chlorobenzyl)(2-(dimethylamino)ethyl)amino)pyridine;Allergan;Anaphylline;Avapena;Suprastin;Synopen;N'-[(4-chlorophenyl)methyl]-N,N-dimethyl-N'-pyridin-2-yleth |
Haloperidol-1-hydroxy-2-b-D-glucuronide | 100442-86-2 | C27H33ClFNO9 | 570.00 | |
Haloperidol N-Oxide | 148406-51-3 | C21H23ClFNO3 | 391.87 | 4-[4-(4-Chlorophenyl)-4-hydroxy-1-oxido-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone; 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone N-Oxide; cis/trans-Haloperidol N-Oxide [Mech. mix. of H103720/H103725] |
Haloperidol Impurity F | 1391052-67-7 | C27H27ClFNO2 | 451.97 | |
Haloperidol Impurity C | 1391052-87-1 | C23H27ClFNO2 | 403.93 | 3-Ethyl Haloperidol; 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(3-ethyl-4-fluorophenyl)-1-butanone |
Haloperidol Impurity B | 1391052-53-1 | C21H23ClFNO2 | 375.87 | 4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(2-fluorophenyl)butan-1-one; 4-Defluoro-2-fluoro Haloperidol |
Haloperidol hydrochloride | 1511-16-6 | C21H24Cl2FNO2 | 412.33 | 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one;hydrochloride haloperidol hydrochloride UNII-UM06W2ADRY UM06W2ADRY Haloperidol (hydrochloride) CHEMBL545608 1511-16-6 |
Haloperidol Decanoate | 74050-97-8 | C31H41ClFNO3 | 530.13 | Decanoic acid 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidinyl ester; 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidyl decanoate; Halomonth; KD-136; R-13672; Depot haloperidol; Einecs 277-679-7; Haldol Decanoate; Neoperid |
Haloperidol d4 N-Oxide | 1246815-56-4 | C21H19D4ClFNO3 | 395.89 | 4-[4-(4-Chlorophenyl-d4)-4-hydroxy-1-oxido-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone; 4-[4-(4-Chlorophenyl-d4)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone N-Oxide |
Haloperidol D4 | 136765-35-0 | C21H19ClD4FNO2 | 379.89 | HALOPERIDOL-D4;4-[4-(4-Chlorophenyl-d4)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone;Aloperidin-d4;Bioperidolo-d4;Brotopon-d4;Dozic-d4;Einalon S-d;R-1625-d4 |
Haloperidol D4 | 1189986-59-1 | C21H19D4ClFNO2 | 379.89 | 4-[4-(4-Chlorophenyl-d4)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone; R-1625-d4; Aloperidin-d4; Bioperidolo-d4; Brotopon-d4; Dozic-d4; Einalon S-d4 |
Haloperidol | 52-86-8 | C21H23ClFNO2 | 375.86 | R-1625; R 1625; R1625; HSDB-3093; HSDB3093; HSDB 3093; Haloperidol; Haldol; Eukystol; Serenace; Aloperidin; Aloperidol; |
Halopemide | 59831-65-1 | C21H22ClFN4O2 | 416.9 | NSC 354856; R34301; N-[2-[4-(5-chloro-2-oxo-3H-benzimidazol-1-yl)piperidin-1-yl]ethyl]-4-fluorobenzamide |
Halofuginone lactate | 82186-71-8 | C19H23BrClN3O6 | 504.76 | |
Halofuginone Hydrochloride | 1217623-74-9 | C16H18BrCl2N3O3 | 451.15 | rel-7-Bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-4(3H)-quinazolinone Hydrochloride; 7-Bromo-6-chlorofebrifugine Hydrochloride; HAL |
Halofuginone hydrobromide | 64924-67-0 | DL-trans-7-Bromo-6- chloro-3-[3-(3-hydroxy- piperidin-2-yl)-2-oxo- propyl]-3H-quinazolin-4- one hydrobromide | ||
Halofuginone | 55837-20-2 | C16H17BrClN3O3 | 414.684 | Halofuginone; Tempostatin; RU 19110; RU19110; RU-19110 |
Halofantrine Hydrochloride | 36167-63-2 | C26H31Cl3F3NO | 536.88 | 3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol;hydrochloride; |
H-Ala-Pro-OMe . HCl | 71067-42-0 | C9H16N2O3 . HCl | 236.7 | H-ALA-PRO-OME HCL |
H-Ala-OH | 56-41-7 | C3H7NO2 | ||
H-Ala-Ala-Pro-OH | 61430-04-4 | C11H19N3O4 | 257.29 | H-ALA-ALA-PRO-OH; L-ALA-ALA-L-PRO |
Hainanmurpanin | 95360-22-8 | C17H18O6 | 318.3 | |
H-Aib-OH | 62-57-5 | H-Aib-OH | ||
Haginin A | 74174-29-1 | C17H16O5 | 300.31 | 3-(4-hydroxy-2,3-dimethoxyphenyl)-2H-chromen-7-ol |
Hafnium,dimethylbis[(1,2,3,4,5-h)-1-propyl-2,4-cyclopentadien-1-yl]- | 255885-01-9 | C18H28 Hf | 422.9 | BIS(N-PROPYLCYCLOPENTADIENYL)HAFNIUM DIMETHYL |
Hafnium chloride(HfCl4), (T-4)- | 13499-05-3 | Cl4Hf | 320.302 | HAFNIUM(IV) CHLORIDE; HAFNIUM CHLORIDE; HAFNIUM TETRACHLORIDE; (beta-4)-hafniumchloride(hfcl4; Hafnium chloride (HfCl4), (T-4)-; HfCl4; HAFNIUM CHLORIDE, SUBLIMED, 99.9%; HAFNIUM (IV) CHLORIDE ANHYDROUS 98+% (1-3% ZR) |
HA-155 | 1229652-22-5 | C24H19BFNO5S | 463.3 | HA 155; HA155; Autotaxin Inhibitor IV |
Ha-15 | 1609402-14-3 | C23H22N4O3S2 | 466.574 | HA15; HA 15; N-(4-(3-((5-(dimethylamino)naphthalene)-1-sulfonamido)phenyl)thiazol-2-yl)acetamide |
HA14-1 | 65673-63-4 | C17H17BrN2O5 | 409.23 | |
HA-130 | 1229652-21-4 | C24H19BFNO5S | 463.29 | SCHEMBL1555945; 1229652-21-4; HA 130 |
HA-1077 dihydrochloride | 203911-27-7 | C14H17N3O2S·2HCl | 364.3 | Fasudil dihydrochloride; 5-((1,4-Diazepan-1-yl)sulfonyl)isoquinoline dihydrochloride |
HA-1004 dihydrochloride | 92564-08-4 | C12H15N5O2S·2HCl | 366.3 | |
HA-100 Dihydrochloride | 210297-47-5 | C13H15N3O2S·2HCl | 350.3 | 5-(Piperazine-1-sulfonyl)isoquinoline dihydrochloride |
H-9 dihydrochloride | 116700-36-8 | C11H13N3O2S.2HCl | 324.22 | N-(2-Aminoethyl)-5-isoquinolinesulfonamide dihydrochloride |
H-8 dihydrochloride | 113276-94-1 | C12H15N3O2S·2HCl | 338.3 | N-[2-(Methylamino)ethyl]-5-isoquinolinesulfonamide dihydrochloride |
H-7 dihydrochloride | 108930-17-2 | C14H17N3O2S.2HCl | 364.29 | (±)-1-(5-Isoquinolinesulphonyl)-2-methylpiperazine dihydrochloride |
H3B-6527 | 1702259-66-2 | C29H34Cl2N8O4 | 629.543 | N-{2-[(6-{[(2,6-Dichloro-3,5-dimethoxyphenyl)carbamoyl](methyl)amino}-4-pyrimidinyl)amino]-5-(4-ethyl-1-piperazinyl)phenyl}acrylamide; H3B-6527; H3B 6527; H3B6527 |
H2L5186303 | 139262-76-3 | C26H20N2O8 | 488.45 | (Z,Z)-4,4'-[1,3-Phenylenebis(oxy-4,1-phenyleneimino)]bis[4-oxo-2-butenoic acid |
H2L 5765834 | 420841-84-5 | C21H12N2O7 | 404.33 | 2,3-Dihydro-2-[3-(4-nitrophenoxy)phenyl]-1,3-dioxo-1H-isoindole-5-carboxylic acid; 2-[3-(4-nitrophenoxy)phenyl]-1,3-dioxoisoindole-5-carboxylic acid |
H-1152 Dihydrochloride | 871543-07-6 | C16H23Cl2N3O2S | 392.34 | (S)-(+)-2-Methyl-1-[(4-methyl-5-isoquinolynyl)sulfonyl]homopiperazine Dihydrochloride;5-[[(2S)-Hexahydro-2-Methyl-1H-1,4-diazepin-1-yl]sulfonyl]-4-Methylisoquinoline dihydrochloride;4-methyl-5-[[(2S)-2-methyl-1,4-diazepan-1-yl]sulfonyl]isoquinoline dihydr |
H10 | 2084811-68-5 | C24H27N7O7S | 557.58 | 3-(N-(2-(4-(2-(4-((3-Carbamoylphenyl)amino)-4-oxobutanamido)ethyl)-1H-1,2,3-triazol-1-yl)ethyl)sulfamoyl)benzoic acid |
H 89 2HCl | 130964-39-5 | C20H20BrN3O2S·2HCl | 519.28 | N-[2-[[3-(4-Bromophenyl)-2-propenyl]amino]ethyl]-5-isoquinolinesulfonamide dihydrochloride |
H 89 | 127243-85-0 | C20H20BrN3O2S | 446.36 | Protein kinase inhibitor H-89; H89; H 89 |
H 151 | 941987-60-6 | C17H17N3O | 279.34 | N-(4-Ethylphenyl)-N'-1H-indol-3-yl-urea |
GZD824 Dimesylate | 1421783-64-3 | C29H27F3N6O.2CH4O3S | 724.77 | |
GZD824 | 1257628-77-5 | C29H27F3N6O | 532.56 | GZD-824; GZD 824 |
GYY-4137 Morpholine salt | 106740-09-4 | C15H25N2O3PS2 | 376.47 | GYY4137; GYY-4137; GYY 4137; GYY 4137 morpholine salt; ZYJ1122; ZYJ 1122; ZYJ-1122. GYY4137 Morpholine salt;(4-Methoxyphenyl)morpholino-phosphinodithioic acid compound with morpholine;ZYJ1122 morpholine salt;ZYJ-1122 morpholine salt |
Gyrophoric acid | 548-89-0 | C24H20O10 | 468.4 | triorsellinic acid; 4-[4-(2,4-dihydroxy-6-methylbenzoyl)oxy-2-hydroxy-6-methylbenzoyl]oxy-2-hydroxy-6-methylbenzoic acid |
Gypsogenin | 639-14-5 | C30H46O4 | 470.68 | Albsapogenin; Githagenin; Gypsophilasaponin; Astrantiagenin D |
Gypenoside XVII | 80321-69-3 | C48H82O18 | 947.15 | Gynosaponin S |
Gypenoside XLVI | 94705-70-1 | C48H82O19 | 963.15 | |
Gypenoside XLIX | 94987-08-3 | C52H86O21 | 1047.23 | Gypenoside XLIX; (3beta)-3-[(O-6-Deoxy-alpha-L-mannopyranosyl-(1-2)-O-[beta-D-xylopyranosyl-(1-3)]-alpha-L-arabinopyranosyl)oxy]-21-(beta-D-glucopyranosyloxy)-20-hydroxy-dammar-24-en-19-al |
Gypenoside XIII | 80325-22-0 | C41H70O12 | 755 | Ginsenoside Mx; Gynosaponin M |
Gypenoside LI | 94987-10-7 | C42H72O14 | 801.01 | |
Gypenoside L | 94987-09-4 | C42H72O14 | 801.01 | |
Gypenoside I | 85889-20-9 | C46H78O18 | 919.1 | |
Gypenoside A | 157752-01-7 | C46H74O17 | 899.07 | |
Gynosaponin I | 1207861-69-5 | C42H72O12 | 769 | (3beta,12beta,20S)-Trihydroxydammar-24-ene 20-O-[alpha-rhamnopyranosyl-(1-2)]-beta-glucopyranoside |
Gymnoside III | 899430-03-6 | C42H58O23 | 930.90 | |
Gymnestrogenin | 19942-02-0 | C30H50O5 | 490.725 | (3S,4aS,5S,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-4a,9-bis(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-3,5,10-triol |
gymnemic acid | 1399-64-0 | |||
Gymnemagenin | 22467-07-8 | C30H50O6 | 506.71 | |
Gymnema sylvestre extract | 90045-47-9 | GYMNEMA SYLVESTRE EXTRACT; Gymnema silvestre, ext.; GYMNEMASYLEVESTREEXTRACT; Gymnema Sylvestre(75%gymnemic acid) | ||
GYKI-52466 | 102771-26-6 | C17H15N3O2 | 293.33 | 4-(8-Methyl-9H-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-5-yl)aniline;GYKI52466 |
GYKI-47261 | 220445-20-5 | C18H15ClN4 | 322.796 | 4-(8-chloro-2-methyl-11H-imidazo[1,2-c][2,3]benzodiazepin-6-yl)aniline; GYKI 47261; GYKI-47261 |
GYKI-46903 HCl | 142999-59-5 | C17H21ClFNO2 | 325.81 | (4R,5R)-6-(4-fluorophenyl)-1-azabicyclo[3.3.1]non-6-en-4-yl propionate hydrochloride |
GYKI-23107 dihydrochloride | 83843-39-4 | C13H24Cl2N2 | 279.25 | 83843-49-6 (free base);N1-(2,6-dimethylphenyl)-N2,N2-dimethylpropane-1,2-diamine dihydrochloride; |
GYKI-23107 | 83843-49-6 | C13H22N2 | 206.33 | N1-(2,6-dimethylphenyl)-N2,N2-dimethylpropane-1,2-diamine |
GYKI-20238 | 30725-74-7 | C11H12Cl2N2S | 274.01 | 2-Methylimino-3-(2,6-dichlorophenyl)-4-methylthiazolidine; |
GYKI-16638 HCl | 307556-59-8 | C21H31ClN2O5S | 458.998 | N-[4-[2-[1-(2,6-dimethoxyphenoxy)propan-2-yl-methylamino]ethyl]phenyl]methanesulfonamide;hydrochloride; |
GYKI-16638 | 778564-77-5 | C21H30N2O5S | 422.54 | N-(4-(2-((1-(2,6-dimethoxyphenoxy)propan-2-yl)(methyl)amino)ethyl)phenyl)methanesulfonamide |
GYKI-16084 | 185739-21-3 | C16H19N3O3 | 301.346 | 2-[3-[[(3R)-2,3-dihydro-1,4-benzodioxin-3-yl]methylamino]propyl]pyridazin-3-one; GYKI-16084; R-2-(3-N-(2-benzo(1,4)dioxanylmethyl)-amino-1-propyl)-3(2H)-pyridazinone hydrochloride |
GYKI-14451 sulfate | 83861-29-4 | C50H76N12O10.H2O4S | 1103.30 | tert-butyl ((R)-1-((S)-2-(((S)-5-guanidino-1-oxopentan-2-yl)carbamoyl)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)carbamate hemisulfate; LY 178207; Boc-D-Phe-Pro-Arg-H;69201-89-4 (free base) |
GYKI14451 | 69201-89-4 | C25H38N6O5 | 502.61 | GYKI-14451;LY-178207;LY178207;Boc-D-Phe-Pro-Arg-H;Tert-butyl ((R)-1-((S)-2-(((S)-5-guanidino-1-oxopentan-2-yl)carbamoyl)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)carbamate |
GYKI-13380 | 75614-09-4 | C16H22N2O3 | 290.36 | LS-79445;4-((3-(Cyclopentyloxy)-4-methoxyphenyl)methyl)-2-imidazolidinone |
GYKI 53784 | 161832-71-9 | C19H20N4O3 | 352.39 | GYKI 53784; LY 303070; 7H-1,3-Dioxolo(4,5-h)(2,3)benzodiazepine-7-carboxamide, 8,9-dihydro-5-(4-aminophenyl)-N,8-dimethyl-, (R)-; UNII-91N8O25H4L; AC1MIO7T |
GYKI 53655 hydrochloride | 143692-48-2 | C19H20N4O3.HCl | 388.85 | LY 300168 hydrochloride; 1-(4-Aminophenyl)-3-methylcarbamyl-4-methyl-3,4-dihydro-7,8-methylenedioxy-5H-2,3-benzodiazepine hydrochloride; 5-(4-aminophenyl)-N,8-dimethyl-8,9-dihydro-[1,3]dioxolo[4,5-h][2,3]benzodiazepine-7-carboxamide hydrochloride |
GYKI 53655 | 143692-18-6 | C19H20N4O3 | 352.39 | 5-(4-aminophenyl)-N,8-dimethyl-8,9-dihydro-[1,3]dioxolo[4,5-h][2,3]benzodiazepine-7-carboxamide |
GYKI 47261 dihydrochloride | 1217049-32-5 | C18H17Cl3N4 | 395.71 | 4-(8-chloro-2-methyl-11H-imidazo[1,2-c][2,3]benzodiazepin-6-yl)aniline;dihydrochloride;220445-20-5 (free base) |
GYKI 14166 | 83997-16-4 | C20H30N6O3.H2O4S | 500.57 | Efegatran;RGH2958; LY 294468; (S)-1-(D-phenylalanyl)-N-((S)-5-guanidino-1-oxopentan-2-yl)pyrrolidine-2-carboxamide sulfate |
Gyki 13324 | 76123-41-6 | C10H18Cl2N6O6 | 389.19 | N-(2-Chloroethyl)-N'-(4-((((2-chloroethyl)amino)carbonyl)nitrosamino)-2,3-dihydroxybutyl)-N-nitrosourea |
GX-674 | 1432913-36-4 | C21H13ClF2N6O3S2 | 534.94 | GX 674; 4-(2-(2-Amino-1H-benzo[d]imidazol-5-yl)-4-chlorophenoxy)-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide |
GW-9820 | 195131-60-3 | C26H35FN2O4 | 458.57 | 2-[4-[2-[(4-fluorophenyl)carbamoyl-heptylamino]ethyl]phenoxy]-2-methylpropanoic acid; GW-9820; GW 9820; GW9820 |
GW9508 | 885101-89-3 | C22H21NO3 | 347.414 | GW-9508; GW 9508; 3-(4-((3-Phenoxybenzyl)amino)phenyl)propanoic acid |
GW-870086 | 827319-43-7 | C31H39F2NO6 | 559.651 | |
GW843682X | 660868-91-7 | C22H18F3N3O4S | 477.46 | 5-(5,6-dimethoxybenzimidazol-1-yl)-3-[[2-(trifluoromethyl)phenyl]methoxy]thiophene-2-carboxamide; Polo-like Kinase Inhibitor III; |
GW842166X | 666260-75-9 | C18H17Cl2F3N4O2 | 449.25 | |
GW841819X | 146135-18-4 | C25H21N5O2 | 423.48 | GW841819X; KB-75882; GTPL7514; SCHEMBL9470080; CHEMBL2153434; TUWDLUFFAHHNEF-UHFFFAOYSA-N |
GW791343 HCl | 309712-55-8 | C20H24F2N4O.3HCl | 483.81 | GW791343; 1019779-04-4; |
GW791343 HCl | 309712-73-0 | C20H27Cl3F2N4O | 483.81 | 2-(3,4-difluoroanilino)-N-[2-methyl-5-(piperazin-1-ylmethyl)phenyl]acetamide;trihydrochloride |
GW788388 | 452342-67-5 | C25H23N5O2 | 425.492 | GW-788388; N-(oxan-4-yl)-4-[4-(5-pyridin-2-yl-1H-pyrazol-4-yl)pyridin-2-yl]benzamide |
GW-6604 | 452342-37-9 | C19H14N4 | 298.34 | 2-phenyl-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridine; |
GW6471 | 880635-03-0 | C35H36F3N3O4 | 619.685 | GW6471; GW-6471; GW 6471 |
GW6471 | 436159-64-7 | C35F3H36N3O4 | 619.67 | [(2S)-2-[[(1Z)-1-Methyl-3-oxo-3-[4-(trifluoromethyl)phenyl]-1-propenyl]amino]-3-[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]propyl]-carbamic acid ethyl ester |
GW-590735 | 622402-22-6 | C23H21F3N2O4S | 478.49 | GW-590735;2-Methyl-2-(4-((4-Methyl-2-(4-(trifluoromethyl)phenyl)thiazole-5-carboxamido)methyl)phenoxy)propanoic acid;2-Methyl-2-[4-[[[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-carbonyl]amino]methyl]phenoxy]propanoic acid |
GW5074 | 220904-83-6 | C15H8Br2INO2 | 520.94 | GW5074; GW 5074; GW-5074; |
GW4869 | 6823-69-4 | C30H30Cl2N6O2 | 577.5 | (E)-3-[4-[(E)-3-[4-(4,5-dihydro-1H-imidazol-2-yl)anilino]-3-oxoprop-1-enyl]phenyl]-N-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]prop-2-enamide;dihydrochloride; GW 4869; GW-4869 |
GW4064 | 278779-30-9 | C28H22Cl3NO4 | 542.84 | GW4064 |
GW3965 Hydrochloride | 405911-17-3 | C33H31ClF3NO3.HCl | 618.51 | |
GW3965 | 405911-09-3 | C33H31ClF3NO3 | 582.05 | 2-(3-(3-((2-chloro-3-(trifluoromethyl)benzyl)(2,2-diphenylethyl)amino)propoxy)phenyl)acetic acid hydrochloride; |
GW-3333 | 212609-68-2 | C22H36N4O4 | 420.55 | 3-[formyl(hydroxy)amino]-4-methyl-N-[3-methyl-1-oxo-1-(pyridin-2-ylamino)pentan-2-yl]-2-(2-methylpropyl)pentanamide; |
GW311616 hydrochloride | 197890-44-1 | C19H32ClN3O4S | 433.99 | GW-311616 hydrochloride; GW 311616 hydrochloride; GW311616A |
GW311616 | 198062-54-3 | C19H31N3O4S | 397.53 | GW-311616; GW 311616 |
GW2580 | 870483-87-7 | C20H22N4O3 | 366.421 | GW 2580; GW-2580; GW2580. |
GW1929 | 196808-24-9 | C30H29N3O4 | 495.57 | GW 1929; GW-1929 |
GW-1100 | 306974-70-9 | C27H25FN4O4S | 520.58 | GW1100; GW1100 |
GW0742 | 317318-84-6 | C21H17F4NO3S2 | 471.49 | GW0742 |
GW 9578 | 247923-29-1 | C26H34F2N2O3S | 492.6 | 2-[[4-[2-[[[(2,4-difluorophenyl)amino]carbonyl]heptylamino]ethyl]phenyl]thio]-2-methyl-propanoic acid |
GW 848687X | 612831-24-0 | C24H18ClF2NO3 | 441.9 | 6-[2-[5-chloro-2-[(2,4-digluorophenyl)methoxy]phenyl]-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid |
GW 803430 | 515141-51-2 | C25H24ClN3O3S | 481.99 | 6-(4-Chlorophenyl)-3-[3-methoxy-4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-thieno[3,2-d]pyrimidin-4(3H)-one |
GW 791343 hydrochloride | 1019779-04-4 | C20H24F2N4O.3HCl | 483.81 | GW791343 (dihydrochloride); 1019779-04-4; 2-((3,4-Difluorophenyl)amino)-N-(2-methyl-5-(piperazin-1-ylmethyl)phenyl)acetamide dihydrochloride; GW 791343; 3075AH |
GW 7647 | 265129-71-3 | C29H46N2O3S | 502.75 | 2-[[4-[2-[[(Cyclohexylamino)carbonyl](4-cyclohexylbutyl)amino]ethyl]phenyl]thio]-2-methylpropanoic acid |
GW 627368X | 439288-66-1 | C30H28N2O6S | 544.62 | N-(benzenesulfonyl)-2-[4-(4,9-diethoxy-3-oxo-1H-benzo[f]isoindol-2-yl)phenyl]acetamide; 4-(4,9-diethoxy-1,3-dihydro-1-oxo-2H-benz[f]isoindol-2-yl)-N-(phenylsulfonyl)-benzeneacetamide; |
GW 583340 dihydrochloride | 1173023-85-2 | C28H25ClFN5O3S2.2HCl | 671.03 | N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[2-[[[2-(methylsulfonyl)ethyl]amino]methyl]-4-thiazolyl]-4-quinazolinamine dihydrochloride |
GW 542573X | 660846-41-3 | C19H28N2O5 | 364.44 | 4-[[[[(2-Methoxyphenyl)amino]carbonyl]oxy]methyl]-piperidinecarboxylic acid-1,1-dimethylethyl ester; tert-butyl 4-[(2-methoxyphenyl)carbamoyloxymethyl]piperidine-1-carboxylate |
GW 441756 | 504433-23-2 | C17H13N3O | 275.30 | 1,3-Dihydro-3-[(1-methyl-1H-indol-3-yl)methylene]-2H-pyrrolo[3,2-b]pyridin-2-one; (3Z)-3-[(1-methylindol-3-yl)methylidene]-1H-pyrrolo[3,2-b]pyridin-2-one; |
GW 406381 | 221148-46-5 | C21H19N3O3S | 393.46 | 2-(4-ethoxyphenyl)-3-(4-methylsulfonylphenyl)pyrazolo[1,5-b]pyridazine |
GW 274150 | 210354-22-6 | C8H17N3O2S | 219.30 | (2S)-2-amino-4-[2-(1-aminoethylideneamino)ethylsulfanyl]butanoic acid GW 274150 GW274150 |
GW 1929 hydrochloride | 1217466-21-1 | C30H29N3O4.HCl | 532.03 | N-(2-Benzoylphenyl)-O-[2-(methyl-2-pyridinylamino)ethyl]-L-tyrosine hydrochloride; (2S)-2-(2-benzoylanilino)-3-[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]propanoic acid hydrochloride |
GV-58 | 1402821-41-3 | C18H26N6OS | 374.50 | GV-58; CHEMBL2206242; SCHEMBL17628602; BDBM50400564; CS-3617 |
GV-196771 | 166974-22-7 | C20H14Cl2N2O3 | 401.24 | GV-196771; GW-196771; AC1OC7O7; SCHEMBL499308; 4,6-dichloro-3-[(E)-(2-oxo-1-phenylpyrrolidin-3-ylidene)methyl]-1H-indole-2-carboxylic acid |
Guvacoline hydrobromide | 495-19-2 | C7H12BrNO2 | 222.08 | GUVACINE METHYL ESTER, HYDROBROMIDE; GUVACOLINE, HYDROBROMIDE; NORARECOLINE; Norarecoline, Guvacine Methyl Ester, Hydrobromide,; 1,2,5,6-Tetrahydro-3-pyridinecarboxylic acid methyl ester; 1,2,3,6-tetrahydropyridine-5-carboxylic acid methyl ester; methyl 1 |
Guvacoline hydrobromide | 17210-51-4 | C7H11NO2·HBr | 222.1 | Norarecoline; 1,2,5,6-tetrahydro-3-pyridinecarboxylic acid, methyl ester, monohydrobromide; methyl 1,2,3,6-tetrahydropyridine-5-carboxylate hydrobromide |
Guvacine hydrochloride | 6027-91-4 | C6H9NO2.HCl | 163.6 | 1,2,5,6-Tetrahydropyridine-3-carboxylic acid hydrochloride |
Guvacine | 498-96-4 | C6H9NO2 | 127.14 | 1,2,5,6-tetrahydropyridine-3-carboxylic acid; 1,2,5,6-Tetrahydro-3-pyridinecarboxylic acid |
Gusperimus | 104317-84-2 | C17H37N7O3 | 387.529 | deoxyspergualin; Deoxyspergualin Hydrochloride; Gusperimus Trihydrochloride; BMS-181173; BMY-42215-1; NKT-01. |
guselkumab | 1350289-85-8 | C6402H9864N1676O1994S42 | 143.6 | Tremfya |
gum storax | 8046-19-3 | STYRAX ESSENCE; STYRAX ESSENCE OLIFFAC; Asiaticstyrax; Gumstyraxhonduras; GumstyraxHonduraswhite; Liquidambarextractives; storax(balsam); Storax,balsam | ||
Gum karaya | 9000-36-6 | |||
Gum arabic | 9000-01-5 | |||
Guluronic acid | 15769-56-9 | C6H10O7 | ||
Guggulsterones E&Z | 95975-55-6 | C21H28O2 | 312.45 | |
GUAVANATE | 41654-15-3 | C9H16O2 | 156.22 | 5-Octenoic acid, methyl ester, (5Z)-, GUAVANATE, METHYL CIS-5-OCTENOATE, Methyl z-5-octenoate |
Guar hydroxypropyl trimonium chloride | 65497-29-2 | C6H16NO2.xCl.xUnspecified | GUM GUAR 2-HYDROXY-3-(TRIMETHYLAMMONIO)&; cosmediaguarc261; Guar,2-hydroxy-3-trimethylammoniopropylether,chloride; Guargum,etherwith3-chloro-2-hydroxypropyltrimethylammoniumchloride; gumguar2-hydroxy-3-(trimethylammonio)-propylet; jaguarc13s; jaguarc14s; | |
Guar gum | 9000-30-0 | Galactomannan | ||
Guanylyl-2'-5'-adenosine ammonium salt | 103192-47-8 | C20H25N10O11P.NH3 | 629.48 | [2-(2-amino-6-oxo-3H-purin-9-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl][5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methylhydrogenphosphate;azane;103192-47-8;G9011_SIGMA;CTK8F1208;Guanylyl(2'->5')adenosineammoniumsalt |
Guanylin (human) | 183200-12-6 | C58H87N15O21S4 | 1458.65 | |
Guanoxyfen sulfate | 1021-11-0 | C20H32N6O6S | 484.57 | PD-34799 hemisulfate;PPG hemisulfate;(3-Phenoxypropyl)guanidine sulfate;(3-Phenoxypropyl)guanidine hemisulfate |
Guanoxabenz | 24047-25-4 | C8H8Cl2N4O | 247.08 | 2-[(E)-(2,6-dichlorophenyl)methylideneamino]-1-hydroxyguanidine; 1-(2,6-dichlorobenzylideneamino)-3-hydroxyguanidine; guanoxabenz; guanoxabenz hydrochloride; guanoxabenz monohydrochloride |
Guanosine-5'-triphosphate sodium salt | 36051-31-7 | C10H13N5Na3O14P3 | 589.13 | Guanosine 5'-triphosphate trisodium salt |
Guanosine 5'-monophosphate | 85-32-5 | C10H14N5O8P | 363.22 | GMP; GUANOSINE-5'-MONOPHOSPHATE FREE ACID; 5-GUANOSINE MONOPHOSPHATE; GUANIDINE PHOSPHATE, MONOBASIC; GUANYLIC ACID; [(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate; 5' Guanylic Acid; 5'-GMP; 5'-Guanylic |
Guaiacol carbonate | 553-17-3 | C15H14O5 | 274.27 | BIS(2-METHOXYPHENYL) CARBONATE; CARBONIC ACID BIS(2-METHOXYL PHENYL ETHER); CARBONIC ACID BIS(2-METHOXYPHENYL) ESTER; BIS(O-METHOXYPHENYL) CARBONATE; GUAIACOL CARBONATE; GUAIACYL CARBONATE; Carbonic acid bis(2-methyoxyphenyl) ester; Carbonic acid guiacol |
Guaiacol | 90-05-1 | C7H8O2 | 2-Methoxyphenol/Guaiacol; GAIACOL; o-Methoxyphenol; o-Hydroxyanisole; 2-Methoxyphenol; Catechol monomethyl ether; Guaiaco; 1-Hydroxy-2-methoxybenzene; a-methoxyphenolsalicyl methyl ether | |
Guaiacin | 36531-08-5 | C20H24O4 | 328.408 | (6R,7S,8S)-8-(4-hydroxy-3-methoxyphenyl)-3-methoxy-6,7-dimethyl-5,6,7,8-tetrahydronaphthalen-2-ol |
GTS-21 dihydrochloride | 156223-05-1 | C19H20N2O2.2HCl | 381.30 | GTS-21; GTS 21; GTS21; DMBX-A |
GTS-21 | 148372-04-7 | C19H20N2O2 | 308.381 | 3-[(2,4-Dimethoxyphenyl)methylene]-3,4,5,6-tetrahydro-2,3'-bipyridine; DMXB-A |
GSK-2269557 HCl salt | 1254036-77-5 | 477.01 | ||
GSK2269557 | 1254036-71-9 | C26H28N6O | 440.54 | CHEMBL2216859; GSK2269557 (free base); GSK-2269557; 2-(6-(1H-indol-4-yl)-1H-indazol-4-yl)-5-((4-isopropylpiperazin-1-yl)methyl)oxazole; 6-(1H-indol-4-yl)-4-(5-{[4-(1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1H-indazole |
GSK-2262167 sodium | 1165923-54-5 | C25H25N4NaO4 | 468.49 | sodium 3-(6-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-5-methyl-3,4-dihydroisoquinolin-2(1H)-yl)propanoate,1165924-28-6 (free acid); 458576-13-0 (hydrate) |
GSK-2262167 sodium | 458576-13-0 | C25H25N4NaO4 | 468.48 | sodium 3-(6-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-5-methyl-3,4-dihydroisoquinolin-2(1H)-yl)propanoate |
GSK2256294A | 1142090-23-0 | C21H24F3N7O | 447.46 | UNII-L33EX3XR0T; GSK2256294A; L33EX3XR0T; SCHEMBL2677671; GSK 2256294A |
GSK-2256098 | 1224887-10-8 | C20H23ClN6O2 | 414.89 | GSK2256098; GSK 2256098; GSK-2256098; GTPL7939; GTPL-7939; GTP L7939. |
GSK2245035 | 1207629-49-9 | C20H34N6O2 | 390.52 | (S)-6-amino-2-(pentan-2-yloxy)-9-(5-(piperidin-1-yl)pentyl)-7,9-dihydro-8H-purin-8-one;1325212-97-2 (maleate salt) |
GSK2194069 | 1332331-08-4 | C25H24N4O3 | 428.48 | GSK 2194069; GSK-2194069 |
GSK2193874 | 1336960-13-4 | C37H38BrF3N4O | 691.62 | GSK 2193874; GSK-2193874; 7-bromo-N-(1-phenylcyclopropyl)-3-[(4-piperidin-1-ylpiperidin-1-yl) methyl]-2-[3-(trifluoromethyl)phenyl]quinoline-4-carboxamide |
GSK2190915 sodium salt | 1196070-26-4 | C38H42N3NaO4S | 659.81 | GSK-2190915A; Fiboflapon sodium; AM-803 sodium |
GSK2190915 | 936350-00-4 | C38H43N3O4S | 637.83 | AM-803; Fiboflapon |
GSK215083 | 607742-80-3 | C20H20FN3O2S | 385.46 | 3-(3-Fluoro-benzenesulfonyl)-8-(4-Methyl-piperazin-1-yl)-quinoline;GSK-215083;Quinoline, 3-((3-fluorophenyl)sulfonyl)-8-(4-methyl-1-piperazinyl)- |
GSK2141795 hydrochloride | 1047635-80-2 | C18H17Cl3F2N4O2 | 465.71 | |
GSK2110183 | 1047634-63-8 | C18H16Cl2F2N4OS | 445.31 | |
GSK-2033 | 1221277-90-2 | C29H28F3NO5S2 | 591.66 | CHEMBL1093266;GTPL8690; SCHEMBL13280409;2,4,6-trimethyl-N-[[4-(3-methylsulfonylphenyl)phenyl]methyl]-N-[[5-(trifluoromethyl)furan-2-yl]methyl]benzenesulfonamide |
GSK-2018682 | 1034688-30-6 | C22H21ClN4O4 | 440.884 | UNII-NJL503AIJA; NJL503AIJA; 4-(4-(5-(5-chloro-6-isopropoxypyridin-3-yl)-1,2,4-oxadiazol-3-yl)-1H-indol-1-yl)butanoic acid |
GSK1997132B | 1168138-37-1 | C24H22F2N4O | 420.46 | (R)-1-((3,5-difluoropyridin-2-yl)methyl)-2-methyl-N-(1-phenylpropyl)-1H-benzo[d]imidazole-5-carboxamide |
GSK199 hydrochloride | 1549811-53-1 | C24H28N6O2·HCl | 469 | [(3R)-3-amino-1-piperidinyl][2-(1-ethyl-1H-pyrrolo[2,3-b]pyridin-2-yl)-7-methoxy-1-methyl-1H-benzimidazol-5-yl]-methanone, monohydrochloride |
GSK-1904529a | 1089283-49-7 | C44H47F2N9O5S | 851.975 | GSK 4529; GSK-1904529a. |
GSK-189254 | 945493-87-8 | C21H25N3O2 | 387.908 | GSK189254; GSK-189254; GSK-189,254. |
GSK1842799 | 1005407-76-0 | C20H28F3N3O2S | 431.52 | (S)-2-amino-2-(5-(4-(octyloxy)-3-(trifluoromethyl)phenyl)-1,3,4-thiadiazol-2-yl)propan-1-ol;GSK-1842799 |
GSK1838705A | 1116235-97-2 | C27H29FN8O3 | 532.57 | GSK1838705A; GSK-1838705A; GSK-1838705A. |
GSK180736A | 817194-38-0 | C19H16FN5O2 | 365.37 | GSK-180736A; 4-(4-fluorophenyl)-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide |
GSK172981 | 1133705-99-3 | C26H22FN3O | 411.48 | (S)-3-amino-N-(cyclopropyl(phenyl)methyl)-2-(3-fluorophenyl)quinoline-4-carboxamide |
GSK163090 | 844903-58-8 | C25H29N5O | 415.54 | 1-(3-(2-(4-(2-methylquinolin-5-yl)piperazin-1-yl)ethyl)phenyl)imidazolidin-2-one; GSK163090; GSK-163090; GSK 163090 |
GSK1521498 | 1007573-18-3 | C24H20F2N4 | 402.44 | GSK-1521498;N-[[2,6-difluoro-4-[3-(1H-1,2,4-triazol-5-yl)phenyl]phenyl]methyl]-2,3-dihydro-1H-inden-2-amine;N-((3,5-difluoro-3'-(1H-1,2,4-triazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-2,3-dihydro-1H-inden-2-amine |
GSK-1440115 | 1003878-16-7 | C30H29Cl2N3O6 | 598.47 | GSK1440115;4'-(1-(((6,7-Dichloro-3-oxo-2,3-dihydro-4H-1,4-benzoxazin-4-yl)acetyl)(methyl)amino)-2-(4-morpholinyl)ethyl)-4-diphenylcarboxylic acid;4-[4-[(1R)-1-[[2-(6,7-dichloro-3-oxo-1,4-benzoxazin-4-yl)acetyl]-methylamino]-2-morpholin-4-ylethyl]phenyl]be |
GSK143 | 1240390-27-5 | C17H22N6O2 | 342.396 | GSK143; GSK 143; GSK-143. |
GSK137647A | 349085-82-1 | C16H19NO3S | 305.4 | 4-methoxy-N-(2,4,6-trimethylphenyl)-benzenesulfonamide; |
GSK1324726A (I-BET726) | 1300031-52-0 | C25H23ClN2O3 | 434.91 | N/A |
GSK-1292263 | 1032823-75-8 | C23H28N4O4S | 456.561 | GSK 1292263; GSK-1292263 |
GSK-1268997 | 1414375-50-0 | C21H23N7O3S | 453.52 | Pazopanib metabolite M26; 5-((4-((2,3-Dimethylindazol-6-yl)-methyl-amino)pyrimidin-2-yl)amino)-2-(hydroxymethyl)benzenesulfonamide |
GSK-1268992 | 1414375-49-7 | C21H23N7O3S | 453.52 | GSK 1268992; Pazopanib metabolite M24;5-((4-((3-(Hydroxymethyl)-2-methyl-indazol-6-yl)-methyl-amino)pyrimidin-2-yl)amino)-2-methyl-benzenesulfonamide |
GSK126 | 1346574-57-9 | C31H38N6O2 | 526.685 | GSK126; GSK-126; GSK 126. |
GSK121 trifluoroacetate salt | 1652591-80-4 | C23H25N5O·CF3COOH | 501.5 | (3-amino-1-piperidinyl)[1-methyl-2-(1-methyl-1H-indol-2-yl)-1H-benzimidazol-5-yl]-methanone, 2,2,2-trifluoroacetate |
GSK-114 2Hcl | 1301760-19-9 | C19H23N5O4S.2HCl | 495.484 | |
GSK-114 | 1301761-96-5 | C19H23N5O4S | 417.48 | 3-((6,7-dimethoxyquinazolin-4-yl)amino)-4-(dimethylamino)-N-methylbenzenesulfonamide; 1301760-19-9 (2HCl) |
GSK-1071306 | 1252927-47-1 | C20H21N7O2S | 423.49 | Pazopanib metabolite M27;5-((4-((2,3-dimethyl-2H-indazol-6-yl)amino)-2-pyrimidinyl)amino)-2-methyl-Benzenesulfonamide |
GSK-1070916A | 942918-07-2 | C30H33N7O | 507.63 | GSK-1070916A; GSK1070916A; GSK 1070916A. |
GSK106 hydrochloride | 1652591-82-6 | C24H27N5O·HCl | 438 | (3-amino-1-piperidinyl)[2-(1-ethyl-1H-indol-2-yl)-1-methyl-1H-benzimidazol-6-yl]-methanone, monohydrochloride |
GSK1059615 | 958852-01-2 | C18H11N3O2S | 333.36 | |
GSK1059615 | 958852-01-1 | C18H11N3O2S | 333.36 | GSK1059615; GSK-1059615; GSK1 059615. |
GSK1016790A | 942206-85-1 | C28H32Cl2N4O6S2 | 655.61 | N-((S)-1-(4-((S)-2-(2,4-dichlorophenylsulfonaMido)-3-hydroxypropanoyl)piperazin-1-yl)-4-Methyl-1-oxopentan-2-yl)benzo[b]thiophene-2-carboxaMide;GSK-1016790A |
GSK-1014802 hydrochloride | 934240-31-0 | C18H20ClFN2O2 | 350.82 | (2S,5R)-5-(4-((2-Fluorobenzyl)oxy)phenyl)pyrrolidine-2-carboxamide hydrochloride;(5R)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide hydrochloride CNV1014802 hydrochloride;CNV-1014802 hydrochloride;Raxatrigine hydrochloride |
GSK0660 | 1014691-61-2 | C19H18N2O5S2 | 418.48 | GSK0660; GSK-0660; GSK 0660. |
Grifolic acid | 80557-12-6 | C23H32O4 | 372.5 | ilicicolinic acid B |
Griffithinam | 240122-32-1 | C17H13NO4 | 295.294 | Uvarilactam; Dibenz[cd,f]indol-4(5H)-one, 1-hydroxy-2,7-dimethoxy- |
Griffithazanone A | 240122-30-9 | C14H11NO4 | 257.2 | (3R,4R)-3,4-Dihydro-3-hydroxy-4-methylbenzo[g]quinoline-2,5,10(1H)-trione |
Griffipavixanthone | 219649-95-3 | C36H28O12 | 652.6 | Indeno[1,2-a]xanthen-13(8H)-one,8a,9,10,12a-tetrahydro-1,3,6,7-tetrahydrox y-9,9,11-trimethyl-8-(3,4,6,8-tetrahydroxy-9-oxo-9H-xanthen-1-yl)-,(8R,8aR,12aS)-rel-(+)- |
GRI 977143 | 325850-81-5 | C22H17NO4S | 391.44 | 2-[[3-(1,3-dioxo-1H-benz[de]isoquinolin-2(3H)-yl)propyl]thio]benzoic acid |
GPBAR-A | 877052-79-4 | C23H15F7N2O2 | 484.37 | 4-[[3,5-Bis(trifluoromethyl)phenyl]methyl]-6-(2-fluorophenyl)-4,5-dihydro-pyrido[3,2-f]-1,4-oxazepin-3(2H)-one |
GpAp | 17332-08-0 | C20H26N10O14P2 | 692.4 | |
GP531 | 142344-87-4 | C16H21N5O4 | 347.37 | 5-amino-1-[(2R,3R,4S,5R)-5-[(benzylamino)methyl]-3,4-dihydroxyoxolan-2-yl]imidazole-4-carboxamide; 5-amino-1-beta-D-(5'-benzylamino-5'-deoxyribofuranosyl)imidazole-4-carboxamide; GP 531; GP-531; GP531 |
Gp4U | 79695-25-3 | C19H27N7O22P4 (free acid) | 829.4 (free acid) | P1- (5'- Guanosyl)- P4- (5'- uridyl)- tetraphosphate, sodium salt |
GP3G (Unmethylated Cap Analog) - solution | 6674-45-9 | C20H27N10O18P3 | 788.41 | G(5')ppp(5')G; P1-(Guanosyl) P3-(5'-(guanosyl))triphosphate, Sodium salt |
GNF-2 | 778270-11-4 | C18H13F3N4O2 | 374.32 | |
Glycyrrhizic acid | 1405-86-3 | C42H62O16 | 822.93 | (3b,20b)-20-Carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-(b-D-glucopyranuronosyl)-b-D-glucopyranosiduronic Acid; 3-O-(2-O-b-D-Glucopyranuronosyl-a-D-glucopyranuronosyl)-18-b-glycyrrhetinic acid |
Glycyrrhisoflavone | 116709-70-7 | C20H18O6 | 354.35 | 3-[3,4-Dihydroxy-5-(3-methyl-2-butenyl)phenyl]-5,7-dihydroxy-4H-1-benzopyran-4-one |
Glycyrrhetic acid 3-O-b-D-glucuronide | 34096-83-8 | C36H54O10 | 646.81 | Glycyrrhetic acid 3-O-glucuronide |
Glycyroside | 125310-04-5 | C27H30O13 | 562.52 | |
Glycyrol | 23013-84-5 | C21H18O6 | 366.36 | 6H-Benzofuro[3,2-c][1]benzopyran-6-one, 3,9-dihydroxy-1-methoxy-2-(3-methyl-2-butenyl)- (9CI); 3,9-Dihydroxy-1-methoxy-2-(3-methyl-2-buten-1-yl)-6H-benzofuro[3,2-c][1]benzopyran-6-one |
Glycyrin | 66056-18-6 | C22H22O6 | 382.41 | 3-(2,4-Dihydroxyphenyl)-5,7-dimethoxy-6-(3-methyl-2-buten-1-yl)-2H-1-benzopyran-2-one |
Glycerol 1-(26-hydroxyhexacosanoate) | 177602-14-1 | C29H58O5 | 486.8 | 26-hydroxyhexacosanoate,propane-1,2,3-triol |
Glycerol | 56-81-5 | C3H8O3 | 92.094 | 1,2,3-Propanetriol; Glycerin |
Glycerite | 1401-55-4 | C76H52O46 | 1701.20 | Gallotannin |
Glycerides, tallow mono-, hydrogenated | 61789-09-1 | C21H43O5- | 0 | Glycerides, tallow mono-, hydrogenated; HYDROGENATED TALLOW GLYCERIDE; Monoglycerides, hydrogenated tallow; RINDERTALG-MONOGLYCERID, GEH. |
Gadolinium oxide | 12064-62-9 | Gd2O3 | 362.49 | |
Gadolinium hydroxide | 100634-91-1 | GdH3O3 | 208.27 | GADOLINIUM(III) HYDROXIDE; GADOLINIUM HYDROXIDE; GADOLINIUM(III) HYDROXIDE HYDRATE, 99.9+; Gadolinium(III) hydroxide hydrate, 99.9% (REO) |
FR900098 sodium salt | 73226-73-0 | C5H11NO5P·Na | 219.1 | (3-(Acetylhydroxyamino)propyl)-phosphonic acid, monosodium salt; BRN 2096083; P-[3-(Acetylhydroxyamino)propyl]-phosphonic acid, monosodium salt |
FR-78844 | 112856-39-0 | C8H9NNa2O6P2S | 355.15 | Disodium phenylthiocarbamoylmethylenediphosphonate;(2-(Phenylamino)-2-thioxoethylidene)bisphosphonic acid disodium salt;Disodium [2-anilino-1-[hydroxy(oxido)phosphoryl]-2-sulfanylideneethyl]-hydroxyphosphinate;FR78844;Phosphonic acid, (2-(phenylamino)-2-t |
FR-64822 | 102671-35-2 | C11H14N4O | 218.26 | N-(4-Pyridylcarbamoyl)amino 1,2,3,6-tetrahydropyridine;1-(3,6-dihydro-2H-pyridin-1-yl)-3-pyridin-4-ylurea;FR64822 |
FR-62765 | 105346-34-7 | C16H18O5 | 290.31 | 2-Furanpropanoic acid, 2,5-dihydro-4-methoxy-5-oxo-3-phenyl-, ethyl ester;FR62765;2,5-Dihydro-4-methoxy-5-oxo-3-phenylfuran-2-propanoic acid ethyl ester;Ethyl 2,5-dihydro-4-methoxy-5-oxo-3-phenyl-2-furanpropanoate;Ethyl 3-(4-methoxy-5-oxo-3-phenyl-2H-fura |
FR295389 sulfuric acid | 1019207-72-7 | C25H35N13O11S3 | 789.81 | FR-295389 sulfuric acid;(6R,7R)-3-[[7-[3-aminopropyl(carbamimidoyl)amino]-2,3-dihydroimidazo[1,2-b]pyrazol-5-yl]methyl]-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-ca |
FR295389 free base | 1019207-71-6 | C25H33N13O7S2 | 691.74 | FR-295389 free base;(6R,7R)-3-[[7-[3-aminopropyl(carbamimidoyl)amino]-2,3-dihydroimidazo[1,2-b]pyrazol-5-yl]methyl]-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carbox |
FR252384 | 447405-11-0 | C18H17N3 | 275.35 | 9-methyl-2-pyridin-3-yl-3,4,5,6-tetrahydrobenzo[2,3]cyclohepta[2,4-b]imidazole; Benzo[3,4]cyclohept[1,2-d]imidazole, 1,4,5,6-tetrahydro-9-methyl-2-(3-pyridinyl)- |
FR 139317 | 142375-60-8 | C33H44N6O5 | 604.75 | PD 147953;2-((1-(Hexahydro-1H-azepinyl)carbonyl)amino-4-methylpentanoyl)-3-(-(1-methyl-1H-indolyl)propionyl)amino-3-(2-pyridyl)propionic acid |
FR 122047 hydrochloride | 130717-51-0 | C23H25N3O3S.HCl | 459.99 | FR 122047 hydrochloride;1-[[4,5-bis-(4-Methoxyphenyl)-2-thiazolyl]carbonyl]-4-methylpiperazine hydrochloride |
FR 121196 | 133920-65-7 | C12H16FN3O3S | 301.34 | N-(4-acetylpiperazin-1-yl)-4-fluorobenzenesulfonamide |
FR 113680 | 126088-92-4 | C35H39N5O6 | 625.72 | Ac-Thr-trp(cho)-phe-N-mebzl;N-acetyl-L-threonyl-1-formyl-D-tryptophyl-N-methyl-N-(phenylmethyl)-L-Phenylalaninamide |
FR 110302 | 119256-94-9 | C28H35NO2 | 417.58 | 2,2-dibutyl-1,2,3,4-tetrahydro-5-(2-quinolinylmethoxy)-1-Naphthalenol |
FQI 1 | 599151-35-6 | C18H17NO4 | 311.33 | 8-(2-ethoxyphenyl)-7,8-dihydro[1,3]dioxolo[4,5-g]quinolin-6(5H)-one; 8-(2-Ethoxy-phenyl)-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]quinolin-6-one |
Fmoc-L-4-Hydroxyphenylglycine | 182883-41-6 | C23H19 N O5 | 389.4 | FMOC-L-NORTYR; (S)-[(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)]-(4-HYDROXY-PHENYL)-ACETIC ACID; Fmoc-L-4-Hydroxyphenylglycine; (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-(4-hydroxyphenyl)acetic acid; REF DUPL: Fmoc-L-4-Hydroxyphenylglycine |
GLYCOL STEARATE SE | 86418-55-5 | C20H40O3 | 328.53000 | |
Glycol dimercaptoacetate | 123-81-9 | C6H10O4S2 | 210.26 | Ethylene glycol dithioglycolate; Ethylene glycol bis-mercaptoacetate; Glycol dimercaptoacetate |
Glycol chitosan (1:x) | 39280-86-9 | |||
Glycol chitosan | 123938-86-3 | (C8H15NO5)n | Glycol chitin, deacetylated | |
Glycogen Phosphorylase Inhibitor | 648926-15-2 | C17H15ClF2N4O4 | 412.8 | GPI; 2-chloro-4,5-difluoro-N-[[[2-methoxy-5-[[(methylamino)carbonyl]amino]phenyl]amino]carbonyl]-benzamide |
Glycogen - from oyster | 9005-79-2 | (C6H10O5)n | ||
Glycofurol | 31692-85-0 | (C2H4O)multC5H10O2 | 146.185 | 2-ethanediyl),alpha-[(tetrahydro-2-furanyl)methyl]-omega-hydroxy-Poly(oxy-1; alpha-((tetrahydro-2-furanyl)methyl)-omega-hydroxy-poly(oxy-2-ethanediyl); Glycofurol75; Glycols,polyethylene,mono(tetrahydrofurfuryl)ether; tetrahydrofurfurylalkoholpolyaethylen |
Glycine,N,N'-(1R,2R)-1,2-cyclohexanediylbis[N-(carboxymethyl)-, hydrate (1:1), rel- | 125572-95-4 | C14H22 N2 O8 . H2 O | 364.35 | TRANS-1,2-CYCLOHEXANEDIAMINE-N,N,N',N'-TETRAACETIC ACID MONOHYDRATE; TRANS-1,2-CYCLOHEXANEDIAMINE-N,N,N'N-TETRAACETIC ACID MONOHYDRATE; TRANS-1,2-CYCLOHEXANEDIAMINETETRAACETIC ACID HYDRATE; TRANS-1,2-CYCLOHEXANEDIAMINETETRAACETIC ACID MONOHYDRATE; TRANS-( |
Glycine,N-(1-iminopentyl)- | 193140-43-1 | C7H14 N2 O2 | 158.19826 | 2-(1-aminopentylideneamino)aceticacid; Pentanimidoylamino-aceticacid; Glycine,N-(1-iminopentyl)-; (Pentanimidoylamino)aceticAcid; SCHEMBL2763593; CTK8H4397 |
Glycine Thymol Blue | 3810-63-7 | C33H40N2O9S | 636.71194 | [5-[3-[3-[[carboxy(methyl)amino]methyl]-4-hydroxy-2-methyl-5-propan-2-ylphenyl]-1,1-dioxo-2,1$l^{6}-benzoxathiol-3-yl]-2-hydroxy-6-methyl-3-propan-2-ylphenyl]methyl-methylcarbamicacid; |
Glycine sulfate | 513-29-1 | C6H17N3O10S | 323.28 | TRIGLYCINE SULFATE; GLYCINE SULFATE; glycine,compd.withH2SO4; glycine,sulfate(3:1); Tris(glycine)sulfate; triaminoacetic acid sulphate; GlycineSulphate99%; Triglycine sulphate |
GLYCERYL POLYMETHACRYLATE | 146126-21-8 | C3H8 O3 | ||
Glyceryl monothioglycolate | 30618-84-9 | C5H10O4S | 166.19 | MERCAPTOACETIC ACID GLYCERYL ESTER; GLYCERYL THIOGLYCOLATE; Aceticacid,mercapto-,monoesterwith1,2,3-propanetriol; Glycerylmonothioglycolate; mercaptoacetic acid, monoester with propane-1,2,3-triol; GLYCEROLMONOTHIOGLYCOLATE |
Glyceryl Monostearate | 123-94-4 | C21H42O4 | 358.563 | Monostearin; 1-Stearoyl-rac-glycerol; Glyceryl stearate; 2,3-dihydroxypropyl octadecanoate |
Glyceryl monoricinoleate | 1323-38-2 | C21H40O5 | 372.5393 | GLYCERYL RICINOLEATE; GLYCERYL MONORICINOLEATE; GLYCEROL RICINOLEATE; GLYCEROL MONORICINOLEATE; 12-hydroxy-,monoesterwith1,2,3-propanetriol,[R-(Z)]-9-Octadecenoicacid; 2,3-Dihydroxypropyl (9Z)-12-hydroxy-9-octadecenoate; 9-Octadecenoic acid, 12-hydroxy-, |
Glyceryl monooleate | 25496-72-4 | C21H40O4 | 356.543 | 9-Octadecenoicacid(Z)-,monoesterwith1,2,3-propanetriol; adchemgmo; ajaxgmo; aldo40; aldomo-fg; dur-em204; emcolo; emeryoleicacidester2221 |
Glyceryl monomyristate | 27214-38-6 | C17H34O4 | 302.4495 | Tetradecanoicacid,monoesterwith1,2,3-propanetriol; Tetradecanoicacid,monoglyceride; TETRADECANOIN; RAC-GLYCEROL 1-MYRISTATE; RAC-1-MYRISTOYLGLYCEROL; MONOMYRISTIN; 1-MYRISTOYL-RAC-GLYCEROL; 1-MONOTETRADECANOYL-RAC-GLYCEROL |
Glyceryl monolaurate | 27215-38-9 | C15H30O4 | 274.398 | MONOLAURIN; RAC-GLYCEROL 1-LAURATE; RAC-1-LAUROYLGLYCEROL; Dodecanoicacid,monoesterwith1,2,3-propanetriol; DODECANOIN; DL-ALPHA-LAURIN |
Glyceryl isostearate | 66085-00-5 | C21H42O4 | 358.5588 | Isooctadecanoicacid,monoesterwith1,2,3-propanetriol; Isostearicacid,1,2,3-propaneriolester(1:1); GLYCEROL MONOISOSTEARATE; isooctadecanoic acid, monoester with glycerol; ALPHA-MONOISOSTEARYLGLYCERYLETHER; Isooctadecansure, Monoester mit Glycerin; Glyceroi |
Glyceryl hexacosanoate | 127098-14-0 | C29H58O4 | 470.768 | Glyceryl-1-hexacosanoate |
Glyceryl distearate | 1323-83-7 | C39H76O5 | 625.02 | Distearoylglycerol mixed isomers |
GLYCERYL DIHYDROXYSTEARATE | 122546-20-7 | C21H42O6 | 390.55458 | GLYCERYLDIHYDROXYSTEARATE; 122546-20-7; Octadecanoicacid,12-hydroxy-,2-hydroxy-1,3-propanediylester(9CI); ACMC-20mq3h; SCHEMBL297150; CTK4B3155 |
Glyceryl Behenate | 77538-19-3 | C25H50O4 | 414.671 | 1,2,3-Propanetriol Docosanoate; Glycerin Docosanoate; Docosanoin |
Glycerophosphoric acid | 57-03-4 | C3H9O6P | 172.07 | EGG PE; EGG PHOSPHATIDYLGLYCEROL; glycerophosphoric acid; GLYCEROL PHOSPHORIC ACID; glycerol-3-phosphate; PHOSPHATIDYL GLYCEROL; PLANT LEAF LIPIDS PHOSPHATIDYL GLYCEROL; 2,3-hydroxy-1-propyl dihydrogen phosphate |
Glycerol triisobutyrate | 14295-64-8 | C15H26O6 | 302.363 g/mol | Glyceroltriisobutyrate; propane-1,2,3-triyltris(2-methylpropanoate); 14295-64-8; Triisobutyrin; EINECS238-224-8; AC1L378Y |
Glycerol propoxylate triglycidyl ether | 37237-76-6 | C21H38O9 | 434.52 | .alpha.,.alpha.',.alpha.''-1,2,3-Propanetriyltris[.omega.-(2,3-epoxypropoxy)poly(oxypropylene)]; [omega-(oxiranylmethoxy)-; 2-ethanediyl)],.alpha.,.alpha.',.alpha.''-1,2,3-propanetriyltris[.omega.-(oxiranylmethoxy)-Poly[oxy(methyl-1; GLYCEROL PROPOXYLATE |
Glycerol phosphate disodium salt hydrate | 55073-41-1 | C3H7Na2O6P.H2O | 216.04 | |
Glycerol Phosphate Calcium Salt Hydrate | 398143-83-4 | C3H9O6P.Ca.xH2O | 212.153 (anhydrous) | Calcium glycerophosphate hydrate; Calcii glycerophosphas; calcium 2,3-dihydroxypropyl phosphate hydrate |
Glycerol Phosphate Calcium Salt | 58409-70-4 | C3H9O6P.Ca | 212.153 | Calcium glycerophosphate, neurosin; calcium 1,3-dihydroxypropan-2-yl dihydrogen phosphate |
Glycerol phenylbutyrate | 611168-24-2 | C33H38O6 | 530.66 | HPN-100;HPN100;Ravicti;Propane-1,2,3-triyl tris(4-phenylbutanoate);2,3-Bis(4-phenylbutanoyloxy)propyl 4-phenylbutanoate |
Glycerol palmitate | 26657-96-5 | C19H38O4 | 330.5026 | glycerol palmitate; Glycerinpalmitat |
Glycerol monostearate | 31566-31-1 | C21H42O4 | 358.563 | |
GLYCEROL FORMAL | 99569-11-6 | C4H8O3 | 0 | Glycerol formal, 98%, ca 60:40 mixture of 1,3- and 2,3-isomers |
GLYCEROL ETHOXYLATE | 31694-55-0 | HO(CH2CH2O)nCH[CH2(OCH2CH2)nOH]2 | 224.2515 | 2,2',2''-Propane-1,2,3-triyltrioxytriethanol; 21156-05-8; 2,2',2''-[propane-1,2,3-triyltris(oxy)]triethanol; Glycereth-7; Glycereth-12; Glycereth-20 |
Glycerol diglycidyl ether | 27043-36-3 | C9H16O5 | 204.22 | 2,3-bis(oxiran-2-ylmethoxy)propan-1-ol; 1-O,2-O-Diglycidylglycerol; SCHEMBL42453; KB-52262; FT-0084695 |
Glycerides, palm-oil mono- and di-, hydrogenated, 3-oxododecanoates | 91052-70-9 | 0 | Glycerides, palm-oil mono- and di-, hydrogenated, 3-oxododecanoates; 3-OXODODECANOICACIDGLYCERIDE | |
Glycerides, C16-18 mono- and di- | 85251-77-0 | |||
Glycerides, C12-18 | 67701-26-2 | |||
Glycerides, C10-18 | 85665-33-4 | |||
Glybuzole | 1492-02-0 | C12H15N3O2S2 | 297.40 | Glybuzole; Desaglybuzole; Gludiase; Sulfamidothiodiazol; Glybuzole [INN:JAN]; N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide |
Glyburide-d3 | 1219803-02-7 | C23H25ClN3O5SD3 | 497.03 | 5chloro-N-[2-(4-oyl)amino] |
Glyburide potassium salt | 52169-36-5 | C23H28ClN3O5S·K | 533.1 | Glibenclamide; 5-chloro-N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-2-methoxy-benzamide, monopotassium salt |
Glyburide Impurity E | 57334-89-1 | C23H27Cl2N3O5S | 528.46 | 3,5-Dichloro-N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-2-methoxybenzamide; UR 623; 3-Chloro Glyburide |
Glyburide | 10238-21-8 | C23H28ClN3O5S | 494 | N/A |
Glyasperin D | 142561-10-2 | C22H26O5 | 370.44 | 4-((R)-5,7-Dimethoxy-6-(3-methyl-but-2-enyl)-1-benzopyran-3-yl)-benzene-1,3-diol |
Glyasperin A | 142474-52-0 | C25H26O6 | 422.5 | 3,5,7-trihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-6-(3-methylbut-2-enyl)chromen-4-one |
Gliclazide | 21187-98-4 | C15H21N3O3S | 323.41 | Gliclazide; Diamicron; Glimicron; Nordialex; Diaikron; S-1702; S-852; S1702; S852; S 1702; S 852 |
Glibornuride | 26944-48-9 | C18H26N2O4S | 366.476 | 1-[(1S,2S,3R,4R)-3-hydroxy-4,7,7-trimethyl-2-bicyclo[2.2.1]heptanyl]-3-(4-methylphenyl)sulfonylurea |
Glibenclamide potassium salt | 23047-14-5 | C23H26ClK2N3O5S | 570.18 | |
Glibenclamide Impurity B | 21165-77-5 | C18H19ClN2O6S | 426.88 | Methyl {{4-{2-[(5-chloro-2-methoxybenzoyl)amino]ethyl}phenyl}sulfonyl}carbamate; N-[[4-[2-[(5-Chloro-2-methoxybenzoyl)amino]ethyl]phenyl]sulfonyl]carbamic Acid Methyl Ester; [[4-[2-[(5-Chloro-2-methoxybenzoyl)amino]ethyl]phenyl]sulfonyl]carbamic Acid Meth |
Gliamilide | 51876-98-3 | C23H33N5O5S | 491.61 | N-[2-[1-[[(5R)-5-bicyclo[2.2.1]hept-2-enyl]methylcarbamoylsulfamoyl]piperidin-4-yl]ethyl]-2-methoxypyridine-3-carboxamide;CP-27,634;CP27,634;3-Pyridinecarboxamide, N-(2-(1-(((((bicyclo(2.2.1)hept-5-en-2-ylmethyl)amino)carbonyl)amino)sulfonyl)-4-piperidiny |
Glesatinib hydrochloride | 1123838-51-6 | C31H27ClF2N5O3S2X | 655.16 | MGCD265 hydrochloride; MGCD-265 hydrochloride; MGCD 265 hydrochloride |
Glepidotin B | 87440-56-0 | C20H20O5 | 340.4 | (2R-trans)-2,3-Dihydro-3,5,7-trihydroxy-6-(3-methyl-2-butenyl)-2-phenyl-4H-1-benzopyran-4-one |
glecaprevir | 1365970-03-1 | C38H46F4N6O9S | 838.87 | pibrentasvir; Mavyret |
Ginsenoside Rf | 52286-58-5 | C42H72O14 | 801.03 | (3b,6a,12b)-3,12,20-Trihydroxydammar-24-en-6-yl-2-O-(b-D-glucopyranosyl)-b-D-glucopyranoside |
Ginsenoside Re | 52286-59-6 | C48H82O18 | 947.18 | (3b,6a,12b)-20-(b-D-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranoside |
Ginsenoside Re | 51542-56-4 | C48H82O18 | 947.166 | Panaxoside RE; Ginsenoside B2; UNII-46F3R0BL3I; Chikusetsusaponin Ivc |
Ginsenoside Rd2 | 83480-64-2 | C47H80O17 | 917.13 | |
Ginsenoside Rd | 52705-93-8 | C48H82O18 | 947.18 | (3b,12b)-20-(b-D-Glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl2-O-(b-D-glucopyranosyl)-b-D-glucopyranoside |
Ginsenoside Rc | 11021-14-0 | C53H90O22 | 1079.30 | (3b,12b)-20-[(6-O-a-L-Arabinofuranosyl-b-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl 2-O-(b-D-glucopyranosyl)-b-D-glucopyranoside; Panaxoside Rc |
Ginsenoside Rb2 | 11021-13-9 | C53H90O22 | 1079.30 | (3b,12b)-20-[(6-O-a-L-Arabinopyranosyl-b-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl 2-O-(b-D-glucopyranosyl)-b-D-glucopyranoside; Ginsenoside C |
Ginsenoside Rb1 | 41753-43-9 | C54H92O23 | 1109.32 | (3b,12b)-20-[(6-O-b-D-Glucopyranosyl-b-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl 2-O-(b-D-glucopyranosyl)-b-D-glucopyranoside; Arasaponin E1; Gypenoside III |
Ginsenoside Ra3 | 90985-77-6 | C59H100O27 | 1241.41 | |
Ginsenoside Ra2 | 83459-42-1 | C58H98O26 | 1211.38 | |
Ginsenoside Ra1 | 83459-41-0 | C58H98O26 | 1211.38 | |
Ginsenoside F5 | 189513-26-6 | C41H70O13 | Chikusetsusaponin L8; (3beta,6alpha,12beta)-3,6,12-Trihydroxydammar-24-en-20-yl 6-O-alpha-L-arabinofuranosyl-beta-D-glucopyranoside | |
Ginsenoside F4 | 181225-33-2 | C42H70O12 | Ginsenoside Rg6; (20E)-Ginsenoside F4 | |
GINSENOSIDE F11 | 115038-42-1 | C42H72O14 | 0 | GINSENOSIDE F11 |
Ginsenoside C-K | 39262-14-1 | C36H62O8 | 622.87 | Ginsenoside K |
Panax Notoginseng Extract | 94279-78-4 | |||
Ginseng extract | 72480-62-7 | 0 | Ginseng extract; Ginseng root; Ginseng root extract; Ginsenosides | |
Ginseng Extract | 90045-38-8 | Mixture | ||
Ginnol | 2606-50-0 | C29H60O | 424.8 | Celidoniol; (S)-nonacosan-10-ol; (10S)-10-Nonacosanol |
Ginkgoneolic acid | 20261-38-5 | C20H32O3 | 6-n-Tridecylsalicylic acid | |
Ginkgolide M | 15291-78-8 | C20H24O10 | 424.40 | |
Ginkgolide K | 153355-70-5 | C20H22O9 | 406.38 | (1R,3S,3aS,4R,6aR,7aS,10aR,11R,11aR)-3-(1,1-Dimethylethyl)-2,3,10a,11-tetrahydro-4,11-dihydroxy-8-methyl-9H-1,7a-(epoxymethano)-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3',2':3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione |
Ginkgolide C | 15291-76-6 | C20H24O11 | 440.40 | Ginkgolide C 15291-76-6 1,7-Dihydroxy-ginkgolide A Ginkgolide C; GINKGOKIDE C AC1L4OUG AC1Q6PCW CTK8F0397 AR-1C0541 AR-1C0542 NSC335757 AN-8390 NSC-335757 TR-031689 N1908 L001208 I06-0420 (1S,2R,3S,3aS,4R,6aR,7aR,7bR,8S,10aS,11R,11aR)-3-( |
Ginkgolide B | 15291-77-7 | C20H24O10 | 424.4 | BN52021 |
Ginkgolide A | 15291-75-5 | C20H24O9 | 408.4 | BN52020 |
Ginkgolic Acid C17:2 | 102811-39-2 | C24H36O3 | 372.5 | Ginkgolic acid 17:2; 6-[(8Z,11Z)-8,11-Heptadecadienyl]salicylic acid |
Ginkgolic acid C17:1 | 111047-30-4 | C24H38O3 | 374.56 | Ginkgolic acid 17:1; (Z)-2-(Heptadec-10-en-1-yl)-6-hydroxybenzoic acid; Ginkgolic acid II |
Gimeracil Impurity 7 | 1227600-22-7 | C6H6ClNO2 | 159.57 | |
Gimeracil Impurity 5 | 1379260-15-7 | C6H6ClNO2 | 159.57 | |
Gimeracil (CDHP) | 103766-25-2 | C5H4ClNO2 | 145.54 | Gimeracil; chlorodihydroxypyridine. |
Gimatecan | 292618-32-7 | C25H25N3O5 | 447.491 | LBQ707; STI481; |
Gilvocarcin V | 77879-90-4 | C27H26O9 | 494.5 | Anandimycin A, Toromycin, 1072B |
Gilvocarcin M | 77879-89-1 | C26H26O9 | 482.5 | Anandimycin B, Toromycin B, 1072A |
Gilteritinib | 1254053-43-4 | C29H44N8O3 | 552.724 | Gilteritinib; ASP2215; ASP-2215; ASP 2215. |
Gigantol | 67884-30-4 | C16H18O4 | 274.31 | 5-[2-(3-hydroxy-5-methoxyphenyl)ethyl]-2-methoxyphenol |
Giffonin R | 1966183-72-1 | C19H16O3 | 292.334 | |
Giffonin P | 1830306-93-8 | C19H22O7 | 362.379 | |
Gidazepam | 129186-29-4 | C17H15BrN4O2 | 387.23 | 2-(7-bromo-2-oxo-5-phenyl-3H-1,4-benzodiazepin-1-yl)acetohydrazide; (1-hydrazinocarbonyl)-7-bromo-5-phenyl-1,2-dihydro-3H-1,4-benzodiazepine-2-one; gidazepam |
GIBH-130 | 1252608-59-5 | C20H20N6O | 360.41 | (4-methyl-6-phenylpyridazin-3-yl)-(4-pyrimidin-2; -ylpiperazin-1-yl)methanone; (4-methyl-6-phenylpyridazin-3-yl)(4-(pyrimidin-2-yl)piperazin-1-yl)methanone; GIBH-130; GIBH130; GIBH 130 |
Gibberellic acid | 77-06-5 | C19H22O6 | 346.38 | Gibberellin A3; Gibberellic acid GA3; Gibreskol; Berelex; Brellin; Cekugib; Pro-Gibb; (1alpha,2beta,4aalpha,4bbeta,10beta)-2,4a,7-Trihydroxy-1-methyl-8-methylenegibb-3-ene-1,10-dicarboxylic acid 1,4a-lactone |
Gibberellin A95 | 78259-50-4 | C19H22O5 | 330.38 | 4a,1-(Epoxymethano)-7,9a-methanobenz[a]azulene, gibb-3-ene-1,10-dicarboxylic Acid Deriv.; GA95; NSC 224287 |
Germicidin B | 150973-78-7 | C10H14O3 | 182.2 | |
Germicidin A | 151271-57-7 | C11H16O3 | 196.2 | |
Germanium(II) selenide | 12065-10-0 | GeSe | 151.6 | Germanium(II) selenide; Germanium selenide (GeSe, 5N) |
germanium tetrafluoride | 7783-58-6 | F4Ge | 148.60 | GERMANIUM FLUORIDE; GERMANIUM(IV) FLUORIDE; GERMANIUM TETRAFLUORIDE; GeF4; Germane, tetrafluoro-; tetrafluoro-german; tetrafluorogermane; GERMANIUM(IV) FLUORIDE, 99.9+%, ELECTRON IC GRADE |
Germanium monoxide | 20619-16-3 | GeO | 88.61 | GERMANIUM MONOXIDE; Germanium oxide (GeO); germaniumoxide(geo); Germanous oxide |
GERMANIUM MONOSULFIDE | 12025-32-0 | SGe | 104.66 | GERMANIUM (II) SULFIDE; GERMANIUM MONOSULFIDE; GERMANIUM SULFIDE; Germanium sulfide (GeS); germaniumsulfide(ges); GeS |
Germanium magnesium fluoride oxide manganese-doped | 68784-13-4 | F2GeMgO2 | 166.9406064 | Germanium magnesium fluoride oxide, manganese-doped |
Germanium disulfide | 12025-34-2 | GeS2 | 136.77 | GERMANIUM DISULFIDE; GERMANIUM SULFIDE; GERMANIUM (IV) SULFIDE; germaniumsulfide(ges2); germanium disulphide; GERMANIUM(IV) SULFIDE: 99.99% |
Geranylgeranylacetone | 6809-52-5 | C23H38O | 330.55 | Teprenone; 6,10,14,18-Tetramethyl-5,9,13,17-nonadecatetraen-2-one; |
Gentiobiulose | 132436-90-9 | C12H22O11 | 342.30 | 6-O-(b-D-Glucopyranosyl)-D-fructose |
Gentamycin sulfate | 1405-41-0 | H2O4S.xUnspecified | NSC-82261; NSC82261; NSC 82261; SCH9724; SCH 9724; SCH-9724 | |
Gentamycin Impurity E | 84107-26-6 | C6H16N2O3Br2 | 324.01 | 2-Deoxystreptamine dihydrobromide; 2-DOS · 2HBr; 4t,6t-Diamino-cyclohexan-1r,2t,3c-triol; 2-Deoxy-1,3-myo-inosadiamine |
Gentamicin X2 sulfate | 36889-17-5 | C19H38N4O10.xH2SO4 (lot specific) | 482.52 (Free base) | |
Gentamicin C2b | 52093-21-7 | C20H41N5O7 | 463.6 | Micronomicin, Sagamicin,Santemycin, Antibiotic KW 1062, Antibiotic XK 62-2 |
Gentamicin C2a | 59751-72-3 | C20H41N5O7.xH2SO4 (lot specific) | 463.57 (Free base) | |
Gentamicin C2 sulfate | 25876-11-3 | C20H41N5O7.xH2SO4 (lot specific) | 463.57 (Free base) | |
Gentamicin C1a | 26098-04-4 | C19H39N5O7.xH2SO4 (lot specific) | 449.54 (Free base) | |
Gentamicin C1 sulfate | 25876-10-2 | C21H43N5O7.xH2SO4 (lot specific) | 477.59 (Free base) | |
GENTAMICIN B | 36889-15-3 | C19H38N4O10 | 482.53 | d-streptamine,o-6-amino-6-deoxy-alpha-d-glucopyranosyl-(1-4)-o-(3-deoxy-4-c-me; gentamycinb; sch14342; thyl-3-(methylamino)-beta-l-arabinopyranosyl-(1-6))-2-deoxy-; 2-(AMINOMETHYL)-6-[4,6-DIAMINO-3-(3,5-DIHYDROXY-5-METHYL-4-METHYLAMINO-OXAN-2-YL)OXY-2-HYD |
Gentamicin A sulfate | 13291-74-2 | C18H36N4O10.xH2SO4 (lot specific) | 468.50 (Free base) | |
Genkwanin | 437-64-9 | C16H12O5 | 284.3 | 4',5-DIHYDROXY-7-METHOXYFLAVONE |
Genistin | 529-59-9 | C21H20O10 | 432.38 | 7-(b-D-Glucopyranosyloxy)-5-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 4,5,7-Trihydroxyisoflavone 7-b-D-glucoside; Genistein-7-O-beta-D-glucopyranoside |
Genistein-d4 | 187960-08-3 | C15H6O5D4 | 274.26 | Genistein-2',3',5',6'-d4; 4-hydroxyphenyl-2,3,5,6-d4; 5,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one-d4; Baichanin A-d4; Bonistein-d4; 4',5,7-Trihydroxyisoflavone-d4; GeniVida-d4; Genisteol-d4; NSC 36586-d4; Prunetol-d4; Sophoricol-d4 |
Genistein-d2 | 315204-48-9 | C15H8O5D2 | 272.26 | Genistein-2',6'-d2 |
Genistein 8-C-glucoside | 66026-80-0 | C21H20O10 | 432.4 | |
Genistein | 446-72-0 | C15H10O5 | 270.24 | Prunetol; Genisteol; 4',5,7-Trihydroxyisoflavone; Sophoricol |
Geniposidic acid | 27741-01-1 | C16H22O10 | 374.342 | (1S,4aS,7aS)-7-(hydroxymethyl)-1-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylic acid |
Geniposide | 24512-63-8 | C17H24O10 | 388.37 | Geniposide |
Genipin | 6902-77-8 | C11H14O5 | 226.23 | Thorazine |
Geninthiocin | 158792-27-9 | C50H49N15O15S | 1132.1 | 14-Demethylberinamycin |
Geneticin sulfate | 108321-42-2 | C20H44N4O18S2 | 692.71 | N/A |
Gemifloxacin Impurity | 213672-25-4 | C17H19FN4O4 | 362.36 | Desmethoxyamino Hydroxy Gemifloxacin; 7-(3-(Aminomethyl)-4-hydroxypyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic Acid |
Gemifloxacin | 175463-14-6 | C18H20FN5O4 | 389.38100 | |
Gemfibrozil-d6 | 1184986-45-5 | C15H16O3D6 | 256.38 | 5-(2,5-Dimethylphenoxy)-2,2-(dimethyl-d6)-pentanoic Acid; 2,2-(Dimethyl-d6)-5-(2,5-xylyloxy)valeric Acid; Decrelip-d6; Genlip-d6; Gevilon-d6; Lipozid-d6; Lopid-d6 |
Gemfibrozil Related Compound A | 500904-61-0 | C18H26O3 | 290.41 | (E,Z)-2,2-dimethyl-5-[2,5-dimethyl-4-(propene-1-yl)phenoxy]valeric acid; 5-[2,5-Dimethyl-4-(1-propen-1-yl)phenoxy]-2,2-dimethylpentanoic acid; 4-(1-Propenyl) Gemfibrozil |
Gemfibrozil Impurity 2 | 109232-37-3 | C11H21ClO2 | 220.74 | Isobutyl 5-chloro-2,2-dimethylvalerate; 5-Chloro-2,2-dimethylpentanoic acid |
Gemcitabine (alpha-Isomer) Hydrochloride | 122111-05-1 | C9H12F2N3O4Cl | 299.65 | 1'-Epi Gemcitabine Hydrochloride; 4-Amino-1-(2-deoxy-2,2-difluoro-a-D-erythro-pentofuranosyl)-2(1H)-pyrimidinone Hydrochloride |
Gemcitabine | 95058-81-4 | C9H11F2N3O4 | 263.2 | 2'-Deoxy-2',2'-difluorocytidine; 4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 2'-Deoxy-2',2'-difluoro-D-cytidine; 2',2'-Difluoro-2'-deoxycytidine |
Gemcadiol | 35449-36-6 | C14H30O2 | 230.389 | CI-720; 2,2,9,9-Tetramethyl-1,10-decanediol |
Gemcabene | 183293-82-5 | C16H30O5 | 302.41 | 6-(5-carboxy-5-methyl-hexoxy)-2,2-dimethyl-hexanoic acid; gemcabene; 6,6'-oxybis(2,2-dimethylhexanoic acid); PD 72953; PD72953 |
Gelsevirine | 38990-03-3 | C21H24N2O3 | 352.4 | Gelsemine, 1-methoxy-; 1-Methoxygelsemine |
Gelsempervine A | 865187-17-3 | C22H26N2O4 | 382.5 | (19E)-Gelsempervine C;16-epi-Nb-Methylvoacarpine |
Gelsemine | 509-15-9 | C20H22N2O2 | 322.4 | (3r-(3alpha,4abeta,5alpha,8alpha,8abeta,9s*,10s*))-5-ethenyl-3,4,4a,5,6,7,8,8a; [3R-(3alpha,4abeta,5alpha,8alpha,8abeta,9S*,10S*)]-5-Etheny l-3,4,4a,5,6,7,8,8a-octahydro-7-methylspiro[3,5,8-ethanylylidene-1H-p yrano[3,4-c]pyridine-10,3'-[3H]indol]-2'(1'H) |
Gelsemicine | 6887-28-1 | C20H26N2O4 | 358.4 | |
Gelomuloside B | 149998-39-0 | C28H32O15 | 608.54 | 6-(((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-4H-chromen-4-one |
Gelomuloside A | 149998-38-9 | C29H34O15 | 622.57 | 6-[[2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one |
Gelomulide N | 1005212-02-1 | C24H32O7 | 432.51 | 1alpha,3beta-Diacetoxy-8beta,14beta-epoxy-ent-abiet-13(15)-en-16,12-olide;1-epi-Gelomulide O |
Gelomulide B | 122537-60-4 | C22H28O6 | 388.454 | (3S,4aS,6aS,7aR,10aS,11aS,11bR,11cR)-4,4,8,11c-tetramethyl-9-oxo-1,2,3,4,4a,5,6,7a,9,11a,11b,11c-dodecahydrobis(oxireno)[2',3':1,10a;2'',3'':3,4]phenanthro[3,2-b]furan-3-yl acetate |
Fmoc-Ala-aldehyde | 146803-41-0 | C18H17NO3 | 295.34 | FMOC-ALA-ALDEHYDE |
Exenatide | 141758-74-9 | C184H282N50O60S | 4186.57 | H-DL-His-Gly-DL-Glu-Gly-DL-xiThr-DL-Phe-DL-xiThr-DL-Ser-DL-Asp-DL-Leu-DL-Ser-DL-Lys-DL-Gln-DL-Met-DL-Glu-DL-Glu-DL-Glu-DL-Ala-DL-Val-DL-Arg-DL-Leu-DL-Phe-DL-xiIle-DL-Glu-DL-Trp-DL-Leu-DL-Lys-DL-Asn-Gly-Gly-DL-Pro-DL-Ser-DL-Ser-Gly-DL-Ala-DL-Pro-DL-Pro-DL- |
Evans Blue | 314-13-6 | C34H24N6Na4O14S4 | 960.82 | 6,6-([(3,3'-DIMETHYL)-1,1'-BIPHENYL]-4,4'-DIYL)BIS(AZO)BIS[4-AMINO-5-HYDROXY-1,3-NAPHTHALENEDISULPHONIC ACID] TETRASODIUM SALT;3,3'-DITOLYL-4,4'-BIS[7-AZO-1-AMINO-8-NAPHTHOL-2,4-(DISODIUM)DISULFONATE];EVANS BLUE;EVAN'S BLUE;EVANS BLUE PURE;EVANS BLUE TET |
Evacetrapib | 1186486-62-3 | C31H36F6N6O2 | 638.659 | LY2484595; LY 2484595; LY-2484595 |
Euxanthone | 529-61-3 | C13H8O4 | 228.2 | 1,7-Dihydroxy-9H-xanthen-9-one;Eyxanthone;9H-Xanthen-9-one, 1,7-dihydroxy- |
Euscaphin B | 956869-95-7 | C14H26O4 | ||
Euscaphic acid | 53155-25-2 | C30H48O5 | 488.7 | |
Eurycomanone | 84633-29-4 | C20H24O9 | 408.4 | |
ETHYL 4-CYANO-2-OXOBUTYRATE | 152831-97-5 | C7H9NO3 | 155.15 | ETHYL 4-CYANO-2-OXOBUTYRATE |
Ethyl 4-chlorobenzoat | 85577-25-9 | C9H5D4ClO2 | 188.64 | 4-Chlorobenzoic Acid-d4; 4-Chlorobenzoic-d4 Acid |
Ethyl 4-chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylate | 144927-57-1 | C9H8ClN3O2 | 225.634 | |
Ethyl 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-b-D-thioglucopyranoside | 99409-32-2 | C22H25NO9S | 479.5 | |
Ethanone, 2-bromo-1-(1H-pyrrolo[2,3-b]pyridin-3-yl)- | 90929-73-0 | C7H6N2O | 0 | Ethanone, 2-bromo-1-(1H-pyrrolo[2,3-b]pyridin-3-yl)- |
Ethanone, 2-amino-1-(4-pyridinyl)-, hydrochloride (1:2) | 51746-83-9 | |||
Gelatin | 9000-70-8 | |||
Geissoschizine methyl ether | 60314-89-8 | C22H26N2O3 | 366.461 | Methyl (Z)-2-[(2S,3E,12bS)-3-ethylidene-2,4,6,7,12,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate |
Gefitinib-d6 | 1228664-49-0 | C22H18ClFN4O3D6 | 452.95 | N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine-d6; Iressa-d6 |
Gefitinib-d3 | 1173976-40-3 | C22H21D3ClFN4O3 | 449.926 | N-(3-Chloro-4-fluorophenyl)-7-(methoxy-d3)-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine; Iressa-d3; ZD 1839-d3; |
Gefitinib N-Oxide | 847949-51-3 | C22H24ClFN4O4 | 462.91 | Gefitinib Morpholine N-oxide; N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-oxido-4-morpholinyl)propoxy]-4-quinazolinamine; 4-(3-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)morpholine 4-oxide |
Gefitinib Impurity X | 230955-75-6 | C11H9ClN2O3 | 252.66 | 6-Acetoxy-4-chloro-7-methoxyquinazoline; 4-Chloro-6-acetoxy-7-methoxyquinazoline; 4-Chloro-7-methoxy-6-quinazolinol 6-acetate; Gefitinib interMediate V; 6-Quinazolinol, 4-chloro-7-Methoxy-, 6-acetate; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinop |
Gefitinib Impurity VIII | 788136-89-0 | C17H13ClFN3O3 | 361.76 | 4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinol 6-acetate; 4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl acetate; 6-Quinazolinol,4-[(3-chloro-4-fluorophenyl)amino]-7-methoxy-, 6-acetate; Gefitinib intermediate VI |
Gefitinib Impurity VII | 179688-53-0 | C11H10N2O4 | 234.21 | 3,4-Dihydro-4-oxo-6-acetoxy-7-methoxyquinazoline; 6-(Acetyloxy)-7-methoxy-4(3H)-quinazolinone; 3,4-Dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate; Gefitinib interMidiate IV; 7-Methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate |
Gefitinib Impurity VI | 7357-67-7 | C7H14ClNO | 163.65 | 4-(3-Chloropropyl)morpholine; 1-Chloro-3-morpholinopropane; 3-(Morpholin-4-yl)propyl Chloride; 3-Chloro-1-(morpholin-4-yl)propane; 3-Morpholinopropyl Chloride; NSC 28831; NSC 38889; N-(3-Chloropropyl)morpholine |
Gefitinib Impurity II | 153437-78-6 | C16H13ClFN3O2 | 333.75 | N-(3-chloro-4-fluorophenyl)-6 ,7-dimethoxyquinazolin-4-amine |
Gefitinib Impurity 2 | 675126-26-8 | C15H19N3O5 | 321.34 | 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile; 2-Nitro-4-Methoxy-5-(3-Morpholinopropoxy)benzonitrile; Benzonitrile, 4-Methoxy-5-[3-(4-Morpholinyl)propoxy]-2-nitro- |
Gefitinib Impurity 1 | 246512-44-7 | C15H23N3O4 | 309.37 | 2-Amino-4-methoxy-5-(3-morpholin-4-ylpropoxy)-benzamide |
Gefitinib Impurity | 13794-72-4 | C10H10N2O3 | 206.20 | 6,7-Dimethoxyquinazoline-4-one; 6,7-Dimethoxy-4(1H)-quinazolinone; 6,7-Dimethoxy-3,4-dihydroquinazolin-4-one; 6,7-Dimethoxy-4(3H)-quinazolinone; 6,7-Dimethoxy-4-quinazolone |
Gefitinib Impurity | 52805-46-6 | C8H7NO2 | 149.15 | 3-Hydroxy-4-methoxybenzonitril; Benzonitrile, 3-hydroxy-4-Methoxy-; 5-Cyano-2-methoxyphenol |
Gefitinib hydrochloride | 184475-55-6 | C22H25Cl2FN4O3 | 483.36 | Iressa hydrochloride; ZD 1839 hydrochloride; ZD-1839 hydrochloride; ZD1839 hydrochloride |
Gefitinib dihydrochloride | 184475-56-7 | 519.83 | 4-(3-Chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]quinazoline dihydrochloride; Gefitinib dihydrochloride | |
Gefitinib 3,4-Difluoro Impurity HCl | 184475-68-1 | C22H25F2N4O3Cl | 466.92 | |
Gefitinib | 184475-35-2 | C22H24ClFN4O3 | 446.90 | ZD1839 |
Gefarnate | 51-77-4 | C27H44O2 | 400.64 | [(2E)-3,7-dimethylocta-2,6-dienyl] (4E,8E)-5,9,13-trimethyltetradeca-4,8,12-trienoate; Farnesylacetate, Geranyl; Gefarnate; Gefarnil; Gepharnate; Geranyl Farnesylacetate; Ulco |
Gedunin | 2753-30-2 | C28H34O7 | 482.57 | |
Gedatolisib (PF-05212384, PKI-587) | 1197160-78-3 | C32H41N9O4 | 615.73 | N/A |
Geclosporin | 74436-00-3 | C63H113N11O12 | 1216.662 | Cyclosporin G; Cyclosporine G |
GEA 5024 | 144575-27-9 | C8H7ClN4O . HCl | 210.62 | 5-AMINO-3-(3-CHLORO-2-METHYLPHENYL)-1,2,3,4-OXATRIAZOLIUM CHLORIDE; GEA 5024 |
GDP-L-galactose sodium salt | 6815-91-4 | C16H23N5O16P2Na2 | 649.30 | Guanosine 5-diphosphate-L-galactose |
GDC-0853 | 1434048-34-6 | C37H44N8O4 | 664.81 | RG 7845;(S)-2-(3'-(hydroxymethyl)-1-methyl-5-((5-(2-methyl-4-(oxetan-3-yl)piperazin-1-yl)pyridin-2-yl)amino)-6-oxo-1,6-dihydro-[3,4'-bipyridin]-2'-yl)-7,7-dimethyl-3,4,7,8-tetrahydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one |
GDC-0837 | 1133432-49-1 | C33H36N6O3S | 596.74 | GDC-0837; GDC 0837; GDC0837. |
GDC-0834 | 1133432-46-8 | C33H36N6O3S | 596.74 | GDC-0834; GDC0834; GDC 0834 |
GDC-0810 (ARN-810) | 1365888-06-7 | C26H20ClFN2O2 | 446.91 | GDC0810; GDC 0810; GDC-0810; ARN810; ARN 810; ARN-810; RG6046; RG-6046; RG 6046. |
GDC-0623 | 1168091-68-6 | C16H14FIN4O3 | 456.216 | GDC-0623; GDC0632; GDC 0632. |
GDC-0575 | 1196541-47-5 | C16H20BrN5O | 378.27 | ARRY-575; RG7741; GDC0575 |
GDC-0425 | 1200129-48-1 | C18H19N5O | 321.38 | 5-((1-ethylpiperidin-4-yl)oxy)-9H-pyrrolo[2,3-b:5,4-c']dipyridine-6-carbonitrile;RG-7602 |
GDC-0349 | 1207360-89-1 | C24H32N6O3 | 452.559 | GDC-0349; GDC 0349; GDC0349; RG7603. |
GDC-0339 | 1428569-85-0 | C20H22F3N7OS | 465.50 | 5-amino-N-[5-[(4R,5R)-4-amino-5-fluoroazepan-1-yl]-1-methylpyrazol-4-yl]-2-(2,6-difluorophenyl)-1,3-thiazole-4-carboxamide GDC-0339 SCHEMBL14801965 BDBM110706 CS-4775 HY-16976 US8614206, 139 |
GDC-0326 | 1282514-88-8 | C19H22N6O3 | 382.42 | (S)-2-((2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)oxy)propanamide |
GDC-0152 | 873652-48-3 | C25H34N6O3S | 498.646 | GDC-0152; GDC0152; GDC 0152. |
GAT-100 | 1663564-42-8 | C25H28N4OS | 432.59 | GAT100; GAT-100; GAT 100; 3-ethyl-5-isothiocyanato-N-(4-(piperidin-1-yl)phenethyl)-1H-indole-2-carboxamide |
Gastrodin Impurity 1 | 26993-16-8 | C13H16O7 | 284.26 | |
Gastrodin | 62499-27-8 | C13H18O7 | 286.28 | 4Hydroxybenzyl alcohol 4-O-b-D-glucoside |
Gastrin-Releasing Peptide, human | 93755-85-2 | C130H204N38O31S2 | 2859.38 | H-Val-Pro-Leu-Pro-Ala-Gly-Gly-Gly-Thr-Val-Leu-Thr-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2; L-valyl-L-prolyl-L-leucyl-L-prolyl-L-alanyl-glycyl-glycyl-glycyl-L-threonyl-L-valyl-L-leucyl-L-threonyl-L-lysyl-L-methionyl-L-tyrosyl-L-prol |
Gastrin-14 | 60748-07-4 | C75H101N15O26 | 1628.69 | LEU-GLU-GLU-GLU-GLU-GLU-ALA-TYR-GLY-TRP-LEU-ASP-PHE-NH2; LEU-GLU-GLU-GLU-GLU-GLU-ALA-TYR-GLY-TRP-MET-ASP-PHE-NH2; [LEU15]-GASTRIN, 5-17; [LEU11]-MINIGASTRIN; (LEU11)-MINIGASTRIN I (HUMAN); H-LEU-GLU-GLU-GLU-GLU-GLU-ALA-TYR-GLY-TRP-LEU-ASP-PHE-NH2; H-LEU-G |
Gastrin/CCK antagonist 1 | 162271-52-5 | C28H32FN5O4 | 521.58 | Urea, N-[1-cyclohexyl-2,3,4,5-tetrahydro-2,4-dioxo-5-[2-oxo-2-(1-pyrrolidinyl)ethyl]-1H-1,5-benzodiazepin-3-yl]-N'-(4-fluorophenyl)- |
Gartanin | 33390-42-0 | C23H24O6 | 396.4 | 1,3,5,8-Tetrahydroxy-2,4-bis(3-methyl-2-butenyl)-9H-xanthen-9-one |
Garomefrine hydrochloride | 137431-04-0 | C9H14ClFN2O3S | 284.74 | NS 49;ABT 232; PNO 49B;((R)-(-)-3'-(2-Amino-1-hydroxyethyl)-4'-fluoro-methanesulfonanilide hydrochloride |
Garlic oil | 8000-78-0 | W99 | 0 | FEMA 2503; GARLIC; GARLIC OIL, CHINESE; GARLIC OIL, MEXICAN; allium sativum; alliumsativum(garlic); oilofgarlic; Oils,garlic |
Garjasmin | 144868-43-9 | C11H12O5 | 224.2 | (2aS,4aS,7aS,7bS)-2a,4a,7a,7b-Tetrahydro-2a-hydroxy-2H-1,7-dioxacyclopent[cd]indene-5-carboxylic acid methyl ester |
Garenoxacin Mesylate hydrate | 223652-90-2 | C24H26F2N2O8S | 540.53 | 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxoquinoline-3-carboxylic acid;methanesulfonic acid;hydrate BMS 284756 BMS-284756 BMS284756 garenoxacin |
Garenoxacin mesylate | 223652-82-2 | C24H24F2N2O7S | 522.52 | 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxoquinoline-3-carboxylic acid;methanesulfonic acid; 1-cyclopropyl-8-(difluoromethoxy)-7-(1-methyl-2,3-dihydro-1H-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid |
Garenoxacin | 194804-75-6 | C23H20F2N2O4 | 426.41 | 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxoquinoline-3-carboxylic acid BMS 284756 BMS-284756 BMS284756 garenoxacin |
Gardoside | 54835-76-6 | C16H22O10 | 374.34 | |
Gardneramine | 34274-91-4 | C23H28N2O5 | 412.486 | 1,2-Didehydro-2-deoxo-17-deoxy-2,17-epoxygardneramine oxindole |
GardiquiMod | 1020412-43-4 | C17H23N5O | 313.39742 | CHEMBL1085742; SCHEMBL1256396; CTK8G0003; BDBM50320067; 1-(4-amino-2-((ethylamino)methyl)-1H-imidazo[4,5-c]quinolin-1-yl)-2-methylpropan-2-ol; 1020412-43-4 |
Gardenolic acid B | 108864-53-5 | C30H46O5 | 486.693 | |
Gardenoin J | 1345109-46-7 | C30H48O5 | 488.7 | |
Gardenine | 139682-36-3 | C11H13NO4 | 223.2 | [2aS-(2aalpha,4aalpha,7aalpha,7balpha)]-2,2a,4a,7,7a,7b-Hexahydro-2a-hydroxy-1-oxa-7-azacyclopent[cd]indene-5-carboxylic acid methyl ester |
Gardenin B | 2798-20-1 | C19H18O7 | 358.342 | 4',6,7,8-Tetramethoxy-5-hydroxyflavone;5-Hydroxy-4',6,7,8-tetramethoxyflavone;5-O-Desmethyltangeretin;5-DesMethyltangeretin;5-O-DeMethyltangeretin;Demethyltangeretin |
Gardenia yellow | 94238-00-3 | Unspecified | GARDENIA YELLOW; Crocine; GARDENIAPIGMENT | |
GARDENIA ETHER | 122-73-6 | C12H18O | 178.28 | Amyl(iso) benzyl ether, Benzene, [(3-methylbutoxy)methyl]-, Benzyl isoamyl ether, Ether, benzyl isopentyl, GARDENIA ETHER, Isoamyl benzyl ether, Isopentyl benzyl ether |
Garcinone D | 107390-08-9 | C24H28O7 | 428.48 | 1,3,6-Trihydroxy-8-(3-hydroxy-3-methylbutyl)-7-methoxy-2-(3-methyl-2-buten-1-yl)-9H-xanthen-9-one |
Garcinone C | 76996-27-5 | C23H26O7 | 414.5 | 1,3,6,7-tetrahydroxy-8-(3-hydroxy-3-methylbutyl)-2-(3-methylbut-2-enyl)xanthen-9-one; 9H-Xanthen-9-one,1,3,6,7-tetrahydroxy-8-(3-hydroxy-3-Methylbutyl)-2-(3-Methyl-2-buten-1-yl)- |
Garcinol | 78824-30-3 | C38H50O6 | 602.8 | Camboginol; (1S,3Z,5R,7R)-3-[(3,4-dihydroxyphenyl)-hydroxymethylidene]-6,6-dimethyl-5,7-bis(3-methylbut-2-enyl)-1-[(2S)-5-methyl-2-prop-1-en-2-ylhex-4-enyl]bicyclo[3.3.1]nonane-2,4,9-trione |
Garciniaxanthone E | 173294-74-1 | C28H32O6 | 464.6 | 2-[(2E)-3,7-Dimethyl-2,6-octadien-1-yl]-3,4,6,8-tetrahydroxy-1-(3 -methyl-2-buten-1-yl)-9H-xanthen-9-one |
Garcinexanthone A | 1107620-67-6 | C19H18O6 | 342.4 | 3,4-Dihydro-7,10-dihydroxy-12-methoxy-2,2-dimethyl-2H,6H-pyrano[3,2-b]xanthen-6-one |
Garcenia cambogia | 90045-23-1 | C10H6Cl2N2 | Garcenia cambogia; Garcinia cambogia extract | |
Garbanzol | 1226-22-8 | C15H12O5 | 272.25 | (2R-trans)-3,4',7-Trihydroxyflavanone |
Garamine | 49751-51-1 | C13H27N3O6 | 321.374 | 2-Deoxy-6-O-[3-deoxy-4-C-methyl-3-(methylamino)-b-L-arabinopyranosyl]-D-streptamine |
Gaq3 | 14642-34-3 | |||
Ganoderol A | 104700-97-2 | C30H46O2 | 438.7 | Ganodermenonol |
Ganodermic acid TQ | 112430-66-7 | C32H46O5 | 510.715 | |
Ganodermanontriol | 106518-63-2 | C30H48O4 | 472.7 | 24,25,26-Trihydroxylanosta-7,9(11)-dien-3-one |
Ganodermanondiol | 107900-76-5 | C30H48O3 | 456.711 | (5R,10S,13R,14R,17R)-17-[(2R,5S)-5,6-dihydroxy-6-methylheptan-2-yl]-4,4,10,13,14-pentamethyl-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one |
Ganoderma lucidum extract | 223751-82-4 | Ganoderma lucidum extract; Reishi mushroom extract | ||
Ganoderlactone D | 1801934-15-5 | C27H38O7 | 474.26 | Chol-8-en-24-oicacid, 3,7,12,20-tetrahydroxy-4,4,14-trimethyl-11,15-dioxo-, g-lactone,(3b,5a,7b,12b)- |
GANODERIOLB(P)(PLEASECALL) | 106518-62-1 | C30H46O4 | 470.68 | |
Ganoderiol F | 114567-47-4 | C30H46O3 | 454.7 | 26,27-Dihydroxylanosta-7,9(11),24-trien-3-one |
Ganoderic acid SZ | 865543-37-9 | C30H44O3 | 452.679 | (Z)-Ganoderic acid S; Tyromycic acid |
Ganoderic acid S | 104759-35-5 | C30H44O3 | ||
Ganoderic acid N | 110241-19-5 | C30H42O8 | 530.65 | |
Ganoderic acid LM2 | 508182-41-0 | C30H42O7 | 514.65 | (7beta,23S,24E)-7,23-Dihydroxy-3,11,15-trioxo-lanosta-8,24-dien-26-oic acid |
Ganoderic acid I | 98665-20-4 | C30H44O8 | 532.674 | 6-[(3S,5R,7S,10S,13R,14R,17S)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-4-oxoheptanoic acid |
Ganoderic Acid H | 98665-19-1 | C32H44O9 | 572.7 | |
Ganoderic acid G | 98665-22-6 | C30H44O8 | (3beta,7beta,12beta)-3,7,12-trihydroxy-11,15,23-trioxolanost-8-en-26-oic acid | |
Ganoderic acid F | 98665-14-6 | C32H42O9 | ||
Ganoderic acid DM | 173075-45-1 | C30H44O4 | 468.678 | 3,7-Dioxolanosta-8,24-dien-26-oic acid |
Ganoderic acid D2 | 97653-94-6 | C30H42O8 | 530.65 | 7,12-Dihydroxy-3,11,15,23-tetraoxolanost-8-en-26-oic acid; 7,12-Dihydroxy-3,11,15,23-tetraoxo-(7beta,12beta)-Lanost-8-en-26-oic acid |
Ganoderic acid D | 108340-60-9 | C30H42O7 | ||
Ganoderic acid C6 | 105742-76-5 | C30H42O8 | ||
Ganoderic Acid C2 | 98296-48-1 | C30H46O7 | ||
Ganoderic acid C1 | 95311-97-0 | C30H42O7 | 514.65 | Ganoderic acid C |
Ganoderic acid B | 81907-61-1 | C30H44O7 | (2R,6R)-6-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxo-heptanoic acid | |
Ganoderenic acid E | 110241-23-1 | C30H40O8 | 528.642 | |
Ganoderenic acid D | 100665-43-8 | C30H40O7 | ||
Ganoderenic acid B | 100665-41-6 | C30H42O7 | Lanosta-8,20(22)-dien-26-oicacid, 3,7-dihydroxy-11,15,23-trioxo-, (3b,7b,20E)- | |
Ganoderenic acid A | 100665-40-5 | C30H42O7 | 514.7 | (E)-6-[(7S,10S,13R,14R,15S,17R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid |
Ganirelix Impurity F | 129225-22-5 | C32H31ClN4O5 | 587.08 | AC-D-2-NAL-D-4-CLPHE-D-3-PAL; N-Acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanine |
Gangliotriose | 1355005-58-1 | C20H35NO16 | 545.49 | Asialo-GM2-trisaccharide; N-Acetylgalactosamine b1-4 Lactose; Asialo GM2 oligosaccharide; GalNAc(b1-4)Gal(b1-4)Glc |
Gangliotetraose | 75645-24-8 | C26H45NO21 | 707.64 | Asialo-GM1-tetrasaccharide; Asialo GM1 oligosaccharide |
Ganglioside GT1a | 64522-98-1 | 0 | GT1A-GANGLIOSIDE; IV3(NEUAC)2, II3NEUAC-GGOSE4CER; trisialaoganglioside GT1a | |
GAMMA-CYHALOTHRIN | 76703-62-3 | C23H19ClF3NO3 | 449.85 | GAMMA-CYHALOTHRIN; Cyclopropanecarboxylic acid, 3-(2-chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethyl-, (S)-cyano(3-phenoxyphenyl)methyl ester, (1R,3R)-; (S)-cyano(3-phenoxyphenyl)methyl (1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethyl |
gamma-Cyclodextrin-2-hydroxypropyl ether | 99241-25-5 | C72H128O48 | 1761.76 | HGC; HYDROXYPROPYL-GAMMA-CYCLODEXTRIN; 2-HYDROXYPROPYL-GAMMA-CYCLODEXTRIN; gamma-Cyclodextrin-2-hydroxypropylether; Hydroxypropyl-5-cyclodextrin |
GAMMA-CHLORONORVALINE | 76265-38-8 | C5H10ClNO2 | 151.59 | |
GAMMA-CHLORDENE | 56641-38-4 | C10H6Cl6 | 338.875 | gamma-Chlordene; 56641-38-4 |
Furosemide acyl glucuronide | 72967-59-0 | C18H19ClN2O11S | 506.87 | (2S,3S,4S,5R)-6-[4-Chloro-2-(2-Furylmethylamino)-5-Sulfamoyl-Benzoyl]Oxy-3,4,5-Trihydroxy-Tetrahydropyran-2-Carboxylic Acid; (2S,3S,4S,5R)-6-[[4-Chloro-2-(2-Furylmethylamino)-5-Sulfamoylphenyl]-Oxomethoxy]-3,4,5-Trihydroxy-2-Tetrahydropyrancarboxylic Acid |
Furofenac | 56983-13-2 | C12H14O3 | 206.238 g/mol | Furofenac; Sas-650; Furofenac[INN]; Furofenacum[INN-Latin]; Furofenaco[INN-Spanish]; 56983-13-2 |
Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one,5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, (5R,5aR,8aR,9S)- | 4375-07-9 | C22H22O8 | 414.4 | Etopside |
Foresaconitine | 73870-35-6 | C35H49NO9 | 627.76 | Vilmorrianine C |
Forasartan | 145216-43-9 | C23H28N8 | 416.52 | Forasartan; UNII-065F7WPT0B; SC-52458; CHEMBL315021; 5-[(3,5-dibutyl-1,2,4-triazol-1-yl)methyl]-2-[2-(2H-tetrazol-5-yl)phenyl]pyridine |
Foodblue No.1 aluminum lake | 68921-42-6 | C37H36N2O9S3 | 748.88500 | |
ferroceneacetonitrile | 1316-91-2 | C12H11FeN 10* | 225.07 | FERROCENEACETONITRILE; Ferroceneactonitrile; FERROCENYLACETONITRILE (SEE 1215); FERROCENYLACETONITRILE (SEE 1762); Nsc301053 |
Ferrocene,(8-mercaptooctyl)- (9CI) | 146056-20-4 | C18H26 Fe S | 0 | 8-Ferrocenyl-1-Octanethiol |
Ferrocene,(2-aminoethyl)- | 41312-65-6 | C12H15 Fe N | 229.0992;g/mol | 2-Ferrocenylethylamine;AC1MIZ0W;Ferrocene,(2-aminoethyl)-;FERROCENE,(2-AMINOETHYL)-;OR055803;OR268738 |
Ferrocene, decachloro- | 11121-63-4 | C10Cl10Fe-10 | 530.4853 | |
Fenaclonum | 306-20-7 | C11H14ClNO | 211.691 | 3-chloro-N-(2-phenylethyl)propanamide Fenaclon Phenacone Fenakon Fenaclonum 306-20-7 3-Chloro-N-phenethylpropionamide |
Felypressin Acetate | 914453-97-7 | C46H65N13O11S2. 2.5C2H4O2 | 1040.22 | 2-L-Phenylalanine-8-L-lysinevasopressin Acetate (Salt); 2,3-Bis(phenylalanine)-8-lysineoxytocin Acetate; 2-(Phenylalanine)-8-lysinevasopressin Acetate; 2-Phenylalanine-8-lysine-vasopressin Acetate; |
Falecalcitriol | 83805-11-2 | C27H38F6O3 | 524.58 | Fulstan; Hornel |
EXO-BREVICOMIN | 64313-75-3 | C9H16O2 | 156.22 | EXO-BREVICOMIN; (1S,5R,7S)-7-Ethyl-5-methyl-6,8-dioxabicyclo[3.2.1]octane |
exo-3-azabicyclo[3.1.0]hexane-6-methanol | 134575-13-6 | C6H11NO | 113.16 | |
exo-3-Amino-8-Boc-8-azabicyclo[3.2.1]octane | 744183-20-8 | C12H22N2O2 | 226.318 | |
EXO-3,6-EPOXY-1,2,3,6-TETRAHYDROPHTHALIC ANHYDRIDE | 6766-44-5 | C8H6O4 | 166.13 | EXO-3,6-EPOXY-1,2,3,6-TETRAHYDROPHTHALIC ANHYDRIDE; EXO-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLIC ANHYDRIDE; EXO-7-OXABICYCLO[2.2.1]HEPTENE-2,3-DICARBOXYLIC ANHYDRIDE; 5,6-DEHYDRONORCANTHARIDIN; 7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLIC ANHYDRID |
Gamma-Aminobutyric Acid Almotriptan | 603137-41-3 | C17H25N3O4S | 367.47 | Almotriptan Metabolite M2 |
GAMMA-ACETYLENIC GABA | 57659-38-8 | C6H9NO2 | 127.14 | 4-AMINO-5-HEXYNOIC ACID; GAMMA-ACETYLENIC GABA; 4-amino-5-hexynoicaci; RMI-71645 |
Gamma Linoleic Acid | 506-26-3 | C18H30O2 | 278.43 | gamma-Linolenicacid; GAMOLENICACID; (6Z,9Z,12Z)-octadeca-6,9,12-trienoicacid; 506-26-3; Ligla; (Z,Z,Z)-6,9,12-Octadecatrienoicacid |
Gallium (III) Nitrate | 69365-72-6 | Ga(NO3)3.XH2O | 255.73 | |
Fosfluconazole | 194798-83-9 | C13H13F2N6O4P | 386.26 | [2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-yl] dihydrogen phosphate; Fosfluconazole; Fosfluconazole [INN:BAN]; Procif; UK 292663; UK-292,663; UNII-3JIJ299EWH |
Fosfestrol Sodium | 23519-26-8 | C18H18Na4O8P2 | ||
Fosetyl-aluminum | 39148-24-8 | C6H18O9P3.Al;C6H18AlO9P3 | 354.10 | 32545rp; alietteextra; aluminiumphosethyl; Aluminiumtriethylphosphonate; aluminiumtris(ethylphosphonate); aluminumphosethyl |
Fosdevirine | 1018450-26-4 | C20H17ClN3O3P | 413.80 | GSK2248761;GSK-2248761;GSK2248761A;GSK-2248761A;IDX899;IDX-899;Methyl (E)-(2-carbamoyl-5-chloro-1H-indol-3-yl)(3-(2-cyanovinyl)-5-methylphenyl)phosphinate;5-Chloro-3-[[3-[(E)-2-cyanoethenyl]-5-methylphenyl]-methoxyphosphoryl]-1H-indole-2-carboxamide |
Foscarnet Sodium | 63585-09-1 | CNa3O5P | 191.95 | SL 75212 |
Fosbretabulin disodium | 168555-66-6 | C18H19Na2O8P | 440.295 | Combretastatin A-4 phosphate disodium, CA4P; CA4DP; Combretastatin A-4 phosphate |
Fosbretabulin | 222030-63-9 | C18H21O8P | 396.33 | [2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl] dihydrogen phosphate; 3,4,5-trimethoxy-3'-hydroxy-4'-methoxystilbene; CA4DP; combretastatin A-4; 168555-66-6 (fosbretabulin disodium); 82855-09-2 (combretastatin); 117048 -59-6 (combretasta |
Fosaprepitant Dimeglumine | 265121-04-8 | C23H22F7N4O6P.2C7H17NO5 | 1004.83 | MK-0517; MK 0517; MK0517 |
Fosaprepitant Benzyl Ester | 889852-02-2 | C30H28F7N4O6P | 704.54 | Monobenzyl Fosaprepitant |
Fevipiprant | 872365-14-5 | C19H17F3N2O4S | 426.41 | NVP-QAW-039 QAW-039; 2-(2-methyl-1-(4-(methylsulfonyl)-2-(trifluoromethyl)benzyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)acetic acid |
Fesoterodine-d14 Fumarate | 1185237-08-4 | C26H23NO3D14·C4H4O4 | 534.69 | 2-Methylpropanoic Acid 2-[rac-3-[Bis(1-methylethyl-d7)amino]-1-phenylpropyl] -4-(hydroxymethyl)phenyl Ester (2E)-2-Butenedioate |
Fesoterodine Related Impurity 8 (Fesoterodine Impurity P) | 1380491-71-3 | C48H66N2O4 | 735.07 | Fesoterodinyl (4-Hydroxy-tolterodine phenoxy) Ether; |
Fenticonazole Impurity E | 1313397-06-6 | C37H31Cl2N2OS2 NO3 | 654.71 62.00 | |
Fenticonazole Impurity D | 1313397-05-5 | C24H21Cl2N2OS NO3 | 518.42 | |
Fenticonazole Impurity C Nitrate | 80676-29-5 | C24H20Cl2N2O3S. HNO3 | 550.41 | Fenticonazole Sulfone Nitric Acid Salt; 1-[2-(2,4-Dichlorophenyl)-2-[[4-(phenylsulfonyl)phenyl]methoxy]ethyl]-1H-imidazole Nitrate; |
Fenticonazole Impurity B Nitrate | 80639-95-8 | C24H20Cl2N2O2S. HNO3 | 534.41 | Fenticonazole Sulfoxide Nitric Acid Salt; 1-[2-(2,4-Dichlorophenyl)-2-[[4-(phenylsulfinyl)phenyl]methoxy]ethyl]-1H-imidazole Nitrate; |
Fenthoxon Sulfoxide | 6552-13-2 | Dimethyl-(3-methyl-4- methylsulfinyl phenyl) phosphate | ||
Fenthoxon Sulfone | 14086-35-2 | Dimethyl-(3-methyl-4- methylsulfonyl phenyl) phosphate | ||
Gallic aldehyde | 13677-79-7 | C7H6O4 | 154.12 | Gallaldehyde; 3,4,5-Trihydroxybenzaldehyde |
Gallic acid stearyl ester | 10361-12-3 | C25H42O5 | 422.6 | STEARYL GALLATE; OCTADECYL GALLATE; OCTADECANYL GALLATE; Benzoicacid,3,4,5-trihydroxy-,octadecylester; 3,4,5-TRIHYDROXYBENZOIC ACID STEARYL ESTER; GALLIC ACID STEARYL ESTER; Octadecyl 3,4,5-trihydroxybenzoate; 3,4,5-TRIHYDROXYBENZOIC ACID STEARYL ESTER (T |
Gallic acid | 149-91-7 | C7H6O5 | 170.1 | 3,4,5-trihydroxybenzoic acid |
Gallein | 2103-64-2 | C20H12O7 | 364.31 | 3',4',5',6'-Tetrahydroxyspiro[isobenzofuran-1(3H),9'-(9H)xanthen]-3-one; Alizarin violet; Pyrogallolphthalein; C.I. Mordant Violet 25; 4,5-Dihydroxyfluorescein |
Gallamine Triethiodide | 65-29-2 | C30H60I3N3O3 | 891.53 | |
GALL | 8008-63-7 | |||
Galiellalactone | 133613-71-5 | C11H14O3 | 194.2 | |
Galgravin | 528-63-2 | C22H28O5 | 372.46 | Galbelgin |
Galeterone | 851983-85-2 | C26H32N2O | 388.555 | TOK-001; TOK 001; VN 124; VN/124-1; (3S,8R,9S,10R,13S,14S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol |
Galbanum oxyacetate | 68901-15-5 | C11H18O3 | 198.26 | allyl cyclohexyloxyacetate; galbanum oxyacetate; Cyclohexyloxyacetic acid 2-propenyl ester; CYCLOGALBANATE; (cyclohexyloxy)-aceticaci2-propenylester; Aceticacid,(cyclohexyloxy)-,2-propenylester; Allyl cyclohexoylacetate; Allyl-(cyclohexyloxy)acetat |
Galantide | 138579-66-5 | C104H151N25O26S | 2199.53 | H-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2; glycyl-L-tryptophyl-L-threonyl-L-leucyl-L-asparagyl-L-seryl-L-alanyl-glycyl-L-tyrosyl-L-leucyl-L-leucyl-glycyl-L-prolyl-L-glutaminyl-L-glutaminyl-L-phenylalanyl-L-pheny |
Galanthamine | 357-70-0 | C17H21NO3 | 287.36 | galanthamine; Galantamine; Reminyl; 357-70-0; Lycoremine; (-)-Galanthamine; Galantamin; Lycoremin; Jilkon; Nivalin; Razadyne; Galantamina; Galanthaminum; Galantaminum; Razadyne ER; Galantaminum [INN-Latin]; CHEMBL659; 1qti; Ortho McNeil Neurologics Bran |
Galantaminone | 510-77-0 | C17H19NO3 | 285.34 | (-)-Narwedine; Narwedin |
Galangin-3-rutinoside | 16268-50-1 | C27H30O14 | 578.52 | |
Galangin 3-methyl ether | 6665-74-3 | C16H12O5 | 284.3 | 3-O-Methylgalangin; 5,7-Dihydroxy-3-methoxyflavone |
Galangin | 548-83-4 | C15H10O5 | 270.24 | 3,5,7-trihydroxy-2-phenyl-4h-benzopyran-4-on; 3,5,7-trihydroxyflavone |
Galanganone C | 1922129-46-1 | C32H36O5 | 500.63 | |
Galanganone B | 1922129-43-8 | C34H40O6 | 544.68 | |
Galanganone A | 1922129-42-7 | C32H36O6 | 516.63 | |
Gadolinium chloride hydrate | 19423-81-5 | |||
Gadolinium chloride | 10138-52-0 | GdCl3 | 263.61 | Gadolinium trichloride; trichlorogadolinium |
Gadolinium acetate tetrahydrate | 15280-53-2 | |||
Gadodiamide | 122795-43-1 | C16H28GdN5O9C16H28GdN5O9.xH2O | 591.67 | N/A |
Gadobutrol Impurity 3 | 112188-16-6 | C14H23GdN4O6 | 500.60 | Gd-DO3A |
Gadobutrol | 138071-82-6 | C18H31GdN4O9 | 604.71 | Gadograf; Gadovist; Protovist; ZK 135079; Gd-DO3A-butrol; Gallium 10-(1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-tricarboxylate; AK325914; gallium |
Gadobutrol | 770691-21-9 | C18H31GdN4O9 | 604.71 | Gadograf; Gadovist; Protovist; ZK 135079; Gd-DO3A-butrol; Gallium 10-(1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-tricarboxylate; 770691-21-9; AK325914; gallium; 10-(1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetrazacyclododecane-1,4,7-tric |
Gadobenate Dimeglumine | 127000-20-8 | C22H28GdN3O11 | 1058.14838;g/mol | Gadobenate Dimeglumine |
Gaboxadol | 64603-91-4 | C6H8N2O2 | 140.14 | OV-101;Lu-02-030;MK-0928;Lu-02030;MK0928;Lu02030;THIP;4,5,6,7-Tetrahydroisoxazolo(5,4-c)pyridin-3(2H)-one;4,5,6,7-Tetrahydro-[1,2]oxazolo[5,4-c]pyridin-6-ium-3-one |
Gabexate Mesylate | 39492-01-8 | C16H23N3O4 | 321.375 | GABEXATE;GabexateMesylateBase;[N'-[5-(4-ethoxycarbonylphenoxy)carbonylpentyl]carbamimidoyl]azanium methanesulfonate;4-[(6-Guanidinohexanoyl)oxy]benzoic acid ethyl ester;4-[[6-[[Amino(imino)methyl]amino]-1-oxohexyl]oxy]benzoic acid ethyl ester |
Gabexate mesylate | 56974-61-9 | C17H27N3O7S | 417.48 | 4-[[6-[(Aminoiminomethyl)amino]-1-oxohexyl]oxy]-benzoic acid ethyl ester mesylate; Gabexate; Gabexate mesylate; gabexate mesilate. Arodate; Megacart; Megacert; Mesyl Gabexate; Arodate. |
Gabapentin-d6 HCl | 1432061-73-8 | C9H12NO2D6Cl | 213.74 | Gabapentin-d6 Hydrochloride; 1-(Aminomethyl)cyclohexane-d6-acetic Acid Hydrochloride |
Gabapentin-d4 | 1185039-20-6 | C9H13NO2D4 | 175.26 | |
Gabapentin-D10 | 1126623-20-8 | C9H7D10NO2 | 181.29 | |
Gabapentin Related Material D | 1076198-17-8 | C18H29NO3 | 307.44 | 1-[(3-Oxo-2-azaspiro[4.5]dec-2-yl)methyl]cyclohexaneacetic acid; [1-(3-Oxo-2-aza-spiro[4,5]dec-2-ylmethyl)cyclohexyl]acetic Acid; USP Gabapentin Related Compound D; Gabapentin USP RC D |
Gabapentin Related Material B | 133481-09-1 | C9H13NO2 | 167.21 | (1-cyanocyclohexyl)acetic acid; 2-(1-Cyanocyclohexyl)acetic acid; Gabapentin USP RC B; 1-Cyanocyclohexaneacetic Acid; USP Gabapentin Related Compound B |
Gabapentin Related Compound E | 67950-95-2 | C9H14O4 | 186.21 | 1-Carboxycyclohexaneacetic acid; NSC 90823; Gabapentin USP RC E; 1-(CarboxyMethyl)cyclohexane-1-carboxylic acid |
Gabapentin Impurity 3 | 1130-32-1 | C10H15NO2 | 181.24 | 3,3-Pentamethyleneglutarimide; 1,1-Cyclohexane diacetimide; 3,3-Pentamethylene Glutarimide; 2,4-Dioxo-3-azaspiro[5.5]undecane; 1,1-Cyclohexanediacetimide; 3-Azaspiro[5.5]undecane-2,4-dione; NSC 400093 |
Gabapentin Impurity 2 | 4355-11-7 | C10H16O4 | 200.24 | 3,3-Pentamethyleneglutaric Acid; Cyclohexane-1,1'-diacetic acid; 1,1-Cyclohexanediacetic acid; Cyclohexanediacetic acid; 1,1-Bis(carboxymethyl)cyclohexane; NSC 169443; NSC 39839 |
Gabapentin hydrochloride | 60142-95-2 | C9H17NO2.HCl | 207.7 | |
Gabapentin | 60142-96-3 | C9H17NO2 | 171.24 | 1-(Aminomethyl)-cyclohexaneacetic acid; Neurontin; GOE-3450 |
GA3-AM | 1373154-68-7 | C22H26O8 | 418.44 | (1S,2S,4aR,4bR,7S,9aS,10S,10aR)-1,2,4b,5,6,7,8,9,10,10a-Decahydro-2,7-dihydroxy-1-methyl-8-methylene-13-oxo-4a,1-(epoxymethano)-7,9a-methanobenz[a]azulene-10-acetic acid (acetyloxy)methyl ester; Gibberellic Acid Acetoxymethyl Ester |
GA1-Ganglioside | 71012-19-6 | C62H114N2O23 | 1255.6 | Ganglio-N-tetraosylceramide; Ceramide tetrahexoside; GgOse4Cer; asialo-GM1 |
G-749 | 1457983-28-6 | C25H25BrN6O2 | 521.41 | |
G-573 | 22868-35-5 | C13H9ClN2 | 228.679 | G-573 |
Furosemide-d5 | 1189482-35-6 | C12H6ClN2O5SD5 | 335.78 | 5-(Aminosulfonyl)-4-chloro-2-[(2-furanyl-methyl)amino]benzoic Acid-d5; 4-Chloro-N-furfuryl-5-sulfamoylanthranilic Acid-d5; 2-Furfurylamino-4-chloro- 5-sulfamoylbenzoic Acid-d5; 4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic Acid-d5; Disal-d5; Discoid-d |
Furosemide Impurity F | 4793-38-8 | C12H15ClN2O5S | 334.78 | Tetrahydro Furosemide; 4-Chloro-5-sulfamoyl-N-(tetrahydrofurfuryl)anthranilic Acid; 4-Chloro-5-Sulfamoyl-2-[[((2RS)-Tetrahydrofuran-2-yl)methyl]amino]Benzoic Acid |
Furosemide Impurity D | 5046-19-5 | C17H17N3O6S | 391.41 | 4-Deschloro-4-(2-furanylmethyl)amino Furosemide; 5-(Aminosulfonyl)-2,4-bis[(2-furanylmethyl)amino]benzoic Acid; 2,4-Bis(furfurylamino)-5-sulfamoylbenzoic Acid |
Furosemide Impurity C | 3086-91-7 | C7H7ClN2O4S | 250.66 | 4-Chloro-5-sulfamoylanthranilic acid; 4-Chloro-5-sulfamylanthranilic acid; Desfurylmethylfurosemide; Saluamine; 4-Chloro-5-sulfamoyl-anthranilic Acid; 2-Amino-4-chloro-5-sulfamoylbenzoic Acid; 4-Chloro-5-sulfamoylanthranilic Acid |
Furosemide Impurity B | 2736-23-4 | C7H5Cl2NO4S | 270.09 | 2,4-Dichloro-5-aminosulfonylbenzoicacid; 2,4-Dichloro-5-sulfamoylbenzoic Acid; 3-Sulfamoyl-4,6-dichlorobenzoic acid; 5-Aminosulfonyl-2,4-dichlorobenzoic acid; 5-Carboxy-2,4-dichlorobenzenesulfonamide |
Furosemide Impurity A | 4818-59-1 | C12H11ClN2O5S | 330.75 | Iso Furosemide; 2-Chloro-4-(furfurylaMino)-5-sulfaMoylbenzoic Acid; Isolasix; 5-(Aminosulfonyl)-2-chloro-4-[(2-furanylmethyl)amino]benzoic Acid; H 20 |
Furilazole | 121776-33-8 | C11H13Cl2NO3 | 278.13 | (RS)-3-Dichloroacetyl-5-(2-furanyl)-2,2-dimethyl-1,3-oxazolidine |
FURFURYL PROPIONATE | 623-19-8 | C8H10O3 | 154.17 | 2-Furanmethanol, propanoate, FURFURYL PROPIONATE |
Furfuryl methyl disulfide | 57500-00-2 | C6H8OS2 | 160.25 | 2-[(Methyldisulfanyl)methyl]furan; 2-[(methyldithio)methyl]-fura; 2-[(methyldithio)methyl]furan; 2-furfurylmethyl-disulphide; Furan, 2-[(methyldithio)methyl]-; METHYL FURFURYL DISULFIDE; METHYL FURFURYL DISULPHIDE; LABOTEST-BB LT00159945 |
Furfuryl isopropyl sulfide | 1883-78-9 | C8H12OS | 156.24 | ISOPROPYL FURFURYL SULPHIDE; FURFURYL ISOPROPYL SULFIDE; FURFURYL ISOPROPYL SULPHIDE; FEMA 3161; 2-[[(1-Methylethyl)thio]methyl]furan; 2-Furylmethyl isopropyl sulfide |
Furfuryl glycidyl ether | 5380-87-0 | C8H10O3 | 154.16 | FURFURYL GLYCIDYL ETHER; AKOS NCG-0070; 2,3-EPOXYPROPYL FURFURYL ETHER; 2-[(OXIRANYLMETHOXY)METHYL]FURAN; 2-((2,3-epoxypropoxy)methyl)-fura; 2-((2,3-epoxypropoxy)methyl)furan; 2-((oxiranylmethoxy)methyl)-fura; FURFURYL GLYCIDYL ETHER 98% |
FURFURYL ACETATE | 623-17-6 | C7H8O3 | 140.13 | 2-Furanmethanol, acetate, FURFURYL ACETATE |
FURFURAL ACETONE | 623-15-4 | C8H8O2 | 136.15 | 3-Buten-2-one, 4-(2-furanyl)-, 4-(2-Furyl)-3-buten-2-one, FURFURAL ACETONE, Furfurylidenacetone, FURFURAL ACETONE NO ANTIOXIDANT (special order) |
Furegrelate sodium salt | 85666-17-7 | C15H10NO3·Na | 275.2 | U-63557A; 5-(3-pyridinylmethyl)-2-benzofurancarboxylic acid, sodium salt |
Furcellaran | 9000-21-9 | Danish agar | ||
Furazolidone-D4 | 1217222-76-8 | 3-[(5-Nitro-furan-2- ylmethylene)-amino]- oxazolidin-2-one-D4 | ||
Furazolidone | 67-45-8 | C8H7N5O3 | 225.16 | 3-[[(5-Nitro-2-furanyl)methylene]amino]-2-oxazolidinone;3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one; Topazone;Trifurox |
Furanone C-30 | 247167-54-0 | C5H2Br2O2 | 253.88 | (5Z)-4-Bromo-5-(bromomethylene)-2(5H)-furanone |
Furanodienone | 24268-41-5 | C15H18O2 | 230.3 | Isofuranodienone |
Furanodiene | 19912-61-9 | C15H20O | 216.32 | Isofuranodiene; Furanoelemene (furanodiene) |
Furano(2" | 1454619-70-5 | 3"":7 | 6)-4'-hydroxyflavanone" | C17H12O4 |
Furan-3-carboxylic acid | 488-93-7 | C5H4O3 | 112.08 | furan-3-carboxylic acid |
furan-2-ylmethylazanium; hydroxy(phenyl)phosphinate | 18032-70-7 | C11H14NO4P | 255.207 g/mol | |
FURAN-2-SULFONYL CHLORIDE | 52665-48-2 | C4H3ClO3S | 166.58 | FURAN-2-SULFONYL CHLORIDE; FURAN-2-SULPHONYL CHLORIDE; Furane-2-sulfonylchloride; Furan-2-sulphonyl chloride 97+% |
Furan-2-carboxylic acid | 88-14-2 | C5H4O3 | 112.08 | 2-Furoic acid, alpha-Furancarboxylic acid |
Furan-2,3-dicarboxylic acid | 4282-24-0 | C6H4O5 | 156.09 | IFLAB-BB F2108-0152; FURAN-2,3-DICARBOXYLIC ACID; AKOS 214-66 |
Furan,tetrahydro-2,2,5,5-tetramethyl- | 15045-43-9 | C8H16 O | 128.21 | TETRAHYDRO-2,2,5,5-TETRA-METHYLFURAN; 2,2,5,5-TETRAMETHYLTETRAHYDROFURAN; 2 2 5 5-TETRAMETHYLTETRAHYDROFURAN 97%; 2,2,5,5-Tetramethyltetrahydrofurane; 2,2,5,5-Tetramethyltetrahydrofuran,98% |
FURAN, 3-(CHLOROMETHYL)TETRAHYDRO- | 89181-22-6 | C5H9ClO | 120.58 | FURAN, 3-(CHLOROMETHYL)TETRAHYDRO-; 3-(Chloromethyl)tetrahydrofuran |
Furan, 2-decyl- | 83469-85-6 | C14H24 O | ||
Furamidine dihydrochloride | 55368-40-6 | C18H16N4O.2HCl | 377.27 | 4,4'-(2,5-Furandiyl)bis-benzenecarboximidamide dihydrochloride |
FURAMETPYR | 123572-88-3 | C17H20ClN3O2 | 333.81 | FURAMETPYR; furametpyr (bsi, pa e-iso); s-82658; FURAMETPYR STANDARD |
Furaltadone-D5 | 1015855-64-7 | 5-morpholin-4-ylmethyl- 3-(5-nitro-furan-2- ylmethyleneamino)- oxazolidin-2-one-D5 | ||
Furaltadone Hydrochloride | 3759-92-0 | C13H16N4O6.HCl | 360.75 | |
Furalazine | 556-12-7 | C9H7N5O3 | 233.18 | Furalazinum;Nifuralazinum;Panfuran;1,2,4-Triazin-3-amine, 6-(2-(5-nitro-2-furanyl)ethenyl)- (9CI);Furalazin;6-[(E)-2-(5-nitrofuran-2-yl)ethenyl]-1,2,4-triazin-3-amine;6-[2-(5-Nitro-2-furanyl)vinyl]-1,2,4-triazin-3-amine |
Furagin | 1672-88-4 | C10H8N4O5 | 264.19 | Furazidine; Furazidin |
Furafylline | 80288-49-9 | C12H12N4O3 | 260.3 | 3-(2-furanylmethyl)-3,9-dihydro-1,8-dimethyl-1H-purine-2,6-dione |
fulvene | 497-20-1 | C6H6 | 78.1118 g/mol | |
Fuegin | 6750-10-3 | C15H22O4 | 266.3 | (+)-Fuegin |
Fudosteine | 13189-98-5 | C6H13NO3S | 179.24 | Fudosteine; SS-320A; SS 320A; SS320A; Cleanal; Spelear |
Fucoxanthin | 3351-86-8 | C42H58O6 | 658.92 | All-trans-Fucoxanthin |
Fucosyl-GM1 ganglioside | 71812-11-8 | C79H141N3O35 | 1692.96 | Fucosylated monosialoganglioside GM1 |
Friedelin 3,4-lactone | 29621-75-8 | C30H50O2 | 442.728 | Friedelalactone |
Friedelin | 559-74-0 | C30H50O | 426.7 | FRIEDELAN-3-ONE; DA-FRIEDOOLEANAN-3-ONE; |
FRG8701 | 108498-50-6 | C22H30N2O4S | 418.55 | 2-(furan-2-ylmethylsulfinyl)-N-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]acetamide; FRG 8701; FRG-8701; N-(3-(3-(piperidinylmethyl)phenoxy)propyl)-2-(furfurylsulfinyl)acetamide |
Freselestat | 208848-19-5 | C23H28N6O4 | 452.51 | 2-(5-amino-6-oxo-2-phenylpyrimidin-1-yl)-N-[1-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-3-methyl-1-oxobutan-2-yl]acetamide; ONO 6818; ONO-6818 |
Frentizole | 26130-02-9 | C15H13N3O2S | 299.35 | 1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea; 7EY946394I; frentizole; mono-hydrate of frentizole; FRENTIZOLE; 26130-02-9; Frentizol; Compound 53616; MLS000555007; CHEMBL128988; UNII-7EY946394I; 1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea; NCGC0 |
Fraxiresinol 1-O-glucoside | 89199-94-0 | C27H34O13 | 566.6 | (+)-Fraxiresinol 1-beta-D-glucoside |
Fraxinol | 486-28-2 | C11H10O5 | 222.2 | 5,7-Dimethoxy-6-hydroxycoumarin;6-Hydroxy-5,7-dimethoxy-2H-1-benzopyran-2-one;6-Hydroxy-5,7-dimethoxycoumarin;Fraxil |
Fraxidin | 525-21-3 | C11H10O5 | 222.19 | 6,7-Dimethoxy-8-Hydroxycoumarin;8-Hydroxy-6,7-dimethoxycoumarin;8-Hydroxy-6,7-dimethoxy-2-benzopyrone;8-Hydroxy-6,7-dimethoxy-2H-1-benzopyran-2-one;2H-1-Benzopyran-2-one, 8-hydroxy-6,7-dimethoxy- |
Fraxetin | 574-84-5 | C10H8O5 | 208.17 | 7,8-Dihydroxy-6-methoxycoumarin;7,8-Dihydroxy-6-methoxy-2H-chromen-2-one;2H-1-Benzopyran-2-one, 7,8-dihydroxy-6-methoxy-;Fraccetain |
Fraxamoside | 326594-34-7 | C25H30O13 | 538.5 | |
FRAX597 | 1286739-19-2 | C29H28ClN7OS | 558.10 | N/A |
FRAX486 | 1232030-35-1 | C25H23Cl2FN6O | 513.39 | FRAX486; FRAX-486; 6-(2,4-dichlorophenyl)-8-ethyl-2-(3-fluoro-4-piperazin-1-ylanilino)pyrido[2,3-d]pyrimidin-7-one; C25H23Cl2FN6O; FRAX 486 |
FRAX1036 | 1432908-05-8 | C28H32ClN7O | 518.06 | 6-[2-chloro-4-(6-methylpyrazin-2-yl)phenyl]-8-ethyl-2-[2-(1-methylpiperidin-4-yl)ethylamino]pyrido[2,3-d]pyrimidin-7-one FRAX1036 SCHEMBL14928919 CS-5585 HY-19538 |
FRANGULIN A | 60529-33-1 | C21H20O9 | 416.38 | RAHMNOXANTHIN; EMODIN-6-(L)-O-RHAMNOSIDE; EMODIN-6-O-RHAMNOSIDE; EMODIN-L-RHAMNOSIDE; FRANGULIN; FRANGULIN A; CASCARIN; FRANGULIN(SH) |
Framycetin sulphate | 4146-30-9 | C23H48N6O17S | 712.72 | Neomycin Sulphate B; (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2S,3S,4S,5R,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane- |
Fragransin A2 | 112652-46-7 | C20H24O5 | 344.4 | 4,4'-[(2R,3R,4R,5R)-3,4-Dimethyltetrahydrofuran-2,5-diyl]bis(2-me thoxyphenol) |
FRACTOGEL(R) EMD TMAE | 151354-30-2 | 0 | FRACTOGEL EMD TMAE HICAP 650, M; FRACTOGEL(R) EMD TMAE; FRACTOGEL(R) EMD TMAE HICAP | |
FR-A 19 | 141099-46-9 | C25H34Cl3F2N5 | 548.93 | N,N-bis(3-(4-fluorophenyl)propyl)-N'-(3-(1H-imidazol-4-yl)propyl)-Guanidine trihydrochloride |
FR-900490 | 105424-59-7 | C14H22N6O6 | 370.37 | (2S,3R)-2-[(L-Asparaginyl)amino]-3-[[(S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]amino]butanoic acid;FR900490;BMY 28700;(2S,3R)-3-[[(1S)-1-carboxy-2-(1H-imidazol-5-yl)ethyl]amino]-2-[[(2S)-2,4-diamino-4-oxobutanoyl]amino]butanoic acid;Butanoic acid, L-asparag |
FPS-ZM1 | 945714-67-0 | C20H22ClNO | 327.85 | N-benzyl-4-chloro-N-cyclohexylbenzaMide;4-Chloro-N-cyclohexyl-N-(phenylmethyl)benzamide |
FPR A14 | 329691-12-5 | C23H20N2O5 | 404.42 | AG 14; 1,3-Benzodioxolane-5-carboxylic acid 4'-benzyloxy-3'-methoxybenzylidene hydrazide |
FPL 64176 | 120934-96-5 | C22H21NO3 | 347.41 | 2,5-Dimethyl-4-[2-(phenylmethyl)benzoyl]-1H-pyrrole-3-carboxylic acid methyl ester; Methyl 4-(2-benzylbenzoyl)-2,5-dimethyl-1H-pyrrole-3-carboxylate |
FPL 55712 | 40785-97-5 | C27H30O9 | 498.52 | 7-[3-(4-Acetyl-3-hydroxy-2-propylphenoxy)-2-hydroxypropoxy]-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid |
FPH2 | 957485-64-2 | C14H16ClN5O2S | 353.83 | BRD-9424 |
FPH1 | 708219-39-0 | C16H15ClF2N2O3S | 388.82 | |
FPA 124 | 902779-59-3 | C11H9Cl2CuN3O2S | 381.73 | Akt Inhibitor XI; Dichloro[(2Z)-2-[(4-oxo-4H-1-benzopyran-3-yl)methylene]hydrazinecarbothioamide copper complex |
Foxy-5 | 881188-51-8 | C26H42N6O12S2 | 694.8 | Foxy 5; Foxy5; (2S)-2-[[(2S)-4-carboxy-2-[[(2R)-2-[[2-[[(2S)-3-carboxy-2-[[(2S)-2-formamido-4-methylsulfanylbutanoyl]amino]propanoyl]amino]acetyl]amino]-3-sulfanylpropanoyl]amino]butanoyl]amino]-4-methylpentanoic acid |
Fotemustine | 92118-27-9 | C9H19ClN3O5P | 315.691 | Muphoran, S 10036. |
Fostriecin sodium salt | 87860-39-7 | C19H26O9PNa | 452.37 | Fostriecin Sodium; Antibiotic CI 920 sodium salt; (6R)-5,6-Dihydro-6-[(1E,3R,4R,6R,7Z,9Z,11E)-3,6,13-trihydroxy-3-methyl-4-(phosphonooxy)-1,7,9,11-tridecatetraenyl]-2H-pyran-2-one sodium salt |
Fostriecin | 87810-56-8 | C19H26NaO9P | 452.4 | Phosphotrienin, CI 920, CL 1565A, PD 110161, NSC 339638 |
Fostedil | 75889-62-2 | C18H20NO3PS | 361.4 | |
Fostamatinib sodium | 1025687-58-4 | C23H24FN6O9P.2Na | 624.42 | R935788. Code names: R788 sodium. R935788 sodium. |
Fostamatinib | 901119-35-5 | C23H26FN6O9P | 580.46 | R788 |
Fosravuconazole | 351227-64-0 | C23H20F2N5O5PS | 547.09 | BMS-379224; [(2R,3R)-3-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1,2,4-triazol-1-yl)butan-2-yl]oxymethyl dihydrogen phosphate; |
Fosquidone | 114517-02-1 | C28H22NO6P | 499.459 | Fosquidone; GR63178A |
Fospropofol Disodium | 258516-87-9 | C13H19Na2O5P | 334.26 | disodium;[2,6-di(propan-2-yl)phenoxy]methyl phosphate; Fospropofol Disodium; fospropofol; Aquavan; Lusedra; UNII-30868AY0IF; GPI-15715; GPI 15715; GPI15715; lusedra |
Fosphenytoin sodium salt | 92134-98-0 | C16H13N2O6P·2Na | 406.2 | ACC-9653; Cl-982; 5,5-diphenyl-3-[(phosphonooxy)methyl]-2,4-imidazolidinedione, disodium salt |
Fosnetupitant | 1703748-89-3 | C31H35F6N4O5P | 688.61 | Fosnetupitant; T672P80L2S; Fosnetupitant; Piperazinium, 4-(5-((2-(3,5-bis(trifluoromethyl)phenyl)-2-methyl-1-oxopropyl)methylamino)-4-(2-methylphenyl)-2-pyridinyl)-1-methyl-1-((phosphonooxy)methyl)-, inner salt |
Fosmidomycin sodium salt | 66508-37-0 | C4H9NO5P·Na | 205.1 | Antibiotic FR31564; FR31564; P-[3-(formylhydroxyamino)propyl]-phosphonic acid, monosodium salt; (3-(N-Hydroxyformamido)propyl)phosphonic acid sodium salt |
Fosinopril Impurity D | 128948-00-5 | C19H29O6P | 384.41 | Des(4-cyclohexyl-L-proline) Fosinopril Acetic Acid; [(r)-[(1S)-2-Methyl-1-(i-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] Acetic acid; 2-[(R)-[(1S)-2-Methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]acetic Acid |
Fosinopril Impurity C HCl | 90657-55-9 | C11H20NO2Cl | 233.74 | trans-4-Cyclohexyl-L-proline hydrochloride; (4S)-4-Cyclohexyl-L-proline Hydrochloride |
Fosinopril Impurity A | 83623-61-4 | C12H17O4P | 256.24 | ((4-Phenylbutyl)hydroxyphosphoryl)acetic acid; 4-Phenybutyl 2-Carboxyethylphosphinic Acid; [Hydroxy(4-phenylbutyl)phosphinyl]acetic Acid |
Fosfomycin-13C3 Benzylamine | 1216461-18-5 | C7[13C]3H16NO4P | 248.19 | rac Fosfomycin-13C3 Benzylamine Salt; Phosphomycin-13C3 Benzylamine Salt; rel-(1R,2S)-(1,2-epoxypropyl)phosphonate-13C3 Benzylamine Salt |
Fosfomycin Tromethamine | 78964-85-9 | C7H18NO7P | 259.19 | P-[(2R,3S)-3-Methyl-2-oxiranyl]phosphonic Acid compd. with 2-Amino-2-(hydroxymethyl)-1,3-propanediol; (3-Methyloxiranyl)phosphonic Acid compd. with 2-Amino-2-(hydroxymethyl)-1,3-propanediol; [(2R,3S)-3-Methyloxiranyl]phosphonic Acid compd. with 2-Amino-2- |
Fosfomycin sodium | 26016-99-9 | C3H5Na2O4P | 182.02 | Fosfomycin sodium; Phosphomycin disodium salt; (-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid disodium salt; (1,2-Epoxypropyl)-,disodiumsalt(1r,2s)(-)-phosphonicaci; (2r-cis)-(3-Methyloxiranyl)phosphonicaciddisodiumsalt; (3-Methyloxiranyl)-,disodiumsalt,(2r |
Fosfomycin EP Impurity C (Barium Salt) | 114252-50-5 | C4H10BaNO6P | 336.43 | 2-Amino-3-hydroxy-2-(hydroxymethyl)propyl Phosphate Barium Salt; Trometamol Phosphoric Acid Barium Salt; Fosfomycin EP Impurity C Barium Salt; Trometamine Phosphate Barium Salt |
Fosfomycin calcium | 26472-47-9 | C3H5O4P·Ca | 176.12 | phosphomycin calcium; phosphonomycin calcium |
Fosfomycin | 23155-02-4 | C3H7O4P | 138.06 | Veramina; phosphomycin; Fosfomycinum; L-cis-1,2-epoxypropylphosphonic acid; (-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid; (1R,2S)-epoxypropylphosphonate; cis-(1R,2S)-epoxypropylphosphonic acid; 1R-cis-(1,2-epoxypropyl)phosphonic acid |
Fosfocreatinine | 5786-71-0 | C4H8N3O4P | 193.10 | Phosphatecreatinine; (4,5-Dihydro-1-methyl-4-oxo-1H-imidazol-2-yl)phosporamidic acid; N-(4,5-Dihydro-1-methyl-4-oxo-1H-imidazol-2-yl)amidophosphoric acid; N-Phosphorylcreatinine |
Fosaprepitant | 172673-20-0 | C23H22F7N4O6P | 614.42 | P-[3-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]phosphonic Acid; L 758298; [3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)m |
Formyl Ciprofloxacin | 93594-39-9 | C18H18FN3O4 | 359.36 | Formylciprofloxacin (M4); Ciprofloxacin Formamide |
Formyl acetate | 2258-42-6 | C3H4O3 | 88.06 | Acetic acid formyl ester; Acetic formic anhydride; Formyl acetate |
Formycin B | 13877-76-4 | C10H12N4O5 | 268.23 | |
Formoxanthone A | 869880-32-0 | C23H22O6 | 394.423 | 7,9,12-trihydroxy-2,2-dimethyl-10-(3-methylbut-2-enyl)pyrano[3,2-b]xanthen-6-one |
Formoterol Fumarate Dihydrate EP Impurity I | 532414-36-1 | C19H24N2O4 | 344.41 | rel-(R,S)-Formoterol; anti-rac-Formoterol; rel-N-[2-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1S)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide |
Formoterol fumarate dihydrate | 183814-30-4 | C42H56N4O14 | 840.924 | rel-N-[2-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide Fumarate Dihydrate; Atock; Foradil; Oxeze; BD 40A; CGP 25827A; Formoterol Hemifumarate Dihydrate |
Formoterol | 73573-87-2 | C19H24N2O4 | 344.41 | N-[2-hydroxy-5-[1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]phenyl]formamide |
Formosulfathiazole | 13968-86-0 | |||
Formosanol | 101312-79-2 | C21H24O6 | 372.4 | (1S,3aR,4S,9aR)-4-(4-Hydroxy-3-methoxyphenyl)-1,7-dimethoxy-1,3,3 a,4,9,9a-hexahydronaphtho[2,3-c]furan-6-ol |
Formosanin C | 50773-42-7 | C51H82O20 | 1015.18 | Polyphyllin B |
Formononetin-b-D-glucuronide sodium salt | 18524-03-3 | C22H19O10Na | 466.37 | 3-(4-Methoxyphenyl)-4-oxo-4H-1-benzopyran-7-yl b-D-glucuronic acid; 7-Hydroxy-4-methoxyisoflavone-7-O-b-D-glucuronide; Formononetin-7-O-Glucuronide; Biochanin B-7-O-b-D-glucuronide |
Formonentin | 485-72-3 | C16H12O4 | 268.26 | Formononetol, Biochanin B |
FORMIC-13C ACID | 1633-56-3 | CH2O2 | 47.03 | FORMIC ACID (13C); FORMIC-13C ACID; FORMIC-13C ACID, 99 ATOM % 13C; formic acid C-13 |
formamidine | 463-52-5 | CH4N2 | 44.0559 g/mol | |
Formamide,N-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-[4-hydroxy-1-methyl-2-(2-propen-1-yldithio)-1-buten-1-yl]- | 554-44-9 | C15H22 N4 O2 S2 | 354.4908 | |
Formamide,N-[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]-N-methyl-, rel- | 67844-53-5 | C11H15 N O2 | 193.2423 | |
Formaldehyde-13C(6CI,8CI,9CI) | 3228-27-1 | CH2 O | 31.03 | FORMALDEHYDE (13C); Formaldehyde-13C solution; FORMALDEHYDE-13C, 99 ATOM % 13C, CA. 20 WT. % SOLUTION IN WATER; Formalin-13C |
Formaldehyde, polymer with (chloromethyl)oxirane, 4,4-(1-methylethylidene)bisphenol and phenol | 40216-08-8 | |||
FORMALDEHYDE, POLYMER WITH (CHLOROMETHYL)OXIRANE AND PHENOL | 9003-36-5 | (C6H6O•C3H5ClO•CH2O)x | 216.66100 | |
Formaldehyde polymer with phenyl cyanate | 30944-92-4 | ((C7H5NO).(CH2O))n | 0 | Formaldehyde polymer with phenyl cyanate; Phenol novolac cyanate ester |
Formaldehyde Hydrazone | 6629-91-0 | CH4N2 | 44.06 | Nsc 60510 |
FORMALDEHYDE DIPROPYL ACETAL | 505-84-0 | C7H16O2 | 132.2007 | 1-(propoxymethoxy)propane; Dipropoxymethane; Di-n-propoxymethane; Propylal; 1-(Propoxymethoxy)propane; Di-n-propylformal |
FORMALDEHYDE 2,4-DINITROPHENYLHYDRAZONE | 1081-15-8 | C7H6N4O4 | 210.15 | Methanal 2,4-dinitrophenylhydrazone; FORMALDEHYDE 2,4-DINITROPHENYLHYDRAZONE; FORMALDEHYDE-2,4-DNPH; FORMALDEHYDE-DNPH; FORMALDEHYDE (DNPH DERIVATIVE); FORMALDEHYDE-DNPH, 5X1ML, ACN 100UG/ML |
foretinib | 849217-64-7 | C34H34F2N4O6 | 632.665 | |
Fondaparinux sodium impurity 1 | 348625-84-3 | C13H17NO19S3Na4 | 679.43 | |
Fondaparinux Sodium | 114870-03-0 | C31H43N3Na10O49S8 | 1728.035 | Arixtra; Quixidar; Fondaparinux sodium; Fondaparinux sodium salt; PENTA; Arixtra; Xantidar; SR 90107A; IC-85158; SR-90107A; SR90107A; IC 85158; IC85158 |
Fonazine | 7456-24-8 | C19H25N3O2S2 | 391.55 | Fonazine; Dimetotiazine; Dimethothiazine; Dimetiotazine; Banistyl; Dimethodin; fonazine mesylate; fonazine monomesylate ;Migristene; Promaquid;10-(2-(Dimethylamino)propyl)-N,N-dimethylphenothiazine-2-sulfonamide;7455-39-2(Dimetotiazine Mesilate) |
Fominoben | 18053-31-1 | C21H24ClN3O3 | 401.89 | FOMINOBEN; 3'-Chloro-2'-(N-methyl-N-((morpholinocarbonyl)methyl)aminomethyl)benzanilide; N-[3-Chloro-2-[[methyl-(2-morpholin-4-yl-2-oxoethyl)amino]methyl]phenyl]benzamide; 3'-Chloro-a-[methyl[(morpholinocarbonyl)methyl]amino]-o-benzotoluidide; Benzamide, |
Fomesafen | 72178-02-0 | C15H10ClF3N2O6S | 438.76 | Fomesafene; 5-(2-Chloro-4-(trifluoromethyl)phenoxy)-N-(methylsulfonyl)-2-nitrobenzamide; Reflex |
Follicle stimulating hormone | 146479-72-3 | C42H65N11O12S2 | 0 | FOLLICLE STIMULATING HORMONE; Follicle-stimulating hormone (human A-subunit reduced), complex with follicle-stimulating hormone (human B-subunit reduced); Follicle-stimulating hormone, glycoform b; Follistim; Follistim aq; Follistim-aq; Follistim-aq cartr |
Folitixorin Calcium | 133978-75-3 | C20H21CaN7O6 | 495.509 | Cofactor |
Folipastatin | 139959-71-0 | C23H24O5 | 380.43 | 1,7-bis[(Z)-but-2-en-2-yl]-3,9-dihydroxy-4,10-dimethylbenzo[b][1,4]benzodioxepin-6-one; 3,8-dihydroxy-4,9-dimethyl-1,6-bis[(1Z)-1-methyl-1-propen-1-yl]-11H-dibenzo[b,e][1,4]dioxepin-11-one |
Folinic acid | 58-05-9 | C20H23N7O7 | 473.44 | leucovorin |
Folic acid-d4 | 171777-72-3 | C19H15D4N7O6 | 445.48 | Folic Acid-D4; N-[4-[[(2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl-2,3,5,6-d4]-L- glutamic Aci; (N-[4-[[(2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl-2,3,5,6-d4]-L-); N-[4-[[(2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl]ami |
Folic acid | 59-30-3 | C19H19N7O6 | 441.4 | Pteroylglutamic acid; Vitamin M; (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid |
Folcysteine | 8064-47-9 | C25H28N8O9S | 616.60 | N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-Glutamic Acid Mixture With (4R)-3-Acetyl-4-thiazolidinecarboxylic Acid; N-[4-[[(2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-Glutamic acid Mixture With (R)-3-Acetyl-4 |
Folcisteine | 5025-82-1 | C6H9NO3S | 175.21 | FOLCISTEINE; 3-ACETYL-4-THIAZOLIDINECARBOXYLIC ACID; 3-ACETYL-THIAZOLIDIN-4-CARBOXYLIC ACID; 3-ACETYL-THIAZOLIDINE-4-CARBOXYLIC ACID; Acetyl-Thiazolidine-4-Carboxylic acid; N-Acetyl-thiazolidine-4-carboxylic acid; 3-ethanoyl-1,3-thiazolidine-4-carboxylic |
Fmoc-Phe-Lys(Boc)-PAB-PNP | 1646299-50-4 | C49H51N5O11 | 885.96 | [4-[[(2S)-2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-phenylpropanoyl]amino]-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoyl]amino]phenyl]methyl (4-nitrophenyl) carbonate |
fmoc-L-threonine monohydrate | 73731-37-0 | C19H19NO5 | 341.36 | 2-(9H-Fluoren-9-ylmethoxycarbonylamino)-3-hydroxy-butanoic acid; FMOC-L-THREONINE; FMOC-L-THREONINE MONOHYDRATE; FMOC-L-THR-OH; FMOC-L-THR-OH H2O; FMOC-THREONINE; FMOC-THR-OH; FMOC-THR-OH H2O |
FMOC-L-HYP(BOM)-OH | 187223-15-0 | C28H33N3O8 | 539.58 | N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-O-(TERT-BUTYLOXYCARBONYLAMINOETHYLCARBAMOYL)-TRANS-L-HYDROXYPROLINE; FMOC-L-HYP(BOM)-OH; Fmoc-Hyp(Bcc)-OH; N-alpha-(9-fluorenylmethyloxycarbonyl)-L-Hyp(Boc-aminoethylcarbamoyl) |
Fmoc-Homoserine lactone | 116857-07-9 | C19H17NO4 | 323.34 | FMOC-HOMOSERINE LACTONE |
fmoc-D-proline | 101555-62-8 | C20H19NO4 | 337.37 | (R)-PYRROLIDINE-1,2-DICARBOXYLIC ACID 1-(9H-FLUOREN-9-YLMETHYL) ESTER; N-ALPHA-FMOC-D-PROLINE; N-(9-FLUORENYLMETHOXYCARBONYL)-D-PROLINE; N-(9-FLUORENYLMETHOXYCARBONYL)-D-PYRROLIDINE-2-CARBOXYLIC ACID; N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-D-PROLINE; N-ALPH |
Fmoc-DL-4-Hydroxyphenylglycine | 879500-54-6 | C23H19 N O5 | 389.40066 | Fmoc-DL-4-Hydroxyphenylglycine; 2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-(4-hydroxyphenyl)acetic acid; REF DUPL: Fmoc-DL-4-Hydroxyphenylglycine |
Fmoc-D-Glu(OtBu)-OH | 104091-08-9 | C24H27NO6 | 425.48 | N-ALPHA-FMOC-D-GLUTAMIC ACID GAMMA-T-BUTYL ESTER; N-ALPHA-FMOC-D-GLUTAMIC ACID GAMMA-TERT-BUTYL ESTER; n-(9-fluorenylmethoxycarbonyl)-d-glutamic acid gamma-tert-butyl ester; N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-D-GLUTAMIC ACID GAMMA-T-BUTYL ESTER; N-ALPHA |
Fmoc-D-Arg-OH | 130752-32-8 | C21H24N4O4 · HCl | 432.91 | Fmoc-D-Arg-OH |
Fmoc-D-4-Hydroxyphenylglycine | 178119-93-2 | C23H19 N O5 | 389.40066 | Fmoc-D-4-Hydroxyphenylglycine; (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-(4-hydroxyphenyl)acetic acid; REF DUPL: Fmoc-D-4-Hydroxyphenylglycine |
FMOC-D,L-5,5,5-TRIFLUOROLEUCINE | 777946-04-0 | C21H20F3NO4 | 0 | Fmoc-D,L-5,5,5-trifluoroleucine |
Fmoc-Aminomalonic acid | 296261-32-0 | C18H15NO6 | 341.3148 | Fmoc-Aminomalonic acid |
Fmoc-3,4-Dichloro-L-phenylalanine | 17766-59-5 | C24H19Cl2NO4 | 456.32 | Fmoc-3,4-Dichloro-L-phenylalanine; Fmoc-Phe(3,4-DiCl)-OH |
Fmoc-1-D-Nal-OH | 138774-49-3 | C28H23NO4 | 437.50 | |
Eugenin | 480-34-2 | C11H10O4 | 206.2 | 5-Hydroxy-7-methoxy-2-methyl-4H-chromen-4-one |
Eudesmol | 51317-08-9 | C15H18NNaO3S2 | 347.73 | |
Eudesmin | 29106-36-3 | C22H26O6 | 386.44 | (+)-Eudesmin; 3,6-bis(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan |
Eudesma-3,11-dien-2-one | 86917-79-5 | C15H22O | 218.34 | (4aR,6R,8aS)-4,8a-dimethyl-6-prop-1-en-2-yl-1,4a,5,6,7,8-hexahydronaphthalen-2-one |
Eucryptite (AlLi(SiO4)) | 1302-65-4 | Al. H4 O4 Si . Li | 130.0374 | |
Eucomol | 17934-12-2 | C17H16O6 | 316.31 | (3S)-3,5,7-trihydroxy-3-[(4-methoxyphenyl)methyl]-2H-chromen-4-one |
Eucommiol | 55930-44-4 | C9H16O4 | 188.22 | |
Euchrestaflavanone B | 87402-91-3 | C25H28O6 | 424.49 | Lespedezaflavanone D |
Elacridar | 143664-11-3 | C34H33N3O5 | 563.654 | GF120918; GF-120918; GF 120918; GF-120918A; GF120918A; GF 120918A; GG 918; D03968. Elacridar hydrochloride. |
Ethyl Phenyl(piperidin-2-yl)acetate hydrochloride | 19716-79-1 | C15H21NO2.HCl | 283.7980 | Ethyl Phenyl(piperidin-2-yl)acetate hydrochloride |
Ethyl Benzoate | 93-89-0 | C9H10O2 | 150.18 | Benxoicacidethylester; Ethylester kyseliny benzoove; FEMA 2422; Ethyl Ester Benzoic Acid; Benzoyl Ethyl Ether; NSC 8884 |
Ethyl b-D-xylopyranoside | 6743-62-0 | C7H14O5 | 178.19 | Ethyl xyloside |
Ethyl b-D-thioxylopyranoside | 2595-46-2 | |||
Ethyl b-D-thioglucopyranoside | 7473-36-1 | C8H16O5S | 224.28 | |
Ethyl b-D-thiogalactopyranoside | 56245-60-4 | C8H16O5S | 224.28 | Ethyl 1-thio-D-galactopyranoside |
ethyl azepane-1-carboxylate | 27031-51-2 | C9H17NO2 | 171.237 g/mol | ethylazepane-1-carboxylate; Hexamethylene-urethane; NSC30498; 27031-51-2; BRN1342774; AI3-37769 |
Ethyl alaninate | 3082-75-5 | C5H11NO2 | 117.14634 | |
Fmoc-(2S,5S)-5-amino-1,2,4,5,6,7-hexahydroazepino[3,2,1-hi]indole-4-one-2-carboxylic acid | 204326-24-9 | C28H24N2O5 | 468.49 | Fmoc-Haic(2S,5S)-OH |
FMK 9a | 1955550-51-2 | C23H21FN2O3 | 392.42 | N-[(2S)-1-[(3-fluoro-2-oxopropyl)amino]-1-oxo-3-phenylpropan-2-yl]naphthalene-1-carboxamide |
FMK | 821794-92-7 | C18H19FN4O2 | 342.37 | 1-[4-Amino-7-(3-hydroxypropyl)-5-(4-methylphenyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-2-fluoroethanone;RSK2 kinase inhibitor |
FM-381 | 2226521-65-7 | C24H24N6O2 | 428.496 | FM 381; (E)-2-cyano-3-[5-(3-cyclohexyl-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,4,6,8,11-pentaen-4-yl)furan-2-yl]-N,N-dimethylprop-2-enamide |
FM19G11 | 329932-55-0 | C23H17N3O8 | 463.402 | 2-(4-Methylphenyl)-2-oxoethyl 3-({2,4-dinitrobenzoyl}amino)benzoate |
Fluvoxamine Oxime Impurity | 88699-84-7 | C13H16F3NO2 | 275.27 | (E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one oxime; 5-Methoxy-1-[4-(trifluoroMethyl)phenyl]-1-pentanone Oxime; (1E)-N-Hydroxy-5-methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanimine |
Fluvoxamine Maleate | 61718-82-9 | C19H25F3N2O6 | 434.412 | (E)-5-Methoxy-1-[4-(triflurormethyl)phenyl]-1-pentanone O-(2-Aminoethyl)oxime Maleate; DU-23000; MK-264; Dumirox; Faverin; Fevarin; Floxyfral; Luvox; Maveral |
Fluvoxamine Impurity G | 192876-02-1 | C14H19F3N2O2 | 304.31 | (5E)-5-[(2-Aminoethoxy)Imino]-5-[4-(Trifluoromethyl)Phenyl]-1-Pentanol; (1E)-5-Hydroxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-Aminoethyl)oxime; Desmethyl Fluvoxamine; Fluvoxamino Acid |
Fluvoxamine Impurity F | 1217262-11-7 | C17H26F3N3O2 | 361.41 | N-(Ethylamino) Fluvoxamine; 5-Methoxy-1-[4-(trifluoroMethyl)phenyl]- 1-pentanone O-[2-[(2-AMinoethyl)aMino]ethyl]oxiMe; N-[2-[[[(E)-5-Methoxy-1-[4-(trifluoroMethyl)phenyl]pentylidene]aMino]oxy]ethyl]etane-1,2-diaMine |
Fluvoxamine Impurity E | 1217214-94-2 | C15H22F2N2O2 | 300.35 | Desfluoro Fluvoxamine; 2-[[[(1E)-1-[4-(Difluoromethyl)phenyl]-5-methoxypentylidene]amino]oxy]ethanamine |
Fluvoxamine | 54739-18-3 | C15H21F3N2O2 | 318.33 | |
Flupentixol Impurity 2 | 28973-34-4 | C17H11F3S | 304.34 | |
Flupentixol Impurity 1 | 850808-70-7 | C17H13F3OS | 322.35 | |
Flupentiol | 2709-56-0 | C23H25F3N2OS | 434.52 | 2-[4-[(3Z)-3-[2-(trifluoromethyl)thioxanthen-9-ylidene]propyl]piperazin-1-yl]ethanol; Flupenthixol, Flupenthixol, Depixol, Fluanxol, Emergil, Siplaril |
Flupenthixol dihydrochloride | 2413-38-9 | C23H25F3N2OS.2HCl | 507.44 | (E/Z)-Flupentixol Dihydrochloride; Emergil; FX 703; Metamin; Siplarol; 4-[3-[2-(Trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]-1-piperazineethanol dihydrochloride |
Fluorescent Brightener 357 | 41098-56-0 | C40H38N12Na6O18S6 | 1305.13 | hexasodium; 2-[[4-(diethylamino)-6-[4-[(E)-2-[4-[[4-(diethylamino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl]amino]-2-sulfonatophenyl]ethenyl]-3-sulfonatoanilino]-1,3,5-triazin-2-yl]amino]benzene-1,4-disulfonate; TinopalCH3669; EINECS255-217-5; 41098- |
Fluorescent brightener 353 | 55585-28-9 | C40H34N12Na6O20S6 | 0 | Uvitex MST; tinopal msp; Fluorescent Brightener 353; Fluorescent brightening agent 353 |
fluorescent brightener 28 | 4404-43-7 | C40H44N12O10S2 | 916.994 | 2.5-Bis(5-tertbutyl-2-benzoxazlyl)phiophene; 5-triazin-2-yl]amino]--6-(phenylamino)-3; c.i.fluorescentbrighteningagent28; Fluorescentbrightener(OB); TINOPAL UNPA-GX; TINOPAL LPW; CALCOFLUOR WHITE ST; CALCOFLUOR WHITE M2R |
Fluorescent brightener 264 | 76482-78-5 | C40H38N12Na6O22S6 | 1369.13 | hexasodium 2-[[4-(bis(2-hydroxyethyl)amino)-6-[[4-[(E)-2-[4-[[4-(bis(2 -hydroxyethyl)amino)-6-[(2,5-disulfonatophenyl)amino]-1,3,5-triazin-2- yl]amino]-2-sulfonato-phenyl]ethenyl]-3-sulfonato-phenyl]amino]-1,3,5- triazin-2-yl]amino]benzene-1,4-disulfonat |
Fluorescent brightener 134 | 3426-43-5 | C34H28N10Na2O8S2 | 814.76 | Fluorescent Brightener 134; disodium 4,4'-bis[(4-anilino-6-methoxy-1,3,5-triazin-2-yl)amino]stilbene-2,2'-disulphonate; Fluorescent Brightener 90; Benzenesulfonic acid, 2,2-(1,2-ethenediyl)bis5-4-methoxy-6-(phenylamino)-1,3,5-triazin-2-ylamino-, disodium |
Fluorescent brightener 121 | 12224-11-2 | C15H12ClN3O2S | 333.79 | |
Fluorescent Brightener 101 | 51848-34-1 | |||
Fluorescent Brightener 61 | 12224-04-3 | 0 | Fluorescent Brightener 61 | |
Fluoresceinyl glycine amide | 136091-82-2 | C22H16N2O6 | 404.38 | 2-amino-N-(3',6'-dihydroxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-5-yl)acetamide |
Fluorescein-Dipalmitoylphosphatidylethanolamine | 87706-98-7 | C58H85N2O13PS | 1081.34 | Fluorescein DHPE |
Fluoresceinamine isomer I | 3326-34-9 | C20H13NO5 | 347.32 | 5-Aminofluorescein |
Fluoresceinamine | 27599-63-9 | C20H13NO5 | 347.32 | 5(6)-Aminofluorescein |
Fluorescein-6-isothiocyanate | 18861-78-4 | C21H11NO5S | 389.38 | FITC isomer II |
Flucloxacillin sodium | 1847-24-1 | C19H16ClFN3NaO5S | 475.86 | (2S,5R,6R)-6-[[[3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid Sodium; |
Flucloxacillin | 5250-39-5 | C19H17ClFN3O5S | 453.87 | Floxapen;Flucloxacilina;Flucloxacillinum;Staphylex;[3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl]penicillin;(2S,5R,6R)-6-[[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carbo |
Fluciclatide F-18 | 879894-01-6 | C75H115FN18O27S3 | 1815.025 | [18F]AH111585. |
FLUCHLORALIN | 33245-39-5 | C12H13ClF3N3O4 | 355.7 | N-(2-CHLOROETHYL)-2,6-DINITRO-N-PROPYL-4-(TRIFLUOROMETHYL)ANILINE; FLUCHLORALIN; BASALIN; BAS 392 H; BAS 3920; BAS 3921; BAS 3921 H; BAS 3922 |
Flucarbazone-sodium | 181274-17-9 | C12H10F3N4NaO6S | 418.28 | flucarbazone(presentasflucarbazone-sodium); 4,5-Dihydro-3-methoxy-4-methyl-5-oxo-N-((2-(trifluoromethoxy)phenyl)sulfonyl)-1H-1,2,4-triazole-1-carboxamide sodium salt; FLUCARBAZONE-SODIUM; flucarbazone-sodium (bsi,pa iso); mkh6562; 4,5-Dihydro-3-methoxy-4- |
Flubepride | 56488-61-0 | C20H24FN3O4S | 421.485663;g/mol | Flubepride;56488-61-0;5-(aminosulfonyl)-n-((1-(4-fluorobenzyl)-2-pyrrolidinyl)methyl)-2-methoxybenzamide;Flubepride[INN];AC1Q6VAQ;AC1L50B9 |
Flubenzimine | 37893-02-0 | C17H10F6N4S | 416.35 | Flubenzimin; 2-N,3-diphenyl-4-N,5-N-bis(trifluoromethyl)-1,3-thiazolidine-2,4,5-triimine; |
FLUBENDIAMIDE | 272451-65-7 | C23H22F7IN2O4S | 682.39 | 1-N-[4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)-2-methylphenyl]-3-iodo-2-N-(2-methyl-1-methylsulfonylpropan-2-yl)benzene-1,2-dicarboxamide; flubendiamide; 272451-65-7; 3-Iodo-N2-(2-methyl-1-(methylsulfonyl)propan-2-yl)-N1-(2-methyl-4-(perfluoropropan-2-yl)p |
Flubendazole-D3 | 1173021-08-3 | [5-(4-Fluoro-benzoyl)- 1H-benzoimidazol-2-yl]- carbamic acid methyl-D3 ester | ||
Flubendazole | 31430-15-6 | C16H12FN3O3 | 313.28 | Flumoxanal, NSC 313680 |
Fluazuron | 86811-58-7 | C20H10Cl2F5N3O3 | 506.22 | N-[[[4-Chloro-3-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]amino]carbonyl]-2,6-difluoro-benzamide |
Fluazinam | 79622-59-6 | C13H4Cl2F6N4O4 | 465.09 | SHIRLAN; FLUAZINAM; FROWNCIDE; 3-chloro-n-(3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-2-pyridinamine; 3-CHLORO-N-(3-CHLORO-2,6-DINITRO-4-TRIFLUOROMETHYLPHENYL)-5-TRIFLUOROMETHYL-2-PYRIDYLAMINE; 3-CHLORO-N-(3-CHLORO-5-TRIFLUOROMETH |
Fluanisone | 1480-19-9 | C21H25FN2O2 | 356,44 | 1-(4-fluorophenyl)-4-[4-(2-methoxyphenyl)piperazin-1-yl]butan-1-one |
FLT3-IN-1 | 1370256-78-2 | C25H27N7O3S2 | 537.66 | FLT3-IN-1; CHEMBL2046883; SKLB4771; AOB5016 |
FLT3 Inhibitor III | 852045-46-6 | C21H23N3OS | 365.5 | Fms-like Tyrosine Kinase Inhibitor III; (5-Phenyl-thiazol-2-yl)-(4-(2-pyrrolidin-1-yl-ethoxy)-phenyl)-amine; 5-Phenyl-N-(4-(2-(1-pyrrolidinyl)ethoxy)phenyl)-2-thiazolamine; 5-Phenyl-N-(4-(2-(1-pyrrolidinyl)ethoxy)phenyl)-2-thiazolamine; (5-Phenyl-thiazol- |
Floxuridine | 50-91-9 | C9H11FN2O5 | 246.19 | Deoxyfluorouridine, FDUR, NSC 27640; NSC27640; NSC-27640 |
Floxacrine | 53966-34-0 | C20H13ClF3NO3 | 407.77 | 7-Chloro-3,4-dihydro-10-hydroxy-3-[p-(trifluoromethyl)phenyl]-1,9(2H,10H)-acridinedione;HOE-991;Floxacrina;Floxacrinum;7-Chloro-10-hydroxy-3-[4-(trifluoromethyl)phenyl]-3,4-dihydro-2H-acridine-1,9-dione;HOE991 |
Flovagatran | 871576-03-3 | C27H36BN3O7 | 525.41 | ((R)-1-((S)-N-(D-phenylalanyl)-1-((benzyloxy)carbonyl)pyrrolidine-2-carboxamido)butyl)boronic acid;871575-98-3(sodium) |
Floursand Meals, soybean | 68513-95-1 | LECTIN GLYCINE MAX; GMO SOYA BEAN POWDER; GLYCINE MAX AGGLUTININ SOYBEAN AGGLUTININ; GLYCINE MAX AGGLUTININ; SBA; SBA AGAROSE BOUND; SOYABEAN; SOYA BEAN POWDER | ||
FLORIFENINE | 83863-79-0 | C23H22F3N3O2 | 429.43 | 2-[[7-(Trifluoromethyl)-4-quinolinyl]amino]benzoic Acid 2-(1-Pyrrolidinyl)ethyl Ester; |
Floribundone 1 | 118555-84-3 | C32H22O10 | 566.52 | 5,7'-Biphyscion |
Flavaprenin | 53846-50-7 | C20H20O5 | 340.4 | (2S)- 2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one |
Flavanomarein | 577-38-8 | C21H22O11 | 450.39 | Isookanin-7-glucoside |
Flavamine | 15686-60-9 | C21H23NO2 | 0 | Flavamine; 6-[(Diethylamino)methyl]-3-methylflavone; Rec-7-0052 |
FlAsH-EDT2 | 212118-77-9 | C24H18As2O5S4 | 664.5 | Fluorescein Arsenical Helix Binder; Lumio Green; 4',5'-bis(1,3,2-dithiarsolan-2-yl)-3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one |
FLAG peptide | 98849-88-8 | C41H60N10O20 | 1012.97 | (2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]hexanoyl]amino]-3-carboxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-carbox |
FKGK 18 | 1071001-09-6 | C16H15F3O | 280.3 | 1,1,1-trifluoro-6-(2-naphthalenyl)-2-hexanone |
FKGK 11 | 1071000-98-0 | C13H13F5O | 280.2 | 1,1,1,2,2-pentafluoro-7-phenyl-3-heptanone |
FK-Binding Protein human | 131144-19-9 | C16H11ClN2O2 | 298.72374;g/mol | FKBP-12 |
FK866 | 658084-64-1 | C24H29N3O2 | 391.515 | Daporinad; (E)-N-[4-(1-benzoylpiperidin-4-yl)butyl]-3-pyridin-3-ylprop-2-enamide; APO 866 |
FK330 dihydrate | 682813-92-9 | C29H32ClF3N6O6 | 653.05 | FR260330 dihydrate;FK-330 dihydrate;FR-260330 dihydrate;(2S)-2-[[(E)-3-(4-chlorophenyl)prop-2-enoyl]amino]-N-[2-oxo-2-[4-[6-(trifluoromethyl)pyrimidin-4-yl]oxypiperidin-1-yl]ethyl]-3-pyridin-2-ylpropanamide dihydrate |
FK-330 | 442198-67-6 | C29H28ClF3N6O4 | 617.02 | 2-Pyridinepropanamide, alpha-(((2E)-3-(4-chlorophenyl)-1-oxo-2-propen-1-yl)amino)-N-(2-oxo-2-(4-((6-(trifluoromethyl)-4-pyrimidinyl)oxy)-1-piperidinyl)ethyl)-, (alphaS)- |
FK 960 | 133920-70-4 | C13H16FN3O2 | 265.28 | FK-960; 60MMJ100ZX; N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide |
FK 888 | 138449-07-7 | C36H36N4O4 | 588.69 | FK-888; (4R)-4-Hydroxy-1-[(1-methyl-1H-indol-3-yl)carbonyl]-L-prolyl-N-methyl-3-(2-naphthalenyl)-N-(phenylmethyl)-L-alaninamide; (2S,4R)-N-[(2S)-1-[benzyl(methyl)amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]-4-hydroxy-1-(1-methylindole-3-carbonyl)pyrrolidine |
Fibroblast Growth Factor-Basic | 106096-93-9 | hBFGF; FGF-Basic; Basic fibroblast growth factor; bFGF | ||
FIBRIN | 9001-31-4 | C5H11N3O2 | 0 | BLOOD FIBRIN; FIBRIN; FIBRIN,BLOOD; FIBRIN BOVINE; fibrin washed from bovine blood; fibrin washed from human plasma; fibrin washed from pig plasma; Fibrins |
Fiacitabine | 69123-90-6 | C9H11FIN3O4 | 371.1 | NSC 382097; FIAC; FOAC |
FI-700 | 866883-79-6 | C21H29N9O | 423.525 | FI-700; FI700; FI 700. |
Fexinidazole | 59729-37-2 | C12H13N3O3S | 279.319 | 1-Methyl-2-((4-(methylthio)phenoxy)methyl)-5-nitro-1h-imidazole; |
Fexaramine | 574013-66-4 | C32H36N2O3 | 496.64 | |
Fesoterodine Related Impurity 6 | 1428856-46-5 | C48H66N2O4 | 735.07 | Fesoterodine Diol Dimer Monoester; 2-Methyl-propanoic acid 2-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-[[[3-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-hydroxyphenyl] methoxy]methyl]phenyl ester |
Fesoterodine Related Impurity 5 | 1428856-45-4 | C44H60N2O3 | 664.98 | Fesoterodine Diol Dimer; 4,4'-[Oxybis(methylene)]bis[2-[(1R)-3-[bis(1-methylethyl)amino]-1-phenyl propyl]-phenol |
Fesoterodine Related Impurity 4 | 214601-12-4 | C22H29NO2 | 339.48 | |
Fesoterodine Related Impurity 3 | 1435768-96-9 | C26H35NO3 | 409.57 | 2-Methyl-propanoic Acid 2-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-formylphenyl Ester |
Fesoterodine Related Impurity 2 | 1254942-29-4 | C30H39NO6 | 509.65 | (2E)-2-Butenedioic Acid 1-[[3-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-(2-methyl-1-oxopropoxy)phenyl]methyl] Ester |
Fesoterodine Related Impurity 10 | 1390644-37-7 | C26H35NO3 | 409.57 | (R)-5-Hydroxymethyl Tolterodine Methacrylate; 2-Methyl-2-propenoic Acid 2-[(1R)-3-[bis(1-Methylethyl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl Ester; |
Fesoterodine Impurity O | 250214-69-8 | C23H33NO2 | 355.52 | |
Fesoterodine Impurity B | 1208313-13-6 | C30H43NO4 | 481.68 | 2-Methylpropanoic Acid 2-[3-[(1R)-Bis(1-methylethyl)amino]-1-phenylpropyl]-4-[(2-methyl-1-oxopropoxy)methyl]phenyl Ester; |
Fesoterodine | 250214-44-9 | C26H37NO3 | 411.58 | FESOTERODINE; 2-Methylpropanoic acid 2-[3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl ester |
Fesoterodine | 286930-02-7 | C26H37NO3 | 411.58 | Fesoterodine; UNII-621G617227; 286930-02-7; 250214-44-9; Fesoterodinemaleate; (R)-Fesoterodinefumarate |
Feruloylputrescine | 501-13-3 | C14H20N2O3 | 264.3202 | Feruloylputrescine; N-(4-Aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)propenamide; Subaphylline |
Ferulic acid sodium | 24276-84-4 | C10H9NaO4 | 216.17 | sodium;(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate 4-hydroxy-3-methoxycinnamic acid 8,8'-diferulic acid ferulic acid ferulic acid, (E)-isomer ferulic acid, (Z)-isomer ferulic acid, monosodium salt sodium ferulate |
Ferulic acid | 1135-24-6 | C10H10O4 | 194.19 | Ferulic Acid, Methyl ferulate, trans-Ferulic acid, Coniferic acid, NSC 2821, NSC2821, NSC-2821 |
Ferulenol | 6805-34-1 | C24H30O3 | 366.5 | 4-hydroxy-3-[(2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrien-1-yl]-2H-1-benzopyran-2-one; 4-Hydroxy-3-[(2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrienyl]-2H-1-benzopyran-2-one; (E,E)-4-Hydroxy-3-(3,7,11-trimethyl-2,6,10-dodecatrienyl)-2H-1-benzopyran-2-one |
Ferulamide | 61012-31-5 | C10H11NO3 | 193.2 | 2-PropenaMide, 3-(4-hydroxy-3-Methoxyphenyl)-, (2E)-; 3-(4-Hydroxy-3-methoxyphenyl)acrylamide |
Fertirelin | 38234-21-8 | C55H76N16O12 | 1153.29 | PYR-HIS-TRP-SER-TYR-GLY-LEU-ARG-PRO-NHET; PYROGLU-HIS-TRP-SER-TYR-GLY-LEU-ARG-PRO NHCH2CH3; PGLU-HIS-TRP-SER-TYR-GLY-LEU-ARG-PRO-NHET; FERTIRELIN; GLP-HIS-TRP-SER-TYR-GLY-LEU-ARG-PRO-NHET; [DES-GLY10] LH-RH, ETHYL AMIDE |
Ferrous sulfate monohydrate | 13463-43-9 | 169.92 | Green vitriol; IRON SULFATE, HEPTAHYDRATE; IRON VITRIOL; IRON(II) SULFATE-7-HYDRATE; IRON(II) SULFATE, HYDRATE; IRON (II) SULFATE, HYDROUS; IRON(II) SULPHATE 7-HYDRATE; IRON(II) SULPHATE HEPTAHYDRATE | |
FERROUS SULFATE | 7720-78-7 | FeSO4 | 151.91 | FERROUS SULFATE; FERROIN SOLUTION; FERROUS SULPHATE; IRON(II) SULFATE; COPPERAS; Conferon; Duretter; Duroferon |
Ferrous glycine sulfate | 14729-84-1 | |||
FERROUS CARBONATE | 1335-56-4 | CFeO3 | 115.85 | FERROUS CARBONATE; FERROUS CARBONATE SACCHARATED; IRON (II) CARBONATE; IRON (II) CARBONATE, SACCHARATED |
FERROUS BORIDE | 12006-84-7 | BFe | 66.66 | ironboride(bfe); ironboride(feb); FERROUS BORIDE; FERRIC BORIDE; IRON BORIDE; IRON BROMIDE |
Ferrous bisglycinate | 20150-34-9 | C4H8FeN2O4 | 203.96 | |
Ferrous acetate | 3094-87-9 | 2(C2H3O2).Fe | 173.93 | FERROUS ACETATE; IRON(II) ACETATE; aceticacid,iron(2+)salt; aceticacid,iron(2++)salt; iron(2+)acetate; irondiacetate |
Ferrostatin-1 | 347174-05-4 | C15H22N2O2 | 262.35 | Fer-1; Fer 1; Fer1; Ferrostatin-1; Ferrostatin 1; Ferrostatin1 |
Ferrosilicon | 8049-17-0 | FeSi2 | 112.01 | IRON SILICIDE; ferric silicon; Ferrosilicon,with not less than 30% but less than 90% silicon; FERROSILICON; FERRO SILICA; NLT72%Si; Alcoa Ferrosilicon; Abel Ferro Silicon 75/80 |
Ferroquine | 185055-67-8 | C23H24ClFeN3 | 433.75 | 7-chloro-N-[[2-[(dimethylamino)methyl]cyclopenta-1,4-dien-1-yl]methyl]quinolin-4-amine;cyclopenta-1,3-diene;iron(2+); ferroquine; SSR 97193; SSR-97193; SSR97193 |
Ferrocene | 102-54-5 | Fe(C5H5)2 | 186.0314;g/mol | cyclopenta-1,3-diene; iron(2+); 102-54-5; KSC493Q9P; CTK3J3897; MolPort-019-903-467 |
Ferrioxamine E | 20008-20-2 | C27H45FeN6O9 | 653.53 | 20008-20-2; FerrioxamineEfromStreptomycesantibioticus; 1,12,23-Trihydroxy-1,6,12,17,23,28-hexaazacyclotritriacontane-2,5,13,16,24,27-hexoneIron(III)complex; iron(3+)2,5,13,16,24,27-hexaoxo-1,6,12,17,23,28-hexaazacyclotritriacontane-1,12,23-triolate; AC1L5 |
FerricammoniumEDTA | 21265-50-9 | C10H16FeN3O8 | 362.09434;g/mol | azanium; 2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate; iron(3+); 21265-50-9; ferricammoniumedta; EDTAferricammoniumsalt |
FERRIC STEARATE | 555-36-2 | C54H105FeO6 | 906.25 | FERRIC TRISTEARATE; FERRIC STEARATE; IRON(III) STEARATE; irontristearate,pure; octadecanoicacid,iron(3++)salt; STEARIC ACID IRON(3) SALT; STEARIC ACID IRON(III) SALT; Stearicacidironsalt |
FERRIC SALICYLATE | 30492-15-0 | C21H15FeO9 | 467.18 | FERRIC SALICYLATE; IRON (III) SALICYLATE |
Ferric nitrate nonahydrate | 7782-61-8 | Fe.(NO3)3.9(H2O) | 404.00 | IRON(+3)NITRATE ENNEAHYDRATE; IRON (III) NITRATE; IRON(III) NITRATE-9-HYDRATE; IRON(III) NITRATE ENNEAHYDRATE; IRON (III) NITRATE, HYDROUS; IRON(III) NITRATE NONAHYDRATE; IRON(III) NITRATE, NONOHYDRATE; FERRIC NITRATE 9H2O |
ferric citrate | 3522-50-7 | C6H5FeO7 | 244.94 | |
FERREDOXIN | 9040-09-9 | 0 | FERREDOXIN; ferredoxin from spinach; ferredoxin from spirulina sp.; ferredoxin solution from spinach; Ferredoxin solution from Spinacia oleracea (spinach); FERREDOXIN SOLUTION FROM SPINACH, SOL.IN 0.15 M TRIS; FERREDOXIN, FROM CLOSTRIDIUM*PASTEURIANU M, | |
Ferrate(2-),[4-hydroxy-5-[[2-hydroxy-4-(hydroxy-kO)-5-[2-[2-(hydroxy-kO)-4,6-dinitrophenyl]diazenyl-kN1]phenyl]azo]-2,7-naphthalenedisulfonato(4-)]-,sodium (1:2) | 64611-69-4 | C22H10 Fe N6 O14 S2 . 2 Na | ||
Ferrate(1-),bis[3-[4,5-dihydro-4-[2-[2-(hydroxy-kO)-5-nitrophenyl]diazenyl-kN1]-3-methyl-5-(oxo-kO)-1H-pyrazol-1-yl]benzenesulfonamidato(2-)]-, sodium(1:1) | 72496-87-8 | C32H24 Fe N12 O12 S2 . Na | 911.5709 | |
Fern-7-en-19-one | 222294-61-3 | C30H48O | 424.713 | |
FERb 033 | 1111084-78-6 | C13H9ClFNO3 | 281.67 | 2-Chloro-3'-fluoro-3,4'-dihydroxy-[1,1-biphenyl]-4-carboxaldehyde oxime |
Feprazone | 30748-29-9 | C20H20N2O2 | 320.39 | |
Fenyramidol | 553-69-5 | C13H14N2O | 214.26 | Abbolexin; alpha-[(2-Pyridylamino)methyl]benzyl alcohol; Analexin; Benzenemethanol, alpha-[(2-pyridinylamino)methyl]-; Benzyl alcohol, alpha-[(2-pyridylamino)methyl]-; Bonapar; Cabral; Evaspirine |
Fenvalerate | 51630-58-1 | C25H22ClNO3 | 419.91 | (cyano(3-phenoxyphenyl)methyl-4-chloro-alpha-(1-methylethyl)phenylacetate); (R,S)-.alpha.-Cyano-3-phenoxybenzyl(R,S)-2-(4-chlorophenyl)-3-methylbutyricester; (rs)-alpha-cyano-3-phenoxybenzyl(rs)-2-(4-chlorophenyl)-3-methylbutyrate; 4-chloro-alpha-(1-methy |
Fenugreek Extract | 68990-15-8 | 0 | FEMA 2484; FENUGREEK SOLID EXTRACT; Fenugrec; Fenugrecoil; Fenugrecseed; fenugreekabsolute; Fenugreekoil; Fenugrekabsolute | |
Fentrazamide Metabolite | 98377-35-6 | 1-(2-Chlorophenyl)-1,4- dihydrotetrazol-5-one | ||
Fentrazamide | 158237-07-1 | C16H20ClN5O2 | 349.82 | Fentrazamide; CHEBI:81791; 4-(2-Chlorophenyl)-N-cyclohexyl-N-ethyl-4,5-dihydro-5-oxo-1H-tetrazole-1-carboxamide; Innova |
fentin fluoride | 379-52-2 | C18H15FSn | 369.020 | biomet204; fluorotriphenyl-stannan; fluorotriphenylstannane; fluorotriphenyl-ti; FLUOROTRIPHENYLTIN; TRIPHENYLFLUOROTIN; TRIPHENYLTIN FLUORIDE; fentin fluoride |
FENTIN | 668-34-8 | C18H15 Sn | 0 | Triphenylstannilium; Triphenyltin(1+); Triphenyltin(1+),ion; Triphenyltin(IV)cation |
Fenticonazole Nitrate | 73151-29-8 | C24H20Cl2N2OS·HNO3 | 518.41 | ITF2357; ITF 2357; ITF-2357 |
Fenthoxon | 6552-12-1 | Dimethyl-(3-methyl-4- methylthio phenyl) phos- phate | ||
Fenthion Sulfoxide | 3761-41-9 | O,O-Dimethyl-O-(3- methyl-4-methylsulfinyl phenyl) thiophosphate | ||
Fenthion Sulfone | 3761-42-0 | O,O-Dimethyl-O-(3- methyl-4-methylsulfonyl phenyl) thiophosphate | ||
Fensulfothion Oxon Sulfone | 6132-17-8 | Diethyl-(4-methylsulfonyl phenyl) phosphate | ||
Fensulfothion Oxon | 6552-21-2 | Diethyl-(4-methylsulfinyl phenyl) phosphate | ||
Fenspiride-d5 Hydrochloride | 1246815-28-0 | C15H16N2O2D5Cl | 301.82 | 8-[2-(Phenyl-d5)ethyl]-1-oxa-3,8-diazaspiro[4.5]decan-2-one Hydrochloride |
Fenspiride HCl | 5053-08-7 | C15H20N2O2.HCl | 296.79 | 8-(2-Phenylethyl)-1-oxa-3,8-diazaspiro[4.5]decan-2-one Hydrochloride; |
Fenspiride | 5053-06-5 | C15H20N2O2 | 260.34 | 8-(2-phenylethyl)-1-oxa-3,8-diazaspiro[4.5]decan-2-one |
Fenclorac | 36616-52-1 | C14H16Cl2O2 | 287.184 | Fenclorac; WHR-539; Fencloracum[INN-Latin]; 36616-52-1; Fencloraco[INN-Spanish]; WHR539 |
Fenclofenac | 34645-84-6 | C14H10Cl2O3 | 297.136 | Fenclofenac; Flenac; Rx67408; 34645-84-6; Fenclofenacum[INN-Latin]; Fenclofenaco[INN-Spanish] |
Fenchyl alcohol | 1632-73-1 | C10H18O | 154.25 | Fenchol; 1,3,3-Trimethylbicyclo[2.2.1]heptan-2-ol; (+)-Fenchol |
Fenchlorphos | 299-84-3 | C8H8Cl3O3PS | 321.55 | dimethoxy-sulfanylidene-(2,4,5-trichlorophenoxy)-$l^{5}-phosphane Dermafos fenchlorfos fenchlorphos ronnel |
Fencamfamine | 2240-14-4 | C15H21N | 215.33 | N-ethyl-2-phenylbicyclo[2.2.1]heptan-3-amine;hydrochloride; 2-ethylamino-3-phenylnorcamphane; fencamfamine; fencamfamine hydrochloride; N-ethyl-3-phenylbicyclo(2.2.1)heptan-2-amine; Reactivan |
Fenbutrazate hydrochloride | 6474-85-7 | C23H29NO3.HCl | 403.942 g/mol | |
Fenbutatin oxide | 13356-08-6 | C60H78OSn2 | 1052.67 | bendex; bis(tris(beta,beta-dimethylphenethyl)tin)oxide; di(tri-(2,2-dimethyl-2-phenylethyl)tin)oxide; Distannoxane,hexakis(2-methyl-2-phenylpropyl)-; ent27738; fenbutatin |
Fenbuconazol | 114369-43-6 | C19H17ClN4 | 336.82 | Fenbuconazole; Fenbuconazol; Fenethanil; 114369-43-6; Fenbuconazole[ISO]; CHEBI:83920 |
Fenbendazole-d3 | 1228182-47-5 | (5-Phenylsulfanyl-1H- benzoimidazol-2-yl)- carbamic acid methyl-D3 ester |
||
Fenbendazole-amine hydrochloride | 1448346-29-9 | C13H12ClN3S | 277.77 | 5-Phenylsulfanyl-1H-benzoimidazol-2-ylamine hydrochloride |
Fenbendazole sulfone-D3 | 1228182-49-7 | (5-Benzenesulfonyl-1H- benzoimidazol-2-yl)- carbamic acid methyl-D3 ester | ||
Fenbendazole Sulfone | 54029-20-8 | C15H13N3O4S | 331.35 | [5-(Phenylsulfonyl)-1H-benzimidazol-2-yl]carbamic Acid Methyl Ester; |
Fenbendazole Hydroxide | 72447-64-4 | C15H13N3O3S | 315.347 | methyl N-[6-(4-hydroxyphenyl)sulfanyl-1H-benzimidazol-2-yl]carbamate |
Fenbendazole | 43210-67-9 | C15H13N3O2S | 299.35 | |
Fenamidone Metabolite | 332855-88-6 | (S)-5-Methyl-5-phenyl-3- phenylamino imidazoli- dine-2,4-dione | ||
Felypressin | 56-59-7 | C46H65N13O11S2 | 1040.22 | 2-L-Phenylalanine-8-L-lysine-vasopressin;N-[5-Amino-1-(carbamoylmethylcarbamoyl)pentyl]-1-[19-amino-13,16-dibenzyl-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxa |
Felodipine-d8 | 1346602-65-0 | C18H11D8Cl2NO4 | 392.30 | 4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic Acid 3-Ethyl-d5 5-Methyl-d3 Ester |
Felodipine-d5 | 1242281-38-4 | C18H14Cl2NO4D5 | 389.29 | 4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester-d5 |
Febuxostat-d7 | 1285539-74-3 | C16H9N2O3SD7 | 323.42 | 2-[3-Cyano-4-(2-methylpropoxyphenyl]-4-methyl-5-thiazolecarboxylic Acid-d7 |
Febuxostat-D7 | 85539-74-3 | C16H9D7N2O3S | 323.42 | |
Febuxostat Impurity 9 | 407582-48-3 | C12H8N2O3S | 260.27 | |
Febuxostat Impurity 8 | 144060-62-8 | C16H17NO4S | 319.38 | |
Febuxostat Impurity 7 | 1350352-70-3 | C16H18N2O4S | 334.40 | |
Febuxostat Impurity 6 | 1271738-74-9 | C18H22N2O4S | 362.45 | |
Febuxostat Impurity 5 | 161798-02-3 | C14H12N2O3S | 288.33 | Ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate |
Febuxostat Impurity 3 | 160844-75-7 | C18H20N2O3S | 344.44 | Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate |
Febuxostat Impurity 2 | 161798-03-4 | C18H21NO4S | 347.44 | Ethyl 2-(3-Formyl-4-isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate |
Febuxostat Impurity 19 | 118485-48-6 | C13H13NO3S | 263.32 | 5-Thiazolecarboxylic acid, 2-(2-hydroxyphenyl)-4-methyl-, ethyl ester |
Febuxostat Impurity 14 | 1335202-60-2 | C15H16N2OS | 272.37 | |
Febuxostat Impurity 11 | 31643-49-9 | C8H3N3O2 | 173.13 | 4-Nitrophthalonitrile; |
Febuxostat Impurity 1 | 161798-01-2 | C14H13NO4S | 291.33 | Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate |
Febuxostat Impurity (Dimethyl 2,2'-(4-isobutoxy-1,3-phenylene)bis(4-methylthiazole-5-carboxylate)) | 1330632-47-7 | C22H24N2O5S2 | 460.57 | 2,2'-[4-(2-Methylpropoxy)-1,3-phenylene]bis[4-methyl-5-thiazolecarboxylic Acid 5,5'-Dimethyl Ester |
Febuxostat Impurity (4-Isobutoxy benzene-1,3-bis(carbothio amide)) | 1330632-46-6 | C12H16N2OS2 | 268.40 | 4-(2-Methylpropoxy)-1,3-benzenedicarbothioamide |
Febuxostat Impurity (2,2'-(4-isobutoxy-1,3-phenylene)bis(4-methylthiazole-5-carboxylic acid)) | 1330632-48-8 | C20H20N2O5S2 | 432.52 | 2,2'-[4-(2-Methylpropoxy)-1,3-phenylene]bis[4-methyl-5-thiazolecarboxylic Acid |
Febuxostat Impurity (2-(3-carboxy-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid) | 1239233-87-4 | C16H17NO5S | 335.38 | 2-[3-Carboxy-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic Acid |
Febuxostat Amide Impurity | 1239233-86-3 | C16H18N2O4S | 334.40 | 2-[3-(Aminocarbonyl)-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic acid |
Febuxostat | 144060-53-7 | C16H16N2O3S | 316.37 | Febuxostat; TMX-67; TEI-6720; TMX 67; TEI 6720; TMX67; TEI6720; Uloric; Adenuric; 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid |
Febrifugine dihydrochloride | 32434-42-7 | C16H21Cl2N3O3 | 374.26 | (+)-Febrifugine dihydrochloride |
febrifugin | 24159-07-7 | C16H19N3O3 | BETA-Febrifugine; Isofebrifugine; 3-(3-(3-Hydroxypiperidin-2-yl)-2-oxopropyl)quinazolin-4(3H)-one; 3-[3-[(2R,3S)-3-Hydroxy-2-piperidinyl]-2-oxopropyl]-4(3H)-quinazolinone | |
Febantel-D6 | 1173021-79-8 | N-(2-Methoxy-acetyl- amino-4-phenylsulfanyl- phenyl)-N',N”-bis- (methoxy-D3-carbonyl)- guanidine | ||
Febantel | 58306-30-2 | C20H22N4O6S | 446.48 | |
FE-999024 | 168825-65-8 | C26H31ClN6O2 | 495.02 | CH-2856; FE-999024; L-Alaninamide, 4-chloro-D-phenylalanyl-N-(3-((aminoiminomethyl)amino)propyl)-3-(1-naphthalenyl)- |
FDL169 | 1628416-28-3 | C27H23FN4O4 | 486.49 | CFTR corrector 2 |
FDI 6 | 313380-27-7 | C19H11F4N3OS2 | 437.43 | 3-amino-6-thiophen-2-yl-4-trifluoromethyl-thieno[2,3-b]pyridine-2-carboxylic acid (4-fluoro-phenyl)-amide; 3-amino-N-(4-fluorophenyl)-6-(2-thienyl)-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-carboxamide; 3-amino-N-(4-fluorophenyl)-6-(thiophen-2-yl)-4-(tri |
Fatty acids, coco, potassium salts | 61789-30-8 | 0 | Fatty acids, coco, potassium salts; POTASSIUM COCOATE; Fettsuren, Kokos-, Kaliumsalze; cocoa fatty acids, potassium salts; Fatty acids,coconut oil,potassium salt; Coconut fatty acid potassium salt; coconut oil, potassium salts | |
Fatty acids, C6-24 and C16-18-unsatd., esters with sucrose | 93571-82-5 | |||
Fatty acids, C16-18, C12-18-alkyl esters | 95912-87-1 | |||
Fatty acids, C14-22 | 68424-37-3 | 270.4507 | ||
Fatty acids, C12-18, Meesters, sulfonated, sodium salts | 149458-07-1 | |||
Ethyl 4-chloro-5,7-difluoroquinoline-3-carboxylate | 311346-69-7 | C12H8ClF2NO2 | 271.65 | ethyl4-chloro-5,7-difluoroquinoline-3-carboxylate; 311346-69-7; Ethyl4-Chloro-5,7-Difluoro-3-Quinolinecarboxylate; ST50407621; AC1MW5H6; AC1Q32YR |
Ethyl 4-bromobenzoylformate | 20201-26-7 | C10H9BrO3 | 257.08 | BENZENEACETIC ACID, 4-BROMO-A-OXO-, ETHYL ESTER; Ethyl p-bromophenylglyoxylate; ETHYL 4-(BROMOPHENYL)GLYOXALATE; ETHYL 4-BROMOPHENYLGLYOXYLATE; ETHYL 4-BROMOBENZOYL FORMATE; Ethyl 2-(4-bromophenyl)-2-oxoacetate |
Ethyl 4-bromobenzoate D4 | 787624-25-3 | C9H5D4BrO2 | 233.10 | |
Ethyl 3-(bromomethyl)benzoate | 62290-17-9 | C10H11BrO2 | 243.10 | |
Ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate | 161797-99-5 | C13H13NO3S | 263.31 | |
Ethyl 2-(4-hydroxyphenyl)-1,3-oxazole-4-carboxylate | 200400-76-6 | C12H11NO4 | 233.22 | Ethyl 2-(4-hydroxyphenyl)-1,3-oxazole-4-carboxylate |
Ethanol,2-cyclohexylidene- | 932-89-8 | C8H14 O | 126.19616 | |
Ethanol,2,2'-iminobis-, N-C12-18-alkyl derivs. | 71786-60-2 | |||
Etamsylate | 2624-44-4 | C6H6O5S.C4H11N | 263.31 | Etamsylate |
Etamicastat HCl salt | 677773-32-9 | C14H16ClF2N3OS | 347.81 | BIA5-453 HCl salt; BIA-5-453 HCl salt;(R)-5-(2-aminoethyl)-1-(6,8-difluorochroman-3-yl)-1,3-dihydro-2H-imidazole-2-thione hydrochloride |
Etamicastat | 760173-05-5 | C14H15F2N3OS | 311.35 | (R)-5-(2-aminoethyl)-1-(6,8-difluorochroman-3-yl)-1,3-dihydro-2H-imidazole-2-thione;BIA 5-453;677773-32-9 (HCl salt) |
Etalocib | 161172-51-6 | C33H33FO6 | 566.59 | VML 295; PDSP1_001237; PDSP2_001221; LY293111; LY 293111 |
Emamectin Benzoate | 155569-91-8 | C56H81NO15 | 1008.24 | Emamectin benzoate Proclaim Proclaim 5SG 137512-74-4 Denim Methylamino abamectin benzoate 155569-91-8 Shot Wan Denim (pesticide) Sch 58854 MK 244 Emamectin benzoate (salt) Emamectin benzoate [ISO] Shot W |
Emamectin B1b | 121424-52-0 | C48H73NO13 | 872.1 | |
Emamectin B1a | 121124-29-6 | C49H75NO13 | 886.1 | L 656748 |
Emamectin | 119791-41-2 | C49H75NO13 | 886.133 | Emamectin B1a |
EM574 | 110480-13-2 | C39H69NO12 | 743.96 | Idremcinal; 8,9-didehydro-N-demethyl-9-deoxo-6-deoxy-6,9-epoxy-N-(1-methylethyl)-erythromycin |
Fatty acids lanolin isopropyl esters | 63393-93-1 | NA | Fatty acids lanolin isopropyl esters; Isopropyl lanolate | |
Fatty acids C18-unsatd dimers polymers with tall-oil fatty acids and triethylenetetramine | 68082-29-1 | 0 | Fatty acids, C18-unsatd., dimers, polymers with tall-oil fatty acids and triethylenetetramine; Dimerfettsure C18, ungesttigt, Polymer mit Talllfettsure und Triethylentetramin, mittlere Molmasse ca. 700 g/mol; POLYAMIDOAMINE); tall oil/ triethylenetetramin | |
Fatty acids | 91050-89-4 | (CH2)nO2 | ||
Fats and Glyceridic oils, fish | 8016-13-5 | 0 | Oils, fish; Fish oil DHA/EPA; Fats and Glyceridic oils, fish; Promega; Oele, Fisch-; Krill oil; Fish oil | |
Fatostatin A hydrobromide | 298197-04-3 | C18H18N2S.HBr | 375.33 | Fatostatin A; 4-[4-(4-Methylphenyl)-2-thiazolyl]-2-propylpyridine hydrobromide; 2-Propyl-4-(4-p-tolyl-thiazol-2-yl)-pyridine |
FAT BROWN RR | 6416-57-5 | C16H14N4 | 262.31 | 1-naphthalenazo-2',4'-diaminobenzene; 3-Benzenediamine,4-(1-naphthalenylazo)-1; 4-(1-naphthalenylazo)-1,3-phenylenediamine; 4-(1-naphthalenylazo)-3-benzenediamine; 4-(1-naphthylazo)-m-phenylenediamin; 4-(1-naphthylazo)-m-phenylenediamine; c.i.solventbrown |
Fasudil Pyridine N-Oxide | 186544-56-9 | C14H17N3O3S | 307.37 | |
Fasudil N-Hydroxy Impurity | 1350827-92-7 | C14H17N3O3S | 307.37 | |
Fasudil Impurity 3 | 166895-80-3 | C14H17N3O2S . HCl | 291.37 36.46 | |
Fasudil Impurity 1 | 1423155-03-6 | C14H17N3O2S | 291.37 | |
Fasudil hydrochloride | 105628-07-7 | C14H18ClN3O2S | 327.83 | Fasudil HCl; Eril; Fasudil (Hydrochloride); Fasudil Monohydrochloride; AT-877; HA-1077; AT 877; HA 1077; AT877; HA1077 |
Fasudil Dimer | 1337967-93-7 | C23H22N4O4S2 | 482.58 | |
Fasudil | 103745-39-7 | C14H17N3O2S | 291.369 | HA-1077; 5-(1,4-diazepan-1-ylsulfonyl)isoquinoline |
Fast Yellow G | 2512-29-0 | C17H16N4O4 | 340.34 | Fast Yellow G; Fast Yellow GG (C.I. Orange 17); Pigment Yellow 1 |
FAST RED VIOLET LB SALT | 32348-81-5 | C14H11Cl2N3O | 308.16 | 5-CHLORO-4-BENZAMIDO-2-METHYLBENZENEDIAZONIUM CHLORIDE, HEMI[ZINC CHLORIDE] SALT; FAST RED VIOLET LB SALT; FAST RED VIOLET SALT LB; CI NO 37160; RED VIOLET LB SALT; FAST RED VIOLET LB SALT DYE CONTENT: 85% |
FAST RED VIOLET LB BASE | 121-22-2 | C14H13ClN2O | 260.72 | CLOTH FAST RED; FAST BORDEAUX 3B; FAST RED VIOLET LB BASE; BENZYL RED 3B; 4'-AMINO-2'-CHLORO-5'-METHYLBENZANILIDE; TIMTEC-BB SBB003087 |
Fast red KL salt | 86780-25-8 | C8H8N3O2 | 213.62 | FAST RED KL SALT; BENZENEDIAZONIUM, 2-(AMINOCARBONYL)-5-METHOXY HEMI[ZINC CHLORIDE] SALT; 2-CARBAMOYL-5-METHOXYBENZENEDIAZONIUM CHLORIDE HEMI(ZINC CHLORIDE) SALT; FAST RED KL SALT PURE; Pure; 2-(Aminocarbonyl)-5-methoxybenzenediazonium; Azoic DC 121; Fast |
Fast Red Al salt | 84195-93-7 | C28H14Cl4N4O4Zn | 677.64 | ANTHRAQUINONE-1-DIAZONIUM CHLORIDE; AZOIC DIAZO COMPONENT 36; FAST RED AL SALT; bis[9,10-dioxoanthracene-1-diazonium] tetrachlorozincate(2-); FAST RED AL SALT C.I. 37275; Bis-(9,10-dioxoanthracene-1-diazonium) tetrachlorozincate; FAST RED AL SALT, PURE |
fast red 3 gl salt | 14263-89-9 | C6H3ClN3O2.1/2ZnCl4 | 391.75 | 4-chloro-2-nitro-benzenediazoniutetrachlorozincate(2-)(2:1); Benzenediazonium,4-chloro-2-nitro-,(T-4)-tetrachlorozincate(2-)(2:1); 4-Chloro-2-nitrobenzenediazonium chloride hemi(zinc chloride) salt; 4-chloro-2-nitrobenzenediazonium tetrachlorozincate (2:1 |
Fast Green FCF | 2353-45-9 | C37H34N2Na2O10S3 | 808.9 | Food green 3; N-ethyl-N-[4-[[4-[ethyl[(3-sulfophenyl)methyl]amino]phenyl](4-hydroxy-2-sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo-benzenemethanaminium, disodium salt |
Fast Blue B | 14263-94-6 | C14H12N4O2.ZnCl4 | 475.49 | FAST BLUE B SALT FOR MICROSCOPY; 1'-biphenyl]-4,4'-bis(diazonium),3,3'-dimethoxy-[(beta-4)-tetrachlorozinc; ate(2-)(1:1); fastbluebsalt(dyecontentca.90%); 3,3-dimethoxybiphenyl-4,4-di(diazonium) zinc chloride; Azoic Diazo No.48 zinc salt; Fast Blue B zin |
Fast blue | 74749-42-1 | C14H12Cl2N4O2 | 339.18 | CI 37235; CI NO 37235; DIAZO BLUE B SALT; DIAZO BLUE B; FAST BLUE SALT B; FAST BLUE; FAST BLUE BASE B; FAST BLUE B FLUOROBORATE |
Fasoracetam | 110958-19-5 | C10H16N2O2 | 196.248 | (5R)-5-(piperidine-1-carbonyl)-2-pyrrolidone; (5R)-5-piperidin-1-ylcarbonylpyrrolidin-2-one |
Fasobegron | 643094-49-9 | C24H24ClNO4 | 425.91 | [1,1'-Biphenyl]-4-carboxylic acid, 4'-[2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]aMino]ethyl]-3-Methoxy-;4-[4-[2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]ethyl]phenyl]-2-methoxybenzoic acid;(R)-4'-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)ethyl) |
Fasitibant chloride hydrochloride | 869880-33-1 | C36H50Cl4N6O6S | 836.71 | MEN 16132; (S)-4-amino-5-(4-(4-((2,4-dichloro-3-(((2,4-dimethylquinolin-8-yl)oxy)methyl)phenyl)sulfonamido)tetrahydro-2H-pyran-4-carbonyl)piperazin-1-yl)-N,N,N-trimethyl-5-oxopentan-1-aminium chloride hydrochloride;1157852-02-2(Fasitibant chloride) |
FAS-IN-1 | 1375105-96-6 | C26H27N3O4S | 477.58 | FAS-IN-1; CHEMBL2147032; SCHEMBL4541971; OGGOWHOQMIINAZ-UHFFFAOYSA-N; BDBM50391837; CS-3932 |
Fasentin | 392721-37-8 | C11H9ClF3NO2 | 279.64 | N-(4-Chloro-3-(trifluoromethyl)phenyl)-3-oxobutanamide |
Fascaplysin chloride | 114719-57-2 | C18H11N2O·Cl | 306.8 | NSC 622398 |
Farrerol 7-O-glucoside | 885044-12-2 | C23H26O10 | 462.45 | (2S)-7-(beta-D-Glucopyranosyloxy)-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-6,8-dimethyl-4H-1-benzopyran-4-one |
Farrerol | 24211-30-1 | C17H16O5 | 300.3 | 6,8-DIMETHYL-4',5,7-TRIHYDROXYFLAVANONE; (S)-2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-dimethyl-4-benzopyrone; 5,7,4'-Trihydroxy-6,8-Dimethoxyflavanone |
Faropenem Related Compound 4 | 106559-80-2 | C15H19NO5S | 325.39 | |
Faropenem Related Compound 3 | 120705-67-1 | C21H33NO5SSi | 439.65 | |
Faropenem Related Compound 2 | 429691-43-0 | C21H33NO7SSi | 471.65 | |
Faropenem Related Compound 1 | 106560-32-1 | C16H29NO4SSi | 359.56 | |
Faropenem potassium | 106559-89-1 | C12H14KNO5S | 323.40 | 4-Thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-7-oxo-3-(tetrahydro-2-furanyl)-, monopotassium salt, (5R-(3(R*),5-alpha,6-alpha(R*)))-;Potassium (1'R,2''R,5R,6S)-6-(1'-hydroxyethyl)-2-(2''-tetrahydrofuranyl)-penem-3-carboxylate; |
Faropenem Impurity Sodium Salt | 195716-77-9 | C12H14NO5S. Na | 284.31 22.99 | |
Faropenem Impurity 7 | 120705-68-2 | C21H33NO5SSi | 439.65 | |
Faropenem Impurity 13 | 613670-77-2 | C8H9NO3S | 199.23 | |
Faropenem daloxate | 141702-36-5 | C17H19NO8S | 397.4 | Faropenem medoxil |
Faropenem | 106560-14-9 | C12H15NO5S | 285.314 | Fropenem; (5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-[(2R)-oxolan-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid |
Farnesylacetic acid | 6040-06-8 | C17H28O2 | 264.40 | (4E,8E)-5,9,13-trimethyltetradeca-4,8,12-trienoic acid; farnesyl acetate; farnesylacetate; farnesylacetic acid; farnesylacetic acid, (E,E)-isomer; Farnesylacetic acid; 23224-49-9; 6040-06-8; farnesylaceticacid; AC1O6SBB; SCHEMBL2573228; ZINC5158552; (4E,8 |
Farnesylacetic acid | 23224-49-9 | C17H28O2 | 264.40 | (4E,8E)-5,9,13-trimethyltetradeca-4,8,12-trienoic acid; farnesyl acetate; farnesylacetate; farnesylacetic acid; farnesylacetic acid, (E,E)-isomer; Farnesylacetic acid; 23224-49-9; 6040-06-8; farnesylaceticacid; AC1O6SBB; SCHEMBL2573228; ZINC5158552; (4E,8 |
Farnesyl Pyrophosphate ammonium salt | 116057-57-9 | C15H25O7P2·3NH4 | 433.4 | FPP; P-[(2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrien-1-yl] ester-diphosphoric acid, triammonium salt; Diphosphoric Acid Mono(3,7,11-trimethyl-2,6,10-dodecatrienyl) Ester |
Farnesyl Diphosphate-d6 (deuterated) | 895550-58-0 | C15H22O7P2D6 | 388.37 | {[hydroxy({[(2E,6E)-11-(D3)methyl-3,7-dimethyl(12,12,12-D3)dodeca-2,6,10-trien-1-yl]oxy})phosphoryl]oxy}phosphonic acid |
Farnesane | 3891-98-3 | C15H32 | 212.42 | 2,6,10-Trimethyldodecane; |